##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 0.2-328-gd3fd603
##SAMPLE=<ID=NA12878_58,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Diseases of the nervous system,DiseaseStatus=affected>
##DESCRIPTION=NA12878_58=Genotype of variant in sample.
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=coding_and_splicing_refseq=Coding and splicing details based on RefSeq (Gene, RefSeq id, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=1000g=Allele frequency in 1000 genomes project.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous counts and hemizygous counts of gnomAD project (genome data).
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=Sift=Sift effect prediction and score for each transcript: D=damaging, T=tolerated.
##DESCRIPTION=PolyPhen=PolyPhen (humVar) effect prediction and score for each transcript: D=probably damaging, P=possibly damaging, B=benign.
##DESCRIPTION=fathmm-MKL=fathmm-MKL score (for coding/non-coding regions). Deleterious threshold > 0.5.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=MaxEntScan=MaxEntScan splicing prediction (reference bases score/alternate bases score).
##DESCRIPTION=GeneSplicer=GeneSplicer splicing prediction (state/type/coordinates/confidence/score).
##DESCRIPTION=dbscSNV=dbscSNV splicing prediction (ADA/RF score).
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=gene_blacklist=The gene(s) are contained on the blacklist of unreliable genes.
##FILTER=off-target=Variant marked as 'off-target'.
#chr	start	end	ref	obs	NA12878_58	filter	quality	gene	variant_type	coding_and_splicing	coding_and_splicing_refseq	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	1000g	gnomAD	gnomAD_hom_hemi	gnomAD_sub	phyloP	Sift	PolyPhen	fathmm-MKL	CADD	REVEL	MaxEntScan	GeneSplicer	dbscSNV	COSMIC	NGSD_hom	NGSD_het	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	866511	866511	-	CCCT	hom	off-target	QUAL=612;DP=21;AF=1.00;MQM=60;SAP=49;ABP=0	SAMD11	intron	SAMD11:ENST00000342066:intron_variant:MODIFIER:intron4/13:c.305+54_305+57dup::	SAMD11:NM_152486.3:intron_variant:MODIFIER:intron4/13:c.305+54_305+57dup::						rs60722469		0.6075	4316,.	0.2536,0.5401,0.4539,0.7002,0.5774					3.26						n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SAMD11 (inh=n/a oe_syn=1.70 oe_mis=1.51 oe_lof=0.90), LINC02593 (inh=n/a oe_syn=1.32 oe_mis=1.22 oe_lof=0.74)
chr1	883899	883899	T	G	het		QUAL=1506;DP=140;AF=0.46;MQM=60;SAP=104;ABP=5	NOC2L	missense	NOC2L:ENST00000327044:missense_variant:MODERATE:exon13/19:c.1528A>C:p.Asn510His:PF03715 [Noc2p family]	NOC2L:NM_015658.4:missense_variant:MODERATE:exon13/19:c.1528A>C:p.Asn510His:						rs72631890	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	7.5420	D(0.02)	P(0.80)	0.99,0.99	24.70	0.28					0	4	0 / 0					SAMD11 (inh=n/a oe_syn=1.70 oe_mis=1.51 oe_lof=0.90), NOC2L (inh=n/a oe_syn=1.60 oe_mis=1.25 oe_lof=1.03)
chr1	1423281	1423281	G	A	het		QUAL=4310;DP=301;AF=0.54;MQM=60;SAP=3;ABP=7	ATAD3B	missense	ATAD3B:ENST00000308647:missense_variant:MODERATE:exon12/16:c.1253G>A:p.Arg418Gln:PF00004 [ATPase family associated with various cellular activities (AAA)]	ATAD3B:NM_001317238.2:missense_variant:MODERATE:exon10/14:c.1115G>A:p.Arg372Gln:,ATAD3B:NM_031921.6:missense_variant:MODERATE:exon12/16:c.1253G>A:p.Arg418Gln:						rs79849353		0.0001	0,.	0.0000,0.0000,0.0001,0.0001,0.0001	6.2700	T(0.10)	P(0.47)	0.95,0.95	16.97	0.35					1	5	0 / 0					ATAD3B (inh=n/a oe_syn=1.33 oe_mis=1.39 oe_lof=1.10)
chr1	9796038	9796038	C	T	het		QUAL=5008;DP=438;AF=0.46;MQM=60;SAP=4;ABP=9	CLSTN1	missense	CLSTN1:ENST00000361311:missense_variant:MODERATE:exon11/18:c.1609G>A:p.Gly537Arg:PF13385 [Concanavalin A-like lectin/glucanases superfamily],CLSTN1:ENST00000377288:missense_variant:MODERATE:exon11/18:c.1582G>A:p.Gly528Arg:PF13385 [Concanavalin A-like lectin/glucanases superfamily],CLSTN1:ENST00000377298:missense_variant:MODERATE:exon12/19:c.1639G>A:p.Gly547Arg:PF13385 [Concanavalin A-like lectin/glucanases superfamily]	CLSTN1:NM_001009566.3:missense_variant:MODERATE:exon12/19:c.1639G>A:p.Gly547Arg:,CLSTN1:NM_001302883.1:missense_variant:MODERATE:exon11/18:c.1582G>A:p.Gly528Arg:,CLSTN1:NM_014944.4:missense_variant:MODERATE:exon11/18:c.1609G>A:p.Gly537Arg:	regulatory_region_variant:open_chromatin_region					rs72633875	0.0002	0.0001		0.0000,0.0000,0.0001,0.0001,0.0001	7.8200	D(0.00),D(0.00),D(0.00)	D(1.00),D(1.00),D(1.00)	0.98,0.98	32.00	0.60		gain/acceptor/9796038-9796039/Medium/6.416053			0	6	0 / 0					CLSTN1 (inh=n/a oe_syn=1.06 oe_mis=0.88 oe_lof=0.17)
chr1	13717050	13717050	C	A	het		QUAL=188;DP=40;AF=0.45;MQM=25;SAP=42;ABP=4	PRAMEF17	missense	PRAMEF17:ENST00000376098:missense_variant:MODERATE:exon2/3:c.537C>A:p.His179Gln:	PRAMEF17:NM_001099851.3:missense_variant:MODERATE:exon2/3:c.537C>A:p.His179Gln:						rs751932173		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.4530	D(0.03)	D(0.99)	0.00,0.06	11.31	0.05					0	4	0 / 0					PRAMEF17 (inh=n/a oe_syn=1.23 oe_mis=1.11 oe_lof=1.70)
chr1	24768616	24768616	G	A	het		QUAL=2610;DP=230;AF=0.45;MQM=60;SAP=3;ABP=8	NIPAL3	5'UTR,synonymous	NIPAL3:ENST00000003912:5_prime_UTR_variant:MODIFIER:exon5/13:c.-13G>A::,NIPAL3:ENST00000339255:synonymous_variant:LOW:exon4/12:c.234G>A:p.Leu78=:PF05653 [Magnesium transporter NIPA],NIPAL3:ENST00000358028:synonymous_variant:LOW:exon4/8:c.234G>A:p.Leu78=:PF05653 [Magnesium transporter NIPA],NIPAL3:ENST00000374399:synonymous_variant:LOW:exon4/12:c.234G>A:p.Leu78=:PF05653 [Magnesium transporter NIPA],NIPAL3:ENST00000428131:synonymous_variant:LOW:exon3/7:c.234G>A:p.Leu78=:PF05653 [Magnesium transporter NIPA]	NIPAL3:NM_001322854.1:synonymous_variant:LOW:exon4/12:c.234G>A:p.Leu78=:,NIPAL3:NM_001322855.1:synonymous_variant:LOW:exon5/13:c.234G>A:p.Leu78=:,NIPAL3:NM_001322856.1:synonymous_variant:LOW:exon5/13:c.234G>A:p.Leu78=:,NIPAL3:NM_001322857.1:synonymous_variant:LOW:exon4/12:c.234G>A:p.Leu78=:,NIPAL3:NM_001322858.1:5_prime_UTR_variant:MODIFIER:exon4/13:c.-400G>A::,NIPAL3:NM_001322859.1:intron_variant:MODIFIER:intron2/9:c.-149-3059G>A::,NIPAL3:NM_001322860.1:intron_variant:MODIFIER:intron2/8:c.-89-7355G>A::,NIPAL3:NM_001322861.1:intron_variant:MODIFIER:intron1/8:c.-149-3059G>A::,NIPAL3:NM_001322862.1:5_prime_UTR_variant:MODIFIER:exon5/13:c.-13G>A::,NIPAL3:NM_001322863.1:5_prime_UTR_variant:MODIFIER:exon4/12:c.-13G>A::,NIPAL3:NM_001322864.1:synonymous_variant:LOW:exon3/11:c.231G>A:p.Leu77=:,NIPAL3:NM_001322865.2:synonymous_variant:LOW:exon4/8:c.234G>A:p.Leu78=:,NIPAL3:NM_001322866.1:synonymous_variant:LOW:exon4/12:c.207G>A:p.Leu69=:,NIPAL3:NM_001322868.1:synonymous_variant:LOW:exon4/10:c.234G>A:p.Leu78=:,NIPAL3:NM_001330409.1:synonymous_variant:LOW:exon5/13:c.234G>A:p.Leu78=:,NIPAL3:NM_020448.5:synonymous_variant:LOW:exon4/12:c.234G>A:p.Leu78=:,NIPAL3:NR_136506.1:non_coding_transcript_exon_variant:MODIFIER:exon4/11:n.646G>A::,NIPAL3:NR_136507.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/5:n.506-7355G>A::,NIPAL3:NR_136508.1:non_coding_transcript_exon_variant:MODIFIER:exon4/11:n.646G>A::						rs72652567	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.6380			0.78,0.97	11.40						0	7	0 / 0					NIPAL3 (inh=n/a oe_syn=1.06 oe_mis=0.88 oe_lof=0.50)
chr1	40218695	40218695	G	A	het		QUAL=3289;DP=239;AF=0.54;MQM=60;SAP=24;ABP=6	PPIE	missense,3'UTR	PPIE:ENST00000324379:missense_variant:MODERATE:exon9/10:c.808G>A:p.Glu270Lys:PF00160 [Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD],PPIE:ENST00000356511:missense_variant:MODERATE:exon9/10:c.808G>A:p.Glu270Lys:PF00160 [Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD],PPIE:ENST00000372830:missense_variant:MODERATE:exon9/11:c.808G>A:p.Glu270Lys:PF00160 [Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD],PPIE:ENST00000470213:3_prime_UTR_variant:MODIFIER:exon8/8:c.*57G>A::	PPIE:NM_001195007.1:missense_variant:MODERATE:exon9/11:c.808G>A:p.Glu270Lys:,PPIE:NM_001319293.1:missense_variant:MODERATE:exon9/10:c.769G>A:p.Glu257Lys:,PPIE:NM_006112.4:missense_variant:MODERATE:exon9/10:c.808G>A:p.Glu270Lys:,PPIE:NM_203456.2:missense_variant:MODERATE:exon9/10:c.808G>A:p.Glu270Lys:,PPIE:NR_036543.1:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.856G>A::,PPIE:NR_036544.1:non_coding_transcript_exon_variant:MODIFIER:exon9/10:n.817G>A::						rs72665281	0.0002	0.0001	0,.	0.0000,0.0002,0.0000,0.0001,0.0001	9.2680	T(0.08),T(0.07),T(0.07), 	B(0.04),B(0.22),B(0.12), 	0.98,0.98	24.50	0.21					0	7	0 / 0					PPIE (inh=n/a oe_syn=0.96 oe_mis=0.74 oe_lof=0.17), BMP8B (inh=n/a oe_syn=0.87 oe_mis=0.86 oe_lof=0.68)
chr1	53370357	53370357	G	T	het		QUAL=1881;DP=144;AF=0.52;MQM=60;SAP=47;ABP=4	ECHDC2	stop_gained	ECHDC2:ENST00000358358:stop_gained:HIGH:exon6/9:c.570C>A:p.Tyr190Ter:PF00378 [Enoyl-CoA hydratase/isomerase],ECHDC2:ENST00000371522:stop_gained:HIGH:exon7/10:c.663C>A:p.Tyr221Ter:PF00378 [Enoyl-CoA hydratase/isomerase],ECHDC2:ENST00000536120:stop_gained:HIGH:exon10/13:c.525C>A:p.Tyr175Ter:PF00378 [Enoyl-CoA hydratase/isomerase]	ECHDC2:NM_001198961.2:stop_gained:HIGH:exon7/10:c.663C>A:p.Tyr221Ter:,ECHDC2:NM_001198962.1:stop_gained:HIGH:exon6/8:c.570C>A:p.Tyr190Ter:,ECHDC2:NM_001319958.2:stop_gained:HIGH:exon7/10:c.432C>A:p.Tyr144Ter:,ECHDC2:NM_018281.4:stop_gained:HIGH:exon6/9:c.570C>A:p.Tyr190Ter:	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant					rs72670819	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	4.6160			0.88,0.93	36.00						0	7	0 / 0					ECHDC2 (inh=n/a oe_syn=1.02 oe_mis=0.98 oe_lof=0.84)
chr1	65684548	65684548	G	C	het		QUAL=1698;DP=148;AF=0.47;MQM=47;SAP=27;ABP=4	AK4	missense	AK4:ENST00000327299:missense_variant:MODERATE:exon3/5:c.377G>C:p.Arg126Pro:PF05191 [Adenylate kinase active site lid],AK4:ENST00000395334:missense_variant:MODERATE:exon4/6:c.377G>C:p.Arg126Pro:PF05191 [Adenylate kinase active site lid],AK4:ENST00000545314:missense_variant:MODERATE:exon4/6:c.377G>C:p.Arg126Pro:PF05191 [Adenylate kinase active site lid],AK4:ENST00000546702:missense_variant:MODERATE:exon3/5:c.221G>C:p.Arg74Pro:PF05191 [Adenylate kinase active site lid]	AK4:NM_001005353.2:missense_variant:MODERATE:exon4/6:c.377G>C:p.Arg126Pro:,AK4:NM_001330616.2:missense_variant:MODERATE:exon3/5:c.221G>C:p.Arg74Pro:,AK4:NM_013410.4:missense_variant:MODERATE:exon3/5:c.377G>C:p.Arg126Pro:,AK4:NM_203464.2:missense_variant:MODERATE:exon4/6:c.377G>C:p.Arg126Pro:						rs199711184	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	7.1870	D(0.00),D(0.00),D(0.00),D(0.00)	D(0.99),D(0.99),D(0.99),D(0.99)	0.98,0.99	28.60	0.91					0	8	0 / 0					AK4 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.30)
chr1	89660991	89660991	C	G	het		QUAL=857;DP=145;AF=0.30;MQM=60;SAP=31;ABP=52	GBP4	missense	GBP4:ENST00000355754:missense_variant:MODERATE:exon3/11:c.352G>C:p.Asp118His:PF02263 [Guanylate-binding protein N-terminal domain]	GBP4:NM_052941.5:missense_variant:MODERATE:exon3/11:c.352G>C:p.Asp118His:	regulatory_region_variant:promoter_flanking_region					rs75750014	0.0002	0.0001		0.0000,0.0000,0.0000,0.0000,0.0001	4.1850	D(0.00)	D(0.98)	0.97,0.99	26.30	0.71					0	4	0 / 0					GBP4 (inh=n/a oe_syn=1.00 oe_mis=0.93 oe_lof=0.89)
chr1	116247826	116247826	T	C	het		QUAL=1563;DP=121;AF=0.52;MQM=60;SAP=25;ABP=3	CASQ2	missense	CASQ2:ENST00000261448:missense_variant:MODERATE:exon9/11:c.926A>G:p.Asp309Gly:PF01216 [Calsequestrin],CASQ2:ENST00000456138:missense_variant:MODERATE:exon7/9:c.713A>G:p.Asp238Gly:PF01216 [Calsequestrin]	CASQ2:NM_001232.3:missense_variant:MODERATE:exon9/11:c.926A>G:p.Asp309Gly:	regulatory_region_variant:promoter_flanking_region	114251 [GENE=CASQ2 PHENOS=Ventricular tachycardia,catecholaminergic polymorphic,2,611938,Autosomal recessive];	292129 [uncertain significance DISEASE=Catecholaminergic polymorphic ventricular tachycardia];			rs72703607	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	7.6910	D(0.03),D(0.04)	P(0.75),P(0.59)	0.98,0.99	29.30	0.75					0	7	0 / 0					CASQ2 (inh=AR+AD oe_syn=1.07 oe_mis=1.04 oe_lof=0.94)
chr1	118537142	118537142	T	C	het		QUAL=832;DP=84;AF=0.42;MQM=60;SAP=25;ABP=8	SPAG17	missense	SPAG17:ENST00000336338:missense_variant:MODERATE:exon35/49:c.5065A>G:p.Ile1689Val:	SPAG17:NM_206996.4:missense_variant:MODERATE:exon35/49:c.5065A>G:p.Ile1689Val:						rs72697565	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	3.1280	T(0.09)	D(0.99)	0.83,0.98	23.90	0.19					0	5	0 / 0					SPAG17 (inh=n/a oe_syn=0.98 oe_mis=0.99 oe_lof=0.50)
chr1	151105076	151105076	G	A	het		QUAL=1384;DP=118;AF=0.47;MQM=60;SAP=6;ABP=4	SEMA6C	missense	SEMA6C:ENST00000341697:missense_variant:MODERATE:exon19/19:c.2677C>T:p.Arg893Trp:	SEMA6C:NM_001178061.2:missense_variant:MODERATE:exon20/20:c.2773C>T:p.Arg925Trp:,SEMA6C:NM_001178062.2:missense_variant:MODERATE:exon19/19:c.2653C>T:p.Arg885Trp:,SEMA6C:NM_030913.5:missense_variant:MODERATE:exon19/19:c.2677C>T:p.Arg893Trp:						rs75585997	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.8160	D(0.00)	D(0.99)	0.80,0.97	29.40	0.24					0	8	0 / 0					SEMA6C (inh=n/a oe_syn=0.96 oe_mis=0.81 oe_lof=0.42)
chr1	158548788	158548788	A	G	het	gene_blacklist	QUAL=1438;DP=121;AF=0.46;MQM=60;SAP=13;ABP=4	OR10X1	missense	OR10X1:ENST00000368150:missense_variant:MODERATE:exon1/1:c.902T>C:p.Ile301Thr:	OR10X1:NM_001004477.1:missense_variant:MODERATE:exon1/1:c.902T>C:p.Ile301Thr:						rs72698782	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	5.8630	D(0.00)	B(0.04)	0.96,0.86	22.70	0.16					0	5	0 / 0					OR10X1 (inh=n/a oe_syn=1.40 oe_mis=1.29 oe_lof=1.08)
chr1	201331068	201331068	A	G	het		QUAL=1796;DP=133;AF=0.53;MQM=60;SAP=39;ABP=4	TNNT2	missense	TNNT2:ENST00000236918:missense_variant:MODERATE:exon12/15:c.677T>C:p.Ile226Thr:PF00992 [Troponin],TNNT2:ENST00000360372:missense_variant:MODERATE:exon11/14:c.647T>C:p.Ile216Thr:PF00992 [Troponin],TNNT2:ENST00000367315:missense_variant:MODERATE:exon11/14:c.653T>C:p.Ile218Thr:PF00992 [Troponin],TNNT2:ENST00000367317:missense_variant:MODERATE:exon12/15:c.662T>C:p.Ile221Thr:PF00992 [Troponin],TNNT2:ENST00000367318:missense_variant:MODERATE:exon13/16:c.662T>C:p.Ile221Thr:PF00992 [Troponin],TNNT2:ENST00000367320:missense_variant:MODERATE:exon12/15:c.563T>C:p.Ile188Thr:PF00992 [Troponin],TNNT2:ENST00000367322:missense_variant:MODERATE:exon12/15:c.653T>C:p.Ile218Thr:PF00992 [Troponin],TNNT2:ENST00000421663:missense_variant:MODERATE:exon12/15:c.671T>C:p.Ile224Thr:PF00992 [Troponin],TNNT2:ENST00000458432:missense_variant:MODERATE:exon13/16:c.689T>C:p.Ile230Thr:PF00992 [Troponin],TNNT2:ENST00000509001:missense_variant:MODERATE:exon13/16:c.662T>C:p.Ile221Thr:PF00992 [Troponin]	TNNT2:NM_000364.4:missense_variant:MODERATE:exon13/16:c.683T>C:p.Ile228Thr:,TNNT2:NM_001001430.3:missense_variant:MODERATE:exon13/16:c.662T>C:p.Ile221Thr:,TNNT2:NM_001001431.3:missense_variant:MODERATE:exon12/15:c.653T>C:p.Ile218Thr:,TNNT2:NM_001001432.3:missense_variant:MODERATE:exon12/15:c.644T>C:p.Ile215Thr:,TNNT2:NM_001276345.2:missense_variant:MODERATE:exon14/17:c.692T>C:p.Ile231Thr:,TNNT2:NM_001276346.2:missense_variant:MODERATE:exon12/15:c.563T>C:p.Ile188Thr:,TNNT2:NM_001276347.2:missense_variant:MODERATE:exon13/16:c.662T>C:p.Ile221Thr:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	191045 [GENE=TNNT2 PHENOS=Cardiomyopathy,familial restrictive,3,612422,Autosomal dominant/Cardiomyopathy,hypertrophic,2,115195,Autosomal dominant/Left ventricular noncompaction 6,601494,Autosomal dominant/Cardiomyopathy,dilated,1D,601494,Autosomal dominant];	181604 [uncertain significance(replaced by megSAP based on classifications:1x1,1x2,7x3) DISEASE=Hypertrophic cardiomyopathy,Left ventricular noncompaction cardiomyopathy,Familial restrictive cardiomyopathy,Left ventricular noncompaction 6,Familial hypertrophic cardiomyopathy 2,Familial restrictive cardiomyopathy 3,not specified,Cardiovascular phenotype,Dilated Cardiomyopathy, Dominant];	CM1310647 [CLASS=DM MUT=ALT PHEN="Cardiomyopathy hypertrophic" GENE=TNNT2];		rs45520032	0.0002	0.0003	0,.	0.0002,0.0003,0.0000,0.0002,0.0000	6.2440	D(0.02),D(0.02),D(0.02),D(0.02),D(0.02),D(0.02),D(0.02),D(0.02),D(0.02),D(0.02)	P(0.76),P(0.91),P(0.87),P(0.91),P(0.91),B(0.44),P(0.87),P(0.81),P(0.88),P(0.91)	0.69,0.96	26.70	0.91					0	7	0 / 1					TNNT2 (inh=AD oe_syn=0.99 oe_mis=0.74 oe_lof=0.37)
chr1	205210827	205210827	C	T	het		QUAL=2654;DP=365;AF=0.33;MQM=60;SAP=11;ABP=93	TMCC2	synonymous	TMCC2:ENST00000358024:synonymous_variant:LOW:exon2/5:c.402C>T:p.Tyr134=:,TMCC2:ENST00000545499:synonymous_variant:LOW:exon2/5:c.168C>T:p.Tyr56=:	TMCC2:NM_001242925.1:synonymous_variant:LOW:exon2/5:c.168C>T:p.Tyr56=:,TMCC2:NM_014858.4:synonymous_variant:LOW:exon2/5:c.402C>T:p.Tyr134=:						rs77588763	0.0002	0.0001	0,.	0.0004,0.0001,0.0000,0.0000,0.0001	-1.2110			0.05,0.94	2.18						0	4	0 / 0					TMCC2 (inh=n/a oe_syn=1.02 oe_mis=0.71 oe_lof=0.24)
chr1	205389653	205389653	C	T	het		QUAL=1285;DP=90;AF=0.56;MQM=60;SAP=32;ABP=5	LEMD1	synonymous	LEMD1:ENST00000367149:synonymous_variant:LOW:exon2/3:c.12G>A:p.Val4=:PF03020 [LEM domain],LEMD1:ENST00000367151:synonymous_variant:LOW:exon2/5:c.12G>A:p.Val4=:PF03020 [LEM domain],LEMD1:ENST00000367152:synonymous_variant:LOW:exon1/4:c.12G>A:p.Val4=:PF03020 [LEM domain],LEMD1:ENST00000367153:synonymous_variant:LOW:exon2/6:c.12G>A:p.Val4=:PF03020 [LEM domain],LEMD1:ENST00000367154:synonymous_variant:LOW:exon2/4:c.12G>A:p.Val4=:PF03020 [LEM domain],LEMD1:ENST00000391936:synonymous_variant:LOW:exon2/4:c.12G>A:p.Val4=:PF03020 [LEM domain]	LEMD1:NM_001001552.5:synonymous_variant:LOW:exon2/4:c.12G>A:p.Val4=:,LEMD1:NM_001199050.2:synonymous_variant:LOW:exon2/6:c.12G>A:p.Val4=:,LEMD1:NM_001199051.2:synonymous_variant:LOW:exon2/5:c.12G>A:p.Val4=:,LEMD1:NM_001199052.2:synonymous_variant:LOW:exon2/3:c.12G>A:p.Val4=:,LEMD1:NR_037583.2:non_coding_transcript_exon_variant:MODIFIER:exon2/4:n.117G>A::						rs72748911	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.0090			0.02,0.23	1.49						0	5	0 / 0					LEMD1 (inh=n/a oe_syn=1.10 oe_mis=0.99 oe_lof=1.08)
chr1	210857261	210857261	C	T	het		QUAL=2838;DP=242;AF=0.46;MQM=60;SAP=25;ABP=6	KCNH1	missense	KCNH1:ENST00000271751:missense_variant:MODERATE:exon11/11:c.2332G>A:p.Ala778Thr:,KCNH1:ENST00000367007:missense_variant:MODERATE:exon11/11:c.2251G>A:p.Ala751Thr:	KCNH1:NM_002238.4:missense_variant:MODERATE:exon11/11:c.2251G>A:p.Ala751Thr:,KCNH1:NM_172362.3:missense_variant:MODERATE:exon11/11:c.2332G>A:p.Ala778Thr:		603305 [GENE=KCNH1 PHENOS=Temple-Baraitser syndrome,611816,Autosomal dominant/Zimmermann-Laband syndrome 1,135500,Autosomal dominant];				rs72751436	0.0006	0.0002	0,.	0.0000,0.0001,0.0000,0.0002,0.0000	0.3130	T(0.61),T(0.60)	B(0.00),B(0.00)	0.12,0.34	13.15	0.16					0	5	0 / 0					KCNH1 (inh=AD oe_syn=0.99 oe_mis=0.55 oe_lof=0.21)
chr1	215844373	215844373	C	T	het		QUAL=1637;DP=137;AF=0.47;MQM=60;SAP=9;ABP=4	USH2A	missense	USH2A:ENST00000307340:missense_variant:MODERATE:exon64/72:c.14074G>A:p.Gly4692Arg:PF00041 [Fibronectin type III domain],USH2A:ENST00000366943:missense_variant:MODERATE:exon64/73:c.14074G>A:p.Gly4692Arg:PF00041 [Fibronectin type III domain]	USH2A:NM_206933.3:missense_variant:MODERATE:exon64/72:c.14074G>A:p.Gly4692Arg:		608400 [GENE=USH2A PHENOS=Retinitis pigmentosa 39,613809/Usher syndrome,type 2A,276901,Autosomal recessive];	48427 [benign/likely benign DISEASE=Usher syndrome, type 2A,Retinitis pigmentosa 39,not specified,not provided]; 560515 [pathogenic DISEASE=Retinitis pigmentosa 39];	CM095516 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2A" GENE=USH2A];		rs45549044	0.0022	0.0047	0,.	0.0015,0.0019,0.0000,0.0079,0.0036	3.4400	D(0.02),D(0.01)	D(0.99),P(0.90)	0.83,0.98	23.90	0.43					2	174	1 / 37					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	226065191	226065191	G	C	het		QUAL=3719;DP=256;AF=0.55;MQM=60;SAP=10;ABP=9	TMEM63A	synonymous	TMEM63A:ENST00000366835:synonymous_variant:LOW:exon3/25:c.90C>G:p.Ser30=:	TMEM63A:NM_014698.3:synonymous_variant:LOW:exon3/25:c.90C>G:p.Ser30=:		618685 [GENE=TMEM63A PHENOS=Leukodystrophy,hypomyelinating,19,transient infantile,618688,Autosomal dominant];				rs72754986	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0001,0.0000	1.3660			0.81,0.92	9.62						0	5	0 / 0					TMEM63A (inh=n/a oe_syn=0.94 oe_mis=0.84 oe_lof=0.60)
chr1	229667404	229667404	C	G	het		QUAL=1943;DP=148;AF=0.51;MQM=60;SAP=4;ABP=3	ABCB10	missense	ABCB10:ENST00000344517:missense_variant:MODERATE:exon7/13:c.1414G>C:p.Glu472Gln:	ABCB10:NM_012089.3:missense_variant:MODERATE:exon7/13:c.1414G>C:p.Glu472Gln:						rs72751738	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0002,0.0000	0.9790	T(0.47)	B(0.01)	0.71,0.93	8.82	0.13					0	9	0 / 0					ABCB10 (inh=n/a oe_syn=1.06 oe_mis=0.79 oe_lof=0.62), RNU4-21P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236154186	236154186	C	T	het		QUAL=1423;DP=100;AF=0.57;MQM=60;SAP=40;ABP=7	NID1	splice_region&synonymous	NID1:ENST00000264187:splice_region_variant&synonymous_variant:LOW:exon14/20:c.2928G>A:p.Pro976=:,NID1:ENST00000366595:splice_region_variant&synonymous_variant:LOW:exon11/17:c.2529G>A:p.Pro843=:	NID1:NM_002508.3:splice_region_variant&synonymous_variant:LOW:exon14/20:c.2928G>A:p.Pro976=:	regulatory_region_variant:promoter_flanking_region					rs72765416	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0001	-0.4620			0.29,0.91	16.70		10.90>8.28		0.476/0.602		0	5	0 / 0					NID1 (inh=n/a oe_syn=1.01 oe_mis=0.95 oe_lof=0.48)
chr2	17697119	17697119	T	A	het		QUAL=1335;DP=96;AF=0.54;MQM=60;SAP=5;ABP=4	RAD51AP2	missense	RAD51AP2:ENST00000399080:missense_variant:MODERATE:exon1/3:c.2564A>T:p.Lys855Met:	RAD51AP2:NM_001099218.3:missense_variant:MODERATE:exon1/3:c.2564A>T:p.Lys855Met:,RAD51AP2:NM_001321233.1:missense_variant:MODERATE:exon5/7:c.2537A>T:p.Lys846Met:						rs72785705	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0003,0.0000	2.7310	D(0.00)	P(0.85)	0.34,0.30	22.30	0.12					1	5	0 / 0					RAD51AP2 (inh=n/a oe_syn=1.05 oe_mis=1.01 oe_lof=0.88)
chr2	29455199	29455199	A	T	het		QUAL=2948;DP=213;AF=0.54;MQM=60;SAP=15;ABP=6	ALK	missense,intron	ALK:ENST00000389048:missense_variant:MODERATE:exon15/29:c.2603T>A:p.Leu868Gln:PF12810 [Glycine rich protein],ALK:ENST00000431873:intron_variant:MODIFIER:intron2/3:c.792-24288T>A::	ALK:NM_004304.5:missense_variant:MODERATE:exon15/29:c.2603T>A:p.Leu868Gln:		105590 [GENE=ALK PHENOS=Neuroblastoma,susceptibility to,3,613014];	335700 [uncertain significance DISEASE=Neuroblastoma 3,Neuroblastoma Susceptibility];			rs55941323	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	4.1670	T(0.16), 	B(0.06), 	0.85,0.96	20.40	0.38					0	9	0 / 0					ALK (inh=AD oe_syn=1.17 oe_mis=1.00 oe_lof=0.32)
chr2	47132627	47132627	G	A	het		QUAL=674;DP=63;AF=0.48;MQM=60;SAP=45;ABP=3	MCFD2,AC016722.4	missense,intron&non_coding_transcript	MCFD2:ENST00000319466:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:PF13499 [EF-hand domain pair],MCFD2:ENST00000409105:missense_variant:MODERATE:exon5/5:c.416C>T:p.Ala139Val:PF13499 [EF-hand domain pair],MCFD2:ENST00000409147:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:PF13499 [EF-hand domain pair],MCFD2:ENST00000409207:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:PF13499 [EF-hand domain pair],MCFD2:ENST00000409218:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:PF13499 [EF-hand domain pair],MCFD2:ENST00000409800:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:PF13499 [EF-hand domain pair],MCFD2:ENST00000409913:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:PF13499 [EF-hand domain pair],MCFD2:ENST00000409973:missense_variant:MODERATE:exon5/5:c.416C>T:p.Ala139Val:PF13499 [EF-hand domain pair],AC016722.4:ENST00000429761:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.41-1396G>A::,MCFD2:ENST00000444761:missense_variant:MODERATE:exon3/3:c.359C>T:p.Ala120Val:PF13499 [EF-hand domain pair]	MCFD2:NM_001171506.2:missense_variant:MODERATE:exon5/5:c.416C>T:p.Ala139Val:,MCFD2:NM_001171507.2:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:,MCFD2:NM_001171508.2:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:,MCFD2:NM_001171509.3:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:,MCFD2:NM_001171510.3:missense_variant:MODERATE:exon3/3:c.260C>T:p.Ala87Val:,MCFD2:NM_001171511.2:missense_variant:MODERATE:exon3/3:c.359C>T:p.Ala120Val:,MCFD2:NM_139279.6:missense_variant:MODERATE:exon4/4:c.416C>T:p.Ala139Val:		607788 [GENE=MCFD2 PHENOS=Factor V and factor VIII,combined deficiency of,613625];	336381 [uncertain significance DISEASE=Combined deficiency of factor V and factor VIII, 1];			rs80294301	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	7.3720	T(0.08),T(0.08),T(0.16),T(0.08),T(0.08),T(0.16),T(0.16),T(0.08), ,T(0.10)	B(0.29),B(0.29),B(0.29),B(0.29),B(0.29),B(0.29),B(0.29),B(0.29), ,B(0.01)	0.96,0.98	24.30	0.59					0	5	0 / 0					MCFD2 (inh=AR oe_syn=1.12 oe_mis=1.18 oe_lof=0.41)
chr2	73676745	73676745	A	G	het		QUAL=2247;DP=169;AF=0.51;MQM=60;SAP=4;ABP=3	ALMS1	missense	ALMS1:ENST00000264448:missense_variant:MODERATE:exon8/23:c.3088A>G:p.Thr1030Ala:,ALMS1:ENST00000377715:missense_variant:MODERATE:exon8/10:c.3088A>G:p.Thr1030Ala:,ALMS1:ENST00000409009:missense_variant:MODERATE:exon7/22:c.2962A>G:p.Thr988Ala:	ALMS1:NM_015120.4:missense_variant:MODERATE:exon8/23:c.3094A>G:p.Thr1032Ala:		606844 [GENE=ALMS1 PHENOS=Alstrom syndrome,203800,Autosomal recessive];				rs72811915	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-3.3610	T(1.00),T(1.00),T(1.00)	B(0.02),B(0.02),B(0.01)	0.00,0.05	0.01	0.06					0	5	0 / 0					ALMS1 (inh=AR oe_syn=1.14 oe_mis=1.19 oe_lof=0.75)
chr2	74733941	74733941	G	A	het		QUAL=1496;DP=137;AF=0.45;MQM=60;SAP=9;ABP=7	PCGF1	synonymous	PCGF1:ENST00000233630:synonymous_variant:LOW:exon3/9:c.270C>T:p.His90=:	PCGF1:NM_032673.3:synonymous_variant:LOW:exon3/9:c.270C>T:p.His90=:	regulatory_region_variant:promoter					rs72818087	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.3510			0.11,0.87	11.94						0	7	0 / 0					LBX2 (inh=n/a oe_syn=0.96 oe_mis=1.04 oe_lof=0.64), LBX2-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), PCGF1 (inh=n/a oe_syn=0.94 oe_mis=0.52 oe_lof=0.00)
chr2	88828779	88828779	T	C	het		QUAL=4786;DP=436;AF=0.44;MQM=60;SAP=3;ABP=19	TEX37	synonymous	TEX37:ENST00000303254:synonymous_variant:LOW:exon4/4:c.330T>C:p.Tyr110=:PF15217 [TSC21 family]	TEX37:NM_152670.3:synonymous_variant:LOW:exon4/4:c.330T>C:p.Tyr110=:						rs72846110	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.5000			0.00,0.10	0.21						0	5	0 / 0					TEX37 (inh=n/a oe_syn=1.14 oe_mis=1.18 oe_lof=1.33)
chr2	131414741	131414741	T	C	het		QUAL=254;DP=41;AF=0.51;MQM=24;SAP=20;ABP=3	POTEJ,AC140481.1	missense,non_coding_transcript_exon	POTEJ:ENST00000409602:missense_variant:MODERATE:exon15/15:c.2408T>C:p.Leu803Pro:PF00022 [Actin],AC140481.1:ENST00000535037:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.170T>C::	POTEJ:NM_001277083.2:missense_variant:MODERATE:exon15/15:c.2408T>C:p.Leu803Pro:						rs574801308	0.0002	0.0001	0,.	0.0000,0.0000,0.0001,0.0001,0.0001	5.4350	D(0.04), 	D(0.91), 	0.52,0.95	21.70	0.66					0	4	0 / 0					POTEJ (inh=n/a oe_syn=1.33 oe_mis=1.36 oe_lof=0.86)
chr2	162890108	162890108	C	G	het		QUAL=1274;DP=95;AF=0.53;MQM=60;SAP=12;ABP=4	DPP4	missense	DPP4:ENST00000360534:missense_variant:MODERATE:exon10/26:c.830G>C:p.Ser277Thr:PF00930 [Dipeptidyl peptidase IV (DPP IV) N-terminal region]	DPP4:NM_001935.4:missense_variant:MODERATE:exon10/26:c.830G>C:p.Ser277Thr:						rs56270378	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-1.5470	T(0.65)	B(0.01)	0.06,0.24	5.02	0.24					0	8	0 / 0					DPP4 (inh=n/a oe_syn=1.00 oe_mis=0.89 oe_lof=0.44)
chr2	170558097	170558097	A	G	het		QUAL=974;DP=89;AF=0.46;MQM=60;SAP=26;ABP=4	KLHL23,PHOSPHO2	intron,missense	KLHL23:ENST00000272797:intron_variant:MODIFIER:intron3/5:c.-3+4056A>G::,PHOSPHO2:ENST00000359744:missense_variant:MODERATE:exon4/4:c.616A>G:p.Lys206Glu:PF06888 [Putative Phosphatase],KLHL23:ENST00000602521:intron_variant:MODIFIER:intron1/2:c.-267+4056A>G::	PHOSPHO2:NM_001008489.4:missense_variant:MODERATE:exon4/4:c.616A>G:p.Lys206Glu:,PHOSPHO2:NM_001199285.1:missense_variant:MODERATE:exon4/4:c.616A>G:p.Lys206Glu:,PHOSPHO2:NM_001199286.1:missense_variant:MODERATE:exon4/4:c.616A>G:p.Lys206Glu:,PHOSPHO2:NM_001199287.1:missense_variant:MODERATE:exon5/5:c.616A>G:p.Lys206Glu:,PHOSPHO2:NM_001199288.1:missense_variant:MODERATE:exon4/4:c.616A>G:p.Lys206Glu:,PHOSPHO2-KLHL23:NM_001199290.3:intron_variant:MODIFIER:intron3/5:c.-3+4056A>G::,PHOSPHO2-KLHL23:NR_144936.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.358+4056A>G::						rs56036676	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	7.7280	 ,T(0.05), 	 ,B(0.19), 	1.00,0.99	23.20	0.10					0	7	0 / 0					PHOSPHO2 (inh=n/a oe_syn=0.76 oe_mis=0.82 oe_lof=0.85), KLHL23 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.36)
chr2	178740622	178740622	A	C	het		QUAL=1070;DP=102;AF=0.44;MQM=60;SAP=9;ABP=6	PDE11A	missense,5'UTR	PDE11A:ENST00000286063:missense_variant:MODERATE:exon5/20:c.1331T>G:p.Leu444Trp:PF01590 [GAF domain],PDE11A:ENST00000358450:missense_variant:MODERATE:exon6/21:c.581T>G:p.Leu194Trp:PF01590 [GAF domain],PDE11A:ENST00000389683:5_prime_UTR_variant:MODIFIER:exon2/17:c.-2T>G::,PDE11A:ENST00000409504:missense_variant:MODERATE:exon4/20:c.257T>G:p.Leu86Trp:PF01590 [GAF domain],PDE11A:ENST00000449286:missense_variant:MODERATE:exon4/19:c.257T>G:p.Leu86Trp:PF01590 [GAF domain]	PDE11A:NM_001077196.2:5_prime_UTR_variant:MODIFIER:exon2/17:c.-2T>G::,PDE11A:NM_001077197.1:missense_variant:MODERATE:exon6/21:c.581T>G:p.Leu194Trp:,PDE11A:NM_001077358.1:missense_variant:MODERATE:exon4/19:c.257T>G:p.Leu86Trp:,PDE11A:NM_016953.4:missense_variant:MODERATE:exon5/20:c.1331T>G:p.Leu444Trp:		604961 [GENE=PDE11A PHENOS=Pigmented nodular adrenocortical disease,primary,2,610475,Autosomal dominant];				rs72948844	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	6.6390	D(0.00),D(0.00), ,D(0.00),D(0.00)	D(1.00),D(0.97), ,D(1.00),D(1.00)	0.99,0.99	28.20	0.53					0	5	0 / 0					PDE11A (inh=AD oe_syn=0.96 oe_mis=1.00 oe_lof=1.11)
chr2	220081475	220081475	C	T	het		QUAL=2780;DP=190;AF=0.56;MQM=60;SAP=3;ABP=9	ABCB6	missense	ABCB6:ENST00000265316:missense_variant:MODERATE:exon3/19:c.767G>A:p.Arg256Gln:,ABCB6:ENST00000439002:missense_variant:MODERATE:exon2/18:c.629G>A:p.Arg210Gln:	ABCB6:NM_001349828.2:missense_variant:MODERATE:exon2/18:c.629G>A:p.Arg210Gln:,ABCB6:NM_005689.4:missense_variant:MODERATE:exon3/19:c.767G>A:p.Arg256Gln:		605452 [GENE=ABCB6 PHENOS=Dyschromatosis universalis hereditaria 3,615402,Autosomal dominant/Microphthalmia,isolated,with coloboma 7,614497,Autosomal dominant/Blood group,Langereis system,111600/Pseudohyperkalemia,familial,2,due to red cell leak,609153,Autosomal dominant];				rs72955421	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0001,0.0000	0.2760	T(0.13),T(0.16)	B(0.01),B(0.06)	0.27,0.91	20.70	0.25					0	5	0 / 0					ABCB6 (inh=AD oe_syn=1.14 oe_mis=1.02 oe_lof=0.74), ATG9A (inh=n/a oe_syn=1.04 oe_mis=0.68 oe_lof=0.16)
chr2	227875202	227875202	A	G	het		QUAL=687;DP=75;AF=0.43;MQM=60;SAP=56;ABP=7	COL4A4	missense	COL4A4:ENST00000329662:missense_variant:MODERATE:exon45/47:c.4340T>C:p.Ile1447Thr:PF01391 [Collagen triple helix repeat (20 copies)],COL4A4:ENST00000396625:missense_variant:MODERATE:exon46/48:c.4349T>C:p.Ile1450Thr:PF01391 [Collagen triple helix repeat (20 copies)]	COL4A4:NM_000092.5:missense_variant:MODERATE:exon46/48:c.4349T>C:p.Ile1450Thr:		120131 [GENE=COL4A4 PHENOS=Alport syndrome 2,autosomal recessive,203780,Autosomal recessive/Hematuria,familial benign,141200,Autosomal dominant];	334705 [likely benign(replaced by megSAP based on classifications:1x1,1x2,1x3) DISEASE=Alport syndrome,not specified,not provided];			rs72969704	0.0002	0.0004	0,.	0.0003,0.0004,0.0004,0.0006,0.0001	-1.0000	T(0.78),T(0.49)	B(0.00),B(0.00)	0.00,0.17	0.33	0.17					0	9	0 / 2					COL4A4 (inh=AR oe_syn=1.08 oe_mis=0.91 oe_lof=0.47)
chr2	234737380	234737380	G	T	het		QUAL=1835;DP=141;AF=0.53;MQM=60;SAP=11;ABP=4	MROH2A	synonymous	MROH2A:ENST00000389758:synonymous_variant:LOW:exon36/42:c.4218G>T:p.Leu1406=:	MROH2A:NM_001367507.1:synonymous_variant:LOW:exon36/42:c.4224G>T:p.Leu1408=:						rs72970235	0.0004	0.0002	0,.	0.0000,0.0003,0.0000,0.0002,0.0000	-2.0140			0.02,0.15	0.82						0	8	0 / 0					MROH2A (inh=n/a oe_syn=0.80 oe_mis=0.80 oe_lof=0.58)
chr3	14862640	14862640	G	A	het		QUAL=2708;DP=206;AF=0.51;MQM=60;SAP=36;ABP=3	FGD5	missense	FGD5:ENST00000285046:missense_variant:MODERATE:exon1/20:c.2062G>A:p.Gly688Arg:,FGD5:ENST00000543601:missense_variant:MODERATE:exon1/19:c.1339G>A:p.Gly447Arg:	FGD5:NM_001320276.1:missense_variant:MODERATE:exon1/19:c.2062G>A:p.Gly688Arg:,FGD5:NM_152536.4:missense_variant:MODERATE:exon1/20:c.2062G>A:p.Gly688Arg:						rs73028180	0.0002	0.0001		0.0000,0.0000,0.0001,0.0001,0.0000	7.1160	D(0.00),D(0.01)	D(1.00),D(1.00)	0.98,0.99	27.20	0.73					0	5	0 / 0					FGD5 (inh=n/a oe_syn=1.02 oe_mis=0.98 oe_lof=0.07)
chr3	38045851	38045851	G	A	het		QUAL=1167;DP=139;AF=0.37;MQM=60;SAP=3;ABP=22	VILL	synonymous	VILL:ENST00000283713:synonymous_variant:LOW:exon16/20:c.1911G>A:p.Leu637=:PF00626 [Gelsolin repeat],VILL:ENST00000383759:synonymous_variant:LOW:exon15/19:c.1911G>A:p.Leu637=:PF00626 [Gelsolin repeat],VILL:ENST00000465644:synonymous_variant:LOW:exon8/12:c.1065G>A:p.Leu355=:PF00626 [Gelsolin repeat]	VILL:NM_001370264.1:synonymous_variant:LOW:exon13/17:c.1401G>A:p.Leu467=:,VILL:NM_001370265.1:synonymous_variant:LOW:exon12/16:c.1302G>A:p.Leu434=:,VILL:NM_015873.3:synonymous_variant:LOW:exon15/19:c.1911G>A:p.Leu637=:,VILL:NR_163266.1:non_coding_transcript_exon_variant:MODIFIER:exon13/17:n.1899G>A::,VILL:NR_163267.1:non_coding_transcript_exon_variant:MODIFIER:exon12/16:n.1800G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs75449732	0.0002				2.4790			0.93,0.94	12.00						0	4	0 / 0					VILL (inh=n/a oe_syn=0.94 oe_mis=0.96 oe_lof=0.84), PLCD1 (inh=AR+AD oe_syn=0.99 oe_mis=0.97 oe_lof=0.83)
chr3	46939588	46939588	G	A	het		QUAL=5766;DP=465;AF=0.48;MQM=60;SAP=7;ABP=5	PTH1R	missense	PTH1R:ENST00000313049:missense_variant:MODERATE:exon5/14:c.449G>A:p.Arg150His:PF02793 [Hormone receptor domain],PTH1R:ENST00000418619:missense_variant:MODERATE:exon7/16:c.449G>A:p.Arg150His:PF02793 [Hormone receptor domain],PTH1R:ENST00000430002:missense_variant:MODERATE:exon6/15:c.449G>A:p.Arg150His:PF02793 [Hormone receptor domain],PTH1R:ENST00000449590:missense_variant:MODERATE:exon7/16:c.449G>A:p.Arg150His:PF02793 [Hormone receptor domain]	PTH1R:NM_000316.3:missense_variant:MODERATE:exon7/16:c.449G>A:p.Arg150His:,PTH1R:NM_001184744.1:missense_variant:MODERATE:exon6/15:c.449G>A:p.Arg150His:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	168468 [GENE=PTH1R PHENOS=Metaphyseal chondrodysplasia,Murk Jansen type,156400,Autosomal dominant/Failure of tooth eruption,primary,125350,Autosomal dominant/Eiken syndrome,600002,Autosomal recessive/Chondrodysplasia,Blomstrand type,215045,Autosomal recessive];				rs73067029	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0001,0.0000	-0.0580	T(0.55),T(0.55),T(0.55),T(0.55)	B(0.01),B(0.01),B(0.01),B(0.01)	0.35,0.95	21.70	0.15					0	9	0 / 0					PTH1R (inh=AR+AD oe_syn=0.99 oe_mis=0.76 oe_lof=0.21)
chr3	53845236	53845236	G	A	het		QUAL=2963;DP=225;AF=0.51;MQM=60;SAP=26;ABP=3	CACNA1D	missense,3'UTR	CACNA1D:ENST00000288139:missense_variant:MODERATE:exon49/49:c.6349G>A:p.Asp2117Asn:,CACNA1D:ENST00000350061:missense_variant:MODERATE:exon48/48:c.6289G>A:p.Asp2097Asn:,CACNA1D:ENST00000422281:missense_variant:MODERATE:exon46/46:c.6217G>A:p.Asp2073Asn:,CACNA1D:ENST00000544977:3_prime_UTR_variant:MODIFIER:exon9/9:c.*386G>A::	CACNA1D:NM_000720.4:missense_variant:MODERATE:exon49/49:c.6349G>A:p.Asp2117Asn:,CACNA1D:NM_001128839.3:missense_variant:MODERATE:exon46/46:c.6217G>A:p.Asp2073Asn:,CACNA1D:NM_001128840.3:missense_variant:MODERATE:exon48/48:c.6289G>A:p.Asp2097Asn:		114206 [GENE=CACNA1D PHENOS=Primary aldosteronism,seizures,and neurologic abnormalities,615474,Autosomal dominant/Sinoatrial node dysfunction and deafness,614896,Autosomal recessive];	504751 [uncertain significance DISEASE=not specified];			rs41276455	0.0004	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	9.7940	D(0.01),D(0.01),D(0.01), 	D(1.00),P(0.67),D(1.00), 	0.98,0.98	32.00	0.34					0	5	0 / 0					CACNA1D (inh=AR+AD oe_syn=1.02 oe_mis=0.64 oe_lof=0.14), CHDH (inh=n/a oe_syn=0.97 oe_mis=0.85 oe_lof=0.56)
chr3	56651167	56651167	A	G	het		QUAL=1156;DP=82;AF=0.55;MQM=60;SAP=14;ABP=5	CCDC66	missense	CCDC66:ENST00000326595:missense_variant:MODERATE:exon14/18:c.1769A>G:p.Asn590Ser:,CCDC66:ENST00000394672:missense_variant:MODERATE:exon14/18:c.1871A>G:p.Asn624Ser:,CCDC66:ENST00000436465:missense_variant:MODERATE:exon14/18:c.1871A>G:p.Asn624Ser:	CCDC66:NM_001012506.5:missense_variant:MODERATE:exon14/18:c.1769A>G:p.Asn590Ser:,CCDC66:NM_001141947.3:missense_variant:MODERATE:exon14/18:c.1871A>G:p.Asn624Ser:,CCDC66:NM_001353147.1:missense_variant:MODERATE:exon14/18:c.1889A>G:p.Asn630Ser:,CCDC66:NM_001353148.1:missense_variant:MODERATE:exon14/18:c.1853A>G:p.Asn618Ser:,CCDC66:NM_001353149.1:missense_variant:MODERATE:exon14/18:c.1850A>G:p.Asn617Ser:,CCDC66:NM_001353150.1:missense_variant:MODERATE:exon14/18:c.1802A>G:p.Asn601Ser:,CCDC66:NM_001353151.1:missense_variant:MODERATE:exon13/17:c.1772A>G:p.Asn591Ser:,CCDC66:NM_001353152.1:missense_variant:MODERATE:exon15/19:c.1769A>G:p.Asn590Ser:,CCDC66:NM_001353153.1:missense_variant:MODERATE:exon14/18:c.1769A>G:p.Asn590Ser:,CCDC66:NM_001353154.1:missense_variant:MODERATE:exon14/18:c.1742A>G:p.Asn581Ser:,CCDC66:NM_001353155.1:missense_variant:MODERATE:exon14/18:c.1721A>G:p.Asn574Ser:,CCDC66:NM_001353156.1:missense_variant:MODERATE:exon15/19:c.974A>G:p.Asn325Ser:,CCDC66:NM_001353158.1:missense_variant:MODERATE:exon16/20:c.845A>G:p.Asn282Ser:,CCDC66:NM_001353160.1:missense_variant:MODERATE:exon15/19:c.779A>G:p.Asn260Ser:,CCDC66:NR_024460.2:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1939A>G::,CCDC66:NR_148366.1:non_coding_transcript_exon_variant:MODIFIER:exon15/19:n.2069A>G::,CCDC66:NR_148367.1:non_coding_transcript_exon_variant:MODIFIER:exon15/19:n.2073A>G::,CCDC66:NR_148368.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1990A>G::,CCDC66:NR_148369.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1941A>G::,CCDC66:NR_148370.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1943A>G::,CCDC66:NR_148371.1:non_coding_transcript_exon_variant:MODIFIER:exon16/20:n.2152A>G::,CCDC66:NR_148372.1:non_coding_transcript_exon_variant:MODIFIER:exon16/20:n.2125A>G::,CCDC66:NR_148373.1:non_coding_transcript_exon_variant:MODIFIER:exon16/20:n.2140A>G::,CCDC66:NR_148374.1:non_coding_transcript_exon_variant:MODIFIER:exon16/20:n.2142A>G::,CCDC66:NR_148375.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.2009A>G::,CCDC66:NR_148376.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.2022A>G::,CCDC66:NR_148377.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1971A>G::,CCDC66:NR_148378.1:non_coding_transcript_exon_variant:MODIFIER:exon13/17:n.1840A>G::						rs73083704	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.8010	T(0.53),T(0.55),T(0.55)	B(0.01),B(0.01),B(0.01)	0.04,0.18	7.06	0.03					0	7	0 / 0					CCDC66 (inh=n/a oe_syn=1.05 oe_mis=1.14 oe_lof=0.97), TASOR (inh=n/a oe_syn=0.99 oe_mis=0.78 oe_lof=0.16)
chr3	126730873	126730873	G	A	het		QUAL=2621;DP=170;AF=0.58;MQM=60;SAP=4;ABP=12	PLXNA1	missense	PLXNA1:ENST00000251772:missense_variant:MODERATE:exon9/31:c.2116G>A:p.Ala706Thr:,PLXNA1:ENST00000393409:missense_variant:MODERATE:exon9/31:c.2185G>A:p.Ala729Thr:	PLXNA1:NM_032242.3:missense_variant:MODERATE:exon9/31:c.2185G>A:p.Ala729Thr:						rs78052417	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	9.6520	D(0.02),D(0.02)	D(0.99),D(0.99)	0.96,0.97	23.60	0.35					0	7	0 / 0					PLXNA1 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.17)
chr3	126741108	126741108	G	A	het		QUAL=2438;DP=158;AF=0.58;MQM=60;SAP=8;ABP=12	PLXNA1	missense	PLXNA1:ENST00000251772:missense_variant:MODERATE:exon21/31:c.4150G>A:p.Val1384Met:PF08337 [Plexin cytoplasmic RasGAP domain],PLXNA1:ENST00000393409:missense_variant:MODERATE:exon21/31:c.4219G>A:p.Val1407Met:PF08337 [Plexin cytoplasmic RasGAP domain]	PLXNA1:NM_032242.3:missense_variant:MODERATE:exon21/31:c.4219G>A:p.Val1407Met:						rs73196567	0.0002	0.0001		0.0000,0.0000,0.0002,0.0001,0.0001	6.5230	D(0.00),D(0.00)	D(0.92),D(0.92)	0.93,0.97	25.20	0.30					0	5	0 / 0					PLXNA1 (inh=n/a oe_syn=1.07 oe_mis=0.73 oe_lof=0.17)
chr3	182566330	182566330	G	T	het		QUAL=422;DP=36;AF=0.50;MQM=60;SAP=15;ABP=3	ATP11B	missense	ATP11B:ENST00000323116:missense_variant:MODERATE:exon10/30:c.836G>T:p.Arg279Leu:PF00122 [E1-E2 ATPase]	ATP11B:NM_014616.3:missense_variant:MODERATE:exon10/30:c.836G>T:p.Arg279Leu:						rs73177313	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	9.3100	T(0.17)	P(0.86)	0.99,0.99	26.80	0.73					0	7	0 / 0					ATP11B (inh=n/a oe_syn=0.91 oe_mis=0.79 oe_lof=0.28)
chr3	183882962	183882962	C	G	het		QUAL=774;DP=135;AF=0.30;MQM=60;SAP=3;ABP=52	DVL3,EIF2B5	missense,intron	DVL3:ENST00000313143:missense_variant:MODERATE:exon6/15:c.661C>G:p.Arg221Gly:,DVL3:ENST00000431765:missense_variant:MODERATE:exon6/15:c.661C>G:p.Arg221Gly:,EIF2B5:ENST00000444495:intron_variant:MODIFIER:intron15/15:c.2106+20467C>G::	DVL3:NM_004423.4:missense_variant:MODERATE:exon6/15:c.661C>G:p.Arg221Gly:		603945 [GENE=EIF2B5 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive/Ovarioleukodystrophy,603896,Autosomal recessive],601368 [GENE=DVL3 PHENOS=Robinow syndrome,autosomal dominant 3,616894,Autosomal dominant];				rs76594728	0.0002	0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	2.4530	D(0.00),D(0.00), 	P(0.60),P(0.60), 	0.99,0.98	26.50	0.30					0	3	0 / 0					EIF2B5 (inh=AR oe_syn=0.95 oe_mis=0.89 oe_lof=0.26), DVL3 (inh=AD oe_syn=0.95 oe_mis=0.70 oe_lof=0.22)
chr3	184073238	184073238	G	A	het		QUAL=2485;DP=210;AF=0.46;MQM=60;SAP=4;ABP=6	CLCN2,EIF2B5	missense,intron	CLCN2:ENST00000265593:missense_variant:MODERATE:exon12/24:c.1250C>T:p.Pro417Leu:PF00654 [Voltage gated chloride channel],CLCN2:ENST00000344937:missense_variant:MODERATE:exon12/24:c.1250C>T:p.Pro417Leu:PF00654 [Voltage gated chloride channel],CLCN2:ENST00000423355:missense_variant:MODERATE:exon12/23:c.173C>T:p.Pro58Leu:,CLCN2:ENST00000434054:missense_variant:MODERATE:exon11/23:c.1118C>T:p.Pro373Leu:PF00654 [Voltage gated chloride channel],EIF2B5:ENST00000444495:intron_variant:MODIFIER:intron15/15:c.2106+210743G>A::,CLCN2:ENST00000457512:missense_variant:MODERATE:exon12/23:c.1250C>T:p.Pro417Leu:PF00654 [Voltage gated chloride channel]	CLCN2:NM_001171087.3:missense_variant:MODERATE:exon12/24:c.1250C>T:p.Pro417Leu:,CLCN2:NM_001171088.3:missense_variant:MODERATE:exon11/23:c.1118C>T:p.Pro373Leu:,CLCN2:NM_001171089.3:missense_variant:MODERATE:exon12/23:c.1250C>T:p.Pro417Leu:,CLCN2:NM_004366.6:missense_variant:MODERATE:exon12/24:c.1250C>T:p.Pro417Leu:	regulatory_region_variant:promoter_flanking_region	603945 [GENE=EIF2B5 PHENOS=Leukoencephalopathy with vanishing white matter,603896,Autosomal recessive/Ovarioleukodystrophy,603896,Autosomal recessive],600570 [GENE=CLCN2 PHENOS=Epilepsy,juvenile absence,susceptibility to,2,607628,Autosomal dominant/Epilepsy,idiopathic generalized,susceptibility to,11,607628,Autosomal dominant/Epilepsy,juvenile myoclonic,susceptibility to,8,607628,Autosomal dominant/Leukoencephalopathy with ataxia,615651,Autosomal recessive/Hyperaldosteronism,familial,type II,605635,Autosomal dominant];				rs73189627	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	2.7790	T(0.68),T(0.65),T(0.65),T(0.65), ,T(0.73)	B(0.00),B(0.00),B(0.00),B(0.00), ,B(0.00)	0.46,0.34	13.26	0.16					0	5	0 / 0					EIF2B5 (inh=AR oe_syn=0.95 oe_mis=0.89 oe_lof=0.26), CLCN2 (inh=AR+AD oe_syn=1.08 oe_mis=0.92 oe_lof=0.55)
chr4	2306871	2306871	C	T	het		QUAL=3837;DP=374;AF=0.42;MQM=60;SAP=10;ABP=25	ZFYVE28,RP11-478C1.7	missense,intron&non_coding_transcript	ZFYVE28:ENST00000290974:missense_variant:MODERATE:exon8/13:c.1196G>A:p.Arg399His:,RP11-478C1.7:ENST00000510632:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.263-1747C>T::,ZFYVE28:ENST00000511071:missense_variant:MODERATE:exon7/12:c.1106G>A:p.Arg369His:,ZFYVE28:ENST00000515312:missense_variant:MODERATE:exon8/13:c.986G>A:p.Arg329His:	ZFYVE28:NM_001172656.2:missense_variant:MODERATE:exon7/12:c.1106G>A:p.Arg369His:,ZFYVE28:NM_001172659.2:missense_variant:MODERATE:exon8/13:c.986G>A:p.Arg329His:,ZFYVE28:NM_020972.3:missense_variant:MODERATE:exon8/13:c.1196G>A:p.Arg399His:						rs73203327	0.0002	0.0001	0,.	0.0002,0.0000,0.0001,0.0001,0.0000	5.3320	D(0.00), ,D(0.00),D(0.00)	D(0.98), ,D(0.99),D(0.98)	0.98,0.99	24.90	0.41					0	6	0 / 0					ZFYVE28 (inh=n/a oe_syn=1.12 oe_mis=1.03 oe_lof=0.26)
chr4	5333004	5333004	C	T	het		QUAL=1368;DP=114;AF=0.47;MQM=60;SAP=3;ABP=4	STK32B	synonymous	STK32B:ENST00000282908:synonymous_variant:LOW:exon4/12:c.318C>T:p.Gly106=:PF00069 [Protein kinase domain],STK32B:ENST00000510398:synonymous_variant:LOW:exon4/12:c.177C>T:p.Gly59=:PF00069 [Protein kinase domain],STK32B:ENST00000512636:synonymous_variant:LOW:exon4/11:c.177C>T:p.Gly59=:PF00069 [Protein kinase domain]	STK32B:NM_001306082.2:synonymous_variant:LOW:exon5/13:c.177C>T:p.Gly59=:,STK32B:NM_001345969.2:synonymous_variant:LOW:exon4/11:c.318C>T:p.Gly106=:,STK32B:NM_018401.3:synonymous_variant:LOW:exon4/12:c.318C>T:p.Gly106=:						rs73211139	0.0002	0.0001	0,.	0.0000,0.0001,0.0001,0.0001,0.0001	-2.2680			0.02,0.25	0.11						0	7	0 / 0					STK32B (inh=n/a oe_syn=1.28 oe_mis=1.18 oe_lof=0.65)
chr4	27019393	27019393	G	A	het		QUAL=2954;DP=202;AF=0.55;MQM=60;SAP=9;ABP=8	STIM2	missense	STIM2:ENST00000237364:missense_variant:MODERATE:exon11/12:c.1811G>A:p.Arg604His:,STIM2:ENST00000382009:missense_variant:MODERATE:exon12/13:c.1835G>A:p.Arg612His:,STIM2:ENST00000412829:missense_variant:MODERATE:exon11/13:c.1811G>A:p.Arg604His:,STIM2:ENST00000465503:missense_variant:MODERATE:exon12/13:c.1574G>A:p.Arg525His:,STIM2:ENST00000467011:missense_variant:MODERATE:exon11/13:c.1550G>A:p.Arg517His:,STIM2:ENST00000467087:missense_variant:MODERATE:exon11/12:c.1550G>A:p.Arg517His:	STIM2:NM_001169117.2:missense_variant:MODERATE:exon11/13:c.1550G>A:p.Arg517His:,STIM2:NM_001169118.2:missense_variant:MODERATE:exon12/13:c.1574G>A:p.Arg525His:,STIM2:NM_020860.4:missense_variant:MODERATE:exon11/12:c.1550G>A:p.Arg517His:						rs73251774	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	7.8700	D(0.00),D(0.00),D(0.00),D(0.01),T(0.05),D(0.01)	D(1.00),D(0.99),D(0.99),D(0.99),D(0.99),D(1.00)	1.00,0.99	28.30	0.47					0	7	0 / 0					STIM2 (inh=n/a oe_syn=1.06 oe_mis=0.82 oe_lof=0.15)
chr4	38775922	38775922	G	T	het		QUAL=1986;DP=184;AF=0.43;MQM=60;SAP=5;ABP=10	TLR10	stop_gained	TLR10:ENST00000308973:stop_gained:HIGH:exon4/4:c.1290C>A:p.Tyr430Ter:,TLR10:ENST00000361424:stop_gained:HIGH:exon2/2:c.1290C>A:p.Tyr430Ter:,TLR10:ENST00000506111:stop_gained:HIGH:exon2/2:c.1290C>A:p.Tyr430Ter:,TLR10:ENST00000508334:stop_gained:HIGH:exon2/2:c.1290C>A:p.Tyr430Ter:	TLR10:NM_001017388.2:stop_gained:HIGH:exon2/2:c.1290C>A:p.Tyr430Ter:,TLR10:NM_001195106.1:stop_gained:HIGH:exon3/3:c.1290C>A:p.Tyr430Ter:,TLR10:NM_001195107.1:stop_gained:HIGH:exon3/3:c.1290C>A:p.Tyr430Ter:,TLR10:NM_001195108.2:stop_gained:HIGH:exon3/3:c.1248C>A:p.Tyr416Ter:,TLR10:NM_030956.4:stop_gained:HIGH:exon4/4:c.1290C>A:p.Tyr430Ter:						rs73236610	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-1.2470			0.15,0.80	36.00						0	8	0 / 0					TLR10 (inh=n/a oe_syn=0.68 oe_mis=0.97 oe_lof=0.68)
chr4	76704004	76704004	T	C	het		QUAL=303;DP=40;AF=0.40;MQM=60;SAP=23;ABP=6	USO1	missense	USO1:ENST00000514213:missense_variant:MODERATE:exon9/24:c.803T>C:p.Met268Thr:,USO1:ENST00000538159:missense_variant:MODERATE:exon9/25:c.854T>C:p.Met285Thr:	USO1:NM_001290049.1:missense_variant:MODERATE:exon10/26:c.860T>C:p.Met287Thr:,USO1:NM_003715.3:missense_variant:MODERATE:exon9/24:c.848T>C:p.Met283Thr:						rs72649496	0.0002	0.0002	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	7.5000	D(0.00),D(0.00)	B(0.34),B(0.17)	0.98,0.99	23.80	0.54					0	7	0 / 1					USO1 (inh=n/a oe_syn=0.91 oe_mis=0.83 oe_lof=0.23)
chr4	100503159	100503159	C	A	het		QUAL=1822;DP=186;AF=0.41;MQM=60;SAP=6;ABP=17	MTTP	missense	MTTP:ENST00000265517:missense_variant:MODERATE:exon2/18:c.159C>A:p.Asp53Glu:PF01347 [Lipoprotein amino terminal region],MTTP:ENST00000422897:missense_variant:MODERATE:exon2/3:c.159C>A:p.Asp53Glu:PF01347 [Lipoprotein amino terminal region],MTTP:ENST00000457717:missense_variant:MODERATE:exon3/19:c.159C>A:p.Asp53Glu:PF01347 [Lipoprotein amino terminal region],MTTP:ENST00000511045:missense_variant:MODERATE:exon2/18:c.240C>A:p.Asp80Glu:PF01347 [Lipoprotein amino terminal region]	MTTP:NM_000253.3:missense_variant:MODERATE:exon3/19:c.159C>A:p.Asp53Glu:,MTTP:NM_001300785.1:missense_variant:MODERATE:exon2/18:c.240C>A:p.Asp80Glu:		157147 [GENE=MTTP PHENOS=Abetalipoproteinemia,200100,Autosomal recessive/Metabolic syndrome,protection against,605552,Autosomal dominant];				rs72681995	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.0860	T(0.68),T(0.52),T(0.68),T(0.50)	B(0.01),B(0.02),B(0.01),B(0.01)	0.13,0.53	9.77	0.08					0	7	0 / 0					MTTP (inh=AR oe_syn=0.95 oe_mis=0.87 oe_lof=0.39)
chr4	108552848	108552848	G	A	het		QUAL=819;DP=75;AF=0.45;MQM=60;SAP=9;ABP=4	PAPSS1	missense	PAPSS1:ENST00000265174:missense_variant:MODERATE:exon11/12:c.1675C>T:p.Pro559Ser:PF01747 [ATP-sulfurylase]	PAPSS1:NM_005443.5:missense_variant:MODERATE:exon11/12:c.1675C>T:p.Pro559Ser:						rs72673574	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	9.2970	T(0.11)	D(0.98)	1.00,0.99	25.20	0.46					0	5	0 / 0					PAPSS1 (inh=n/a oe_syn=1.01 oe_mis=0.74 oe_lof=0.53)
chr4	119259448	119259448	C	T	het		QUAL=722;DP=118;AF=0.31;MQM=60;SAP=23;ABP=42	PRSS12	missense	PRSS12:ENST00000296498:missense_variant:MODERATE:exon2/13:c.524G>A:p.Gly175Asp:PF00530 [Scavenger receptor cysteine-rich domain]	PRSS12:NM_003619.4:missense_variant:MODERATE:exon2/13:c.524G>A:p.Gly175Asp:	regulatory_region_variant:enhancer,TF_binding_site_variant	606709 [GENE=PRSS12 PHENOS=Mental retardation,autosomal recessive 1,249500,Autosomal recessive];				rs72677056	0.0002	0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	3.6370	D(0.04)	B(0.11)	0.86,0.94	17.77	0.30					0	4	0 / 0					PRSS12 (inh=AR oe_syn=0.96 oe_mis=0.95 oe_lof=0.96)
chr5	33462017	33462017	A	G	het		QUAL=441;DP=45;AF=0.42;MQM=60;SAP=9;ABP=5	TARS1	missense	TARS1:ENST00000265112:missense_variant:MODERATE:exon15/19:c.1636A>G:p.Ile546Val:,TARS1:ENST00000414361:missense_variant:MODERATE:exon14/18:c.1273A>G:p.Ile425Val:,TARS1:ENST00000455217:missense_variant:MODERATE:exon16/20:c.1735A>G:p.Ile579Val:,TARS1:ENST00000502553:missense_variant:MODERATE:exon16/20:c.1636A>G:p.Ile546Val:,TARS1:ENST00000541634:missense_variant:MODERATE:exon14/18:c.1324A>G:p.Ile442Val:	TARS:NM_001258437.1:missense_variant:MODERATE:exon16/20:c.1636A>G:p.Ile546Val:,TARS:NM_001258438.1:missense_variant:MODERATE:exon16/20:c.1735A>G:p.Ile579Val:,TARS:NM_152295.4:missense_variant:MODERATE:exon15/19:c.1636A>G:p.Ile546Val:,TARS:NR_047676.1:non_coding_transcript_exon_variant:MODIFIER:exon16/20:n.2068A>G::,TARS:NR_047677.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1786A>G::,TARS:NR_047678.1:non_coding_transcript_exon_variant:MODIFIER:exon14/18:n.1756A>G::		187790 [GENE=TARS1 PHENOS=Trichothiodystrophy 7,nonphotosensitive,618546,Autosomal recessive];				rs72737350	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	9.3110	T(0.15),T(0.14),T(0.14),T(0.15),T(0.15)	B(0.03),B(0.05),B(0.06),B(0.03),B(0.11)	0.98,0.98	22.70	0.17					0	6	0 / 0					TARS1 (inh=AR oe_syn=1.03 oe_mis=0.84 oe_lof=0.58)
chr5	41055906	41055906	C	G	het		QUAL=1181;DP=109;AF=0.45;MQM=60;SAP=31;ABP=5	MROH2B	missense,intron	MROH2B:ENST00000399564:missense_variant:MODERATE:exon10/42:c.971G>C:p.Ser324Thr:,MROH2B:ENST00000506092:intron_variant:MODIFIER:intron1/31:c.-130+2259G>C::	MROH2B:NM_173489.5:missense_variant:MODERATE:exon10/42:c.971G>C:p.Ser324Thr:						rs72751673	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.1740	T(0.55), 	B(0.01), 	0.03,0.25	10.23	0.04					0	7	0 / 0					MROH2B (inh=n/a oe_syn=1.07 oe_mis=1.08 oe_lof=0.78)
chr5	54522436	54522436	C	G	het		QUAL=2346;DP=182;AF=0.51;MQM=60;SAP=5;ABP=3	MCIDAS	missense	MCIDAS:ENST00000513312:missense_variant:MODERATE:exon3/7:c.277G>C:p.Ala93Pro:	MCIDAS:NM_001190787.3:missense_variant:MODERATE:exon3/7:c.277G>C:p.Ala93Pro:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	614086 [GENE=MCIDAS PHENOS=Ciliary dyskinesia,primary,42,618695,Autosomal recessive];	454528 [uncertain significance DISEASE=Primary ciliary dyskinesia];			rs115971569		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.0510	T(0.24)	B(0.00)	0.30,0.98	22.60	0.05					0	5	0 / 0					MCIDAS (inh=n/a oe_syn=0.80 oe_mis=0.63 oe_lof=0.41), CCNO (inh=AR oe_syn=1.06 oe_mis=1.03 oe_lof=0.56)
chr5	74675250	74675250	T	C	het		QUAL=1583;DP=110;AF=0.55;MQM=60;SAP=13;ABP=6	CERT1	missense	CERT1:ENST00000261415:missense_variant:MODERATE:exon16/17:c.1718A>G:p.Lys573Arg:PF01852 [START domain],CERT1:ENST00000380494:missense_variant:MODERATE:exon18/19:c.2180A>G:p.Lys727Arg:PF01852 [START domain],CERT1:ENST00000405807:missense_variant:MODERATE:exon17/18:c.1796A>G:p.Lys599Arg:PF01852 [START domain]	COL4A3BP:NM_001130105.1:missense_variant:MODERATE:exon18/19:c.2180A>G:p.Lys727Arg:,COL4A3BP:NM_005713.3:missense_variant:MODERATE:exon17/18:c.1796A>G:p.Lys599Arg:,COL4A3BP:NM_031361.3:missense_variant:MODERATE:exon16/17:c.1718A>G:p.Lys573Arg:		604677 [GENE=CERT1 PHENOS=Mental retardation,autosomal dominant 34,616351,Autosomal dominant];				rs55882089	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	8.0180	D(0.02),T(0.06),D(0.02)	D(1.00),D(1.00),D(1.00)	0.98,0.99	24.80	0.49					0	7	0 / 0					CERT1 (inh=AD oe_syn=1.19 oe_mis=0.67 oe_lof=0.21)
chr5	78340296	78340296	T	G	het		QUAL=1235;DP=108;AF=0.46;MQM=60;SAP=20;ABP=4	DMGDH	synonymous,intron	DMGDH:ENST00000255189:synonymous_variant:LOW:exon6/16:c.825A>C:p.Thr275=:PF01266 [FAD dependent oxidoreductase],DMGDH:ENST00000380311:synonymous_variant:LOW:exon3/12:c.222A>C:p.Thr74=:PF01266 [FAD dependent oxidoreductase],DMGDH:ENST00000540686:intron_variant:MODIFIER:intron2/9:c.54-11065A>C::	DMGDH:NM_013391.3:synonymous_variant:LOW:exon6/16:c.825A>C:p.Thr275=:,DMGDH:NR_104002.2:non_coding_transcript_exon_variant:MODIFIER:exon3/12:n.410A>C::,DMGDH:NR_104003.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/9:n.331-11065A>C::		605849 [GENE=DMGDH PHENOS=Dimethylglycine dehydrogenase deficiency,605850,Autosomal recessive];				rs72764936	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.6040			0.25,0.94	6.55						0	5	0 / 0					DMGDH (inh=AR oe_syn=1.08 oe_mis=0.92 oe_lof=0.90)
chr5	79410358	79410358	C	A	het		QUAL=87;DP=16;AF=0.38;MQM=60;SAP=9;ABP=5	SERINC5	intron,missense	SERINC5:ENST00000507668:intron_variant:MODIFIER:intron11/12:c.1239-901G>T::,SERINC5:ENST00000509193:missense_variant:MODERATE:exon12/14:c.1349G>T:p.Gly450Val:PF13900 [removed],SERINC5:ENST00000512972:intron_variant:MODIFIER:intron12/13:c.*171-910G>T::	SERINC5:NM_001174071.3:intron_variant:MODIFIER:intron11/12:c.1239-910G>T::,SERINC5:NM_178276.7:intron_variant:MODIFIER:intron11/12:c.1239-901G>T::,SERINC5:NR_126060.2:non_coding_transcript_exon_variant:MODIFIER:exon12/14:n.1475G>T::,SERINC5:NR_126061.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/13:n.1551-910G>T::					AluSz (SINE/Alu)	rs1023734599		0.0002	0,.	0.0000,0.0000,0.0000,0.0000,0.0000	-0.6450		 ,D(0.99), 	0.00,0.26	7.08	0.08					1	8	0 / 0					SERINC5 (inh=n/a oe_syn=1.10 oe_mis=0.83 oe_lof=0.48)
chr5	90151630	90151630	C	G	het		QUAL=1523;DP=122;AF=0.48;MQM=60;SAP=11;ABP=3	ADGRV1	missense	ADGRV1:ENST00000405460:missense_variant:MODERATE:exon82/90:c.17667C>G:p.His5889Gln:PF01825 [GPCR proteolysis site GPS motif],ADGRV1:ENST00000425867:missense_variant:MODERATE:exon18/26:c.4650C>G:p.His1550Gln:PF01825 [GPCR proteolysis site GPS motif]	ADGRV1:NM_032119.4:missense_variant:MODERATE:exon82/90:c.17667C>G:p.His5889Gln:,ADGRV1:NR_003149.2:non_coding_transcript_exon_variant:MODIFIER:exon82/90:n.17683C>G::		602851 [GENE=ADGRV1 PHENOS=Usher syndrome,type 2C,605472,Digenic dominant,Autosomal recessive/Febrile seizures,familial,4,604352,Autosomal dominant/Usher syndrome,type 2C,GPR98/PDZD7 digenic,605472,Digenic dominant,Autosomal recessive];				rs56382582	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	3.4710	D(0.00),D(0.00)	P(0.85),P(0.87)	0.81,0.96	25.30	0.73		gain/acceptor/90151629-90151630/Medium/3.413874			0	6	0 / 0					ADGRV1 (inh=AR+AD oe_syn=1.02 oe_mis=1.00 oe_lof=0.44)
chr5	120021916	120021916	A	G	het		QUAL=401;DP=199;AF=0.17;MQM=60;SAP=12;ABP=190	PRR16	missense	PRR16:ENST00000379551:missense_variant:MODERATE:exon3/3:c.358A>G:p.Thr120Ala:PF15252 [Domain of unknown function (DUF4589)],PRR16:ENST00000407149:missense_variant:MODERATE:exon2/2:c.427A>G:p.Thr143Ala:PF15252 [Domain of unknown function (DUF4589)],PRR16:ENST00000446965:missense_variant:MODERATE:exon3/3:c.217A>G:p.Thr73Ala:PF15252 [Domain of unknown function (DUF4589)],PRR16:ENST00000505123:missense_variant:MODERATE:exon4/4:c.217A>G:p.Thr73Ala:PF15252 [Domain of unknown function (DUF4589)]	PRR16:NM_001300783.2:missense_variant:MODERATE:exon2/2:c.427A>G:p.Thr143Ala:,PRR16:NM_001308087.1:missense_variant:MODERATE:exon2/2:c.217A>G:p.Thr73Ala:,PRR16:NM_001308088.1:missense_variant:MODERATE:exon4/4:c.217A>G:p.Thr73Ala:,PRR16:NM_016644.2:missense_variant:MODERATE:exon3/3:c.358A>G:p.Thr120Ala:						rs78018931		0.0001		0.0000,0.0000,0.0001,0.0000,0.0000	-0.3520	T(0.38),T(0.67),T(0.30),T(0.30)	B(0.00),B(0.00),B(0.00),B(0.00)	0.06,0.22	2.60	0.02					0	3	0 / 0					PRR16 (inh=n/a oe_syn=0.82 oe_mis=1.18 oe_lof=0.36)
chr5	131925483	131925483	G	C	het		QUAL=396;DP=38;AF=0.45;MQM=60;SAP=4;ABP=4	RAD50	missense	RAD50:ENST00000265335:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:,RAD50:ENST00000378823:missense_variant:MODERATE:exon9/25:c.989G>C:p.Gly330Ala:	RAD50:NM_005732.4:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala:		604040 [GENE=RAD50 PHENOS=Nijmegen breakage syndrome-like disorder,613078];	216618 [uncertain significance DISEASE=Hereditary cancer-predisposing syndrome];			rs55653181	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	6.3330	T(0.20),T(0.21)	B(0.19),B(0.19)	0.98,0.99	22.60	0.26					0	7	0 / 0					RAD50 (inh=AR oe_syn=1.07 oe_mis=0.86 oe_lof=0.70)
chr5	140215726	140215726	C	G	het		QUAL=4850;DP=401;AF=0.47;MQM=60;SAP=90;ABP=6	PCDHA7,PCDHA1,PCDHA4,PCDHA3,PCDHA2,PCDHA6,PCDHA5	synonymous,intron	PCDHA7:ENST00000378125:synonymous_variant:LOW:exon1/1:c.1758C>G:p.Gly586=:,PCDHA1:ENST00000394633:intron_variant:MODIFIER:intron1/3:c.1602+48249C>G::,PCDHA1:ENST00000504120:intron_variant:MODIFIER:intron1/3:c.2394+47457C>G::,PCDHA4:ENST00000512229:intron_variant:MODIFIER:intron1/4:c.2385+26569C>G::,PCDHA3:ENST00000522353:intron_variant:MODIFIER:intron1/3:c.2394+32550C>G::,PCDHA7:ENST00000525929:synonymous_variant:LOW:exon1/4:c.1758C>G:p.Gly586=:,PCDHA2:ENST00000526136:intron_variant:MODIFIER:intron1/3:c.2388+38789C>G::,PCDHA6:ENST00000527624:intron_variant:MODIFIER:intron1/3:c.1602+6448C>G::,PCDHA6:ENST00000529310:intron_variant:MODIFIER:intron1/3:c.2394+5656C>G::,PCDHA5:ENST00000529619:intron_variant:MODIFIER:intron1/4:c.2352+12014C>G::,PCDHA5:ENST00000529859:intron_variant:MODIFIER:intron1/3:c.2352+12014C>G::,PCDHA4:ENST00000530339:intron_variant:MODIFIER:intron1/3:c.2385+26569C>G::	PCDHA1:NM_018900.3:intron_variant:MODIFIER:intron1/3:c.2394+47457C>G::,PCDHA2:NM_018905.3:intron_variant:MODIFIER:intron1/3:c.2388+38789C>G::,PCDHA3:NM_018906.3:intron_variant:MODIFIER:intron1/3:c.2394+32550C>G::,PCDHA4:NM_018907.4:intron_variant:MODIFIER:intron1/3:c.2385+26569C>G::,PCDHA5:NM_018908.3:intron_variant:MODIFIER:intron1/3:c.2352+12014C>G::,PCDHA6:NM_018909.4:intron_variant:MODIFIER:intron1/3:c.2394+5656C>G::,PCDHA7:NM_018910.3:synonymous_variant:LOW:exon1/4:c.1758C>G:p.Gly586=:,PCDHA1:NM_031411.2:intron_variant:MODIFIER:intron1/3:c.1602+48249C>G::,PCDHA6:NM_031849.3:intron_variant:MODIFIER:intron1/3:c.1602+6448C>G::,PCDHA7:NM_031852.1:synonymous_variant:LOW:exon1/1:c.1758C>G:p.Gly586=:						rs76460920	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-1.2530			0.02,0.20	1.05						0	7	0 / 0					PCDHA1 (inh=n/a oe_syn=1.05 oe_mis=1.04 oe_lof=0.58), PCDHA2 (inh=n/a oe_syn=1.12 oe_mis=1.09 oe_lof=1.13), PCDHA3 (inh=n/a oe_syn=1.12 oe_mis=1.08 oe_lof=0.89), PCDHA4 (inh=n/a oe_syn=1.03 oe_mis=1.09 oe_lof=1.17), PCDHA5 (inh=n/a oe_syn=1.06 oe_mis=1.05 oe_lof=0.58), PCDHA6 (inh=n/a oe_syn=1.19 oe_mis=1.12 oe_lof=0.73), PCDHA7 (inh=n/a oe_syn=1.22 oe_mis=1.14 oe_lof=0.66)
chr5	140531881	140531881	C	T	het		QUAL=1268;DP=190;AF=0.32;MQM=56;SAP=7;ABP=59	PCDHB6	synonymous	PCDHB6:ENST00000231136:synonymous_variant:LOW:exon1/1:c.2043C>T:p.Ala681=:,PCDHB6:ENST00000543635:synonymous_variant:LOW:exon2/2:c.1635C>T:p.Ala545=:	PCDHB6:NM_001303145.2:synonymous_variant:LOW:exon2/2:c.1635C>T:p.Ala545=:,PCDHB6:NM_018939.3:synonymous_variant:LOW:exon1/1:c.2043C>T:p.Ala681=:						rs76203836		0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	-7.0570			0.02,0.18	0.51						0	4	0 / 0					PCDHB6 (inh=n/a oe_syn=1.13 oe_mis=1.16 oe_lof=0.90), PCDHB17P (inh=n/a oe_syn=0.93 oe_mis=0.95 oe_lof=0.67)
chr5	140558786	140558786	C	T	het		QUAL=430;DP=215;AF=0.19;MQM=60;SAP=3;ABP=182	PCDHB8	missense	PCDHB8:ENST00000239444:missense_variant:MODERATE:exon1/1:c.1171C>T:p.Pro391Ser:PF00028 [Cadherin domain]	PCDHB8:NM_019120.5:missense_variant:MODERATE:exon1/1:c.1171C>T:p.Pro391Ser:						rs1191538080		0.0001		0.0000,0.0001,0.0000,0.0000,0.0000	3.3150	D(0.00)	D(0.98)	0.97,0.99	23.10	0.28					0	2	0 / 0					PCDHB7 (inh=n/a oe_syn=1.31 oe_mis=1.34 oe_lof=1.31), PCDHB8 (inh=n/a oe_syn=1.35 oe_mis=1.24 oe_lof=0.73), PCDHB16 (inh=n/a oe_syn=1.22 oe_mis=1.13 oe_lof=0.79)
chr5	150275958	150275958	C	T	het		QUAL=1821;DP=151;AF=0.48;MQM=60;SAP=9;ABP=4	ZNF300	synonymous,3'UTR	ZNF300:ENST00000274599:synonymous_variant:LOW:exon6/6:c.843G>A:p.Lys281=:,ZNF300:ENST00000394226:synonymous_variant:LOW:exon6/6:c.843G>A:p.Lys281=:,ZNF300:ENST00000418587:synonymous_variant:LOW:exon5/5:c.735G>A:p.Lys245=:,ZNF300:ENST00000427179:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1658G>A::,ZNF300:ENST00000446148:synonymous_variant:LOW:exon7/7:c.891G>A:p.Lys297=:	ZNF300:NM_001172831.1:synonymous_variant:LOW:exon7/7:c.891G>A:p.Lys297=:,ZNF300:NM_001172832.1:synonymous_variant:LOW:exon5/5:c.735G>A:p.Lys245=:,IRGM:NM_001346557.2:intron_variant:MODIFIER:intron3/3:c.594-4193C>T::,ZNF300:NM_052860.2:synonymous_variant:LOW:exon6/6:c.843G>A:p.Lys281=:						rs79142878	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-2.4270			0.00,0.15	9.78						0	5	0 / 0					ZNF300 (inh=n/a oe_syn=0.99 oe_mis=0.89 oe_lof=0.50)
chr5	160114898	160114898	C	T	het		QUAL=1896;DP=155;AF=0.48;MQM=60;SAP=7;ABP=3	ATP10B,CTC-529G1.1	missense,intron&non_coding_transcript	ATP10B:ENST00000327245:missense_variant:MODERATE:exon5/26:c.184G>A:p.Val62Ile:,CTC-529G1.1:ENST00000524198:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.105+824C>T::	ATP10B:NM_001366652.1:missense_variant:MODERATE:exon4/25:c.184G>A:p.Val62Ile:,ATP10B:NM_001366653.2:missense_variant:MODERATE:exon4/11:c.184G>A:p.Val62Ile:,ATP10B:NM_001366654.2:missense_variant:MODERATE:exon3/10:c.316G>A:p.Val106Ile:,ATP10B:NM_001366655.1:missense_variant:MODERATE:exon4/25:c.184G>A:p.Val62Ile:,ATP10B:NM_001366656.2:missense_variant:MODERATE:exon4/11:c.184G>A:p.Val62Ile:,ATP10B:NM_001366657.1:missense_variant:MODERATE:exon4/25:c.184G>A:p.Val62Ile:,ATP10B:NM_025153.3:missense_variant:MODERATE:exon5/26:c.184G>A:p.Val62Ile:	regulatory_region_variant:promoter_flanking_region					rs72818544	0.0002	0.0001		0.0001,0.0000,0.0000,0.0001,0.0000	0.1130	T(0.28), 	B(0.00), 	0.14,0.27	10.85	0.04					0	7	0 / 0					ATP10B (inh=n/a oe_syn=1.01 oe_mis=1.01 oe_lof=0.82)
chr5	176734648	176734648	G	A	het		QUAL=3439;DP=302;AF=0.45;MQM=60;SAP=15;ABP=9	MXD3	synonymous,intron,missense	MXD3:ENST00000423571:synonymous_variant:LOW:exon5/5:c.639C>T:p.Cys213=:,MXD3:ENST00000427908:intron_variant:MODIFIER:intron5/5:c.505+134C>T::,MXD3:ENST00000439742:missense_variant:MODERATE:exon6/6:c.562C>T:p.Arg188Trp:,MXD3:ENST00000513063:missense_variant:MODERATE:exon7/7:c.562C>T:p.Arg188Trp:	MXD3:NM_001142935.2:intron_variant:MODIFIER:intron5/5:c.505+134C>T::,MXD3:NM_031300.4:missense_variant:MODERATE:exon6/6:c.562C>T:p.Arg188Trp:	regulatory_region_variant:promoter					rs72813183	0.0002	0.0001		0.0000,0.0000,0.0001,0.0001,0.0000	0.4850	 , ,D(0.04),D(0.04)	 , ,P(0.45),P(0.45)	0.65,0.74	24.00	0.11					0	7	0 / 0					RAB24 (inh=n/a oe_syn=1.12 oe_mis=0.57 oe_lof=0.27), PRELID1 (inh=n/a oe_syn=0.80 oe_mis=0.69 oe_lof=0.29), MXD3 (inh=n/a oe_syn=1.28 oe_mis=0.95 oe_lof=0.58)
chr6	27114461	27114461	G	A	het		QUAL=76;DP=390;AF=0.20;MQM=27;SAP=4;ABP=313	H2BC12	synonymous	H2BC12:ENST00000356950:synonymous_variant:LOW:exon1/1:c.117C>T:p.Ser39=:PF00125 [Core histone H2A/H2B/H3/H4],H2BC12:ENST00000396891:synonymous_variant:LOW:exon1/2:c.117C>T:p.Ser39=:PF00125 [Core histone H2A/H2B/H3/H4]	HIST1H2BK:NM_001312653.1:synonymous_variant:LOW:exon1/1:c.117C>T:p.Ser39=:,HIST1H2BK:NM_080593.2:synonymous_variant:LOW:exon1/2:c.117C>T:p.Ser39=:	regulatory_region_variant:promoter					rs149695889		0.0001		0.0001,0.0000,0.0000,0.0001,0.0000	-0.0490			0.25,0.98	12.52						0	4	0 / 0					H2BC12 (inh=n/a oe_syn=3.10 oe_mis=0.93 oe_lof=2.76), H2AC12 (inh=n/a oe_syn=2.76 oe_mis=1.34 oe_lof=1.71), MIR3143 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr6	27115125	27115127	ACA	-	het		QUAL=1833;DP=283;AF=0.31;MQM=60;SAP=12;ABP=88	H2AC12	inframe_deletion	H2AC12:ENST00000377459:inframe_deletion:MODERATE:exon1/1:c.222_224del:p.Asn74del:PF00125 [Core histone H2A/H2B/H3/H4]	HIST1H2AH:NM_080596.2:inframe_deletion:MODERATE:exon1/1:c.222_224del:p.Asn74del:	regulatory_region_variant:promoter					rs763337646		0.0001		0.0000,0.0000,0.0000,0.0000,0.0001	8.4480				22.20						0	4	0 / 0					H2BC12 (inh=n/a oe_syn=3.10 oe_mis=0.93 oe_lof=2.76), H2AC12 (inh=n/a oe_syn=2.76 oe_mis=1.34 oe_lof=1.71), MIR3143 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr6	31525973	31525973	G	A	het		QUAL=1025;DP=81;AF=0.51;MQM=60;SAP=7;ABP=3	NFKBIL1	missense	NFKBIL1:ENST00000376145:missense_variant:MODERATE:exon4/4:c.686G>A:p.Arg229Gln:,NFKBIL1:ENST00000376148:missense_variant:MODERATE:exon4/4:c.731G>A:p.Arg244Gln:	NFKBIL1:NM_001144961.2:missense_variant:MODERATE:exon4/4:c.686G>A:p.Arg229Gln:,NFKBIL1:NM_001144962.2:missense_variant:MODERATE:exon4/4:c.662G>A:p.Arg221Gln:,NFKBIL1:NM_001144963.2:missense_variant:MODERATE:exon4/4:c.617G>A:p.Arg206Gln:,NFKBIL1:NM_005007.4:missense_variant:MODERATE:exon4/4:c.731G>A:p.Arg244Gln:		601022 [GENE=NFKBIL1 PHENOS=Rheumatoid arthritis,susceptibility to,180300];				rs72847261	0.0004	0.0001	0,.	0.0000,0.0000,0.0001,0.0003,0.0001	2.0010	T(0.31),T(0.27)	B(0.41),B(0.01)	0.77,0.95	22.30	0.14					0	8	0 / 0					NFKBIL1 (inh=n/a oe_syn=0.68 oe_mis=0.57 oe_lof=0.31)
chr6	32170247	32170247	C	T	het		QUAL=1750;DP=122;AF=0.57;MQM=60;SAP=5;ABP=9	NOTCH4	missense	NOTCH4:ENST00000375023:missense_variant:MODERATE:exon21/30:c.3361G>A:p.Gly1121Arg:	NOTCH4:NM_004557.4:missense_variant:MODERATE:exon21/30:c.3361G>A:p.Gly1121Arg:,NOTCH4:NR_134949.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron21/29:n.3473-970G>A::,NOTCH4:NR_134950.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron20/28:n.3371-970G>A::						rs72846312	0.0004	0.0001	0,.	0.0000,0.0000,0.0000,0.0002,0.0000	0.4500	T(0.19)	B(0.12)	0.05,0.37	16.72	0.20					1	9	0 / 0					NOTCH4 (inh=n/a oe_syn=0.82 oe_mis=0.82 oe_lof=0.59)
chr6	41754543	41754543	G	T	het		QUAL=3378;DP=274;AF=0.49;MQM=60;SAP=4;ABP=3	PRICKLE4	synonymous	PRICKLE4:ENST00000394260:synonymous_variant:LOW:exon5/5:c.711G>T:p.Ser237=:,PRICKLE4:ENST00000394263:synonymous_variant:LOW:exon6/6:c.831G>T:p.Ser277=:,PRICKLE4:ENST00000458694:synonymous_variant:LOW:exon8/8:c.831G>T:p.Ser277=:	PRICKLE4:NM_013397.6:synonymous_variant:LOW:exon8/8:c.831G>T:p.Ser277=:	regulatory_region_variant:promoter					rs55796069	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.7190			0.02,0.18	7.23						0	5	0 / 0					PRICKLE4 (inh=n/a oe_syn=0.93 oe_mis=0.93 oe_lof=0.62), TOMM6 (inh=n/a oe_syn=1.18 oe_mis=0.72 oe_lof=0.37), USP49 (inh=n/a oe_syn=0.97 oe_mis=0.64 oe_lof=0.15)
chr6	43143596	43143596	C	T	het		QUAL=4052;DP=369;AF=0.44;MQM=60;SAP=48;ABP=15	SRF	synonymous	SRF:ENST00000265354:synonymous_variant:LOW:exon3/7:c.933C>T:p.Ser311=:,SRF:ENST00000457278:synonymous_variant:LOW:exon3/7:c.321C>T:p.Ser107=:	SRF:NM_001292001.2:synonymous_variant:LOW:exon3/7:c.321C>T:p.Ser107=:,SRF:NM_003131.4:synonymous_variant:LOW:exon3/7:c.933C>T:p.Ser311=:						rs72867556	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	2.6760			0.86,0.96	13.41						0	7	0 / 0					SRF (inh=n/a oe_syn=0.94 oe_mis=0.51 oe_lof=0.06)
chr6	128505804	128505804	A	C	het		QUAL=616;DP=114;AF=0.30;MQM=60;SAP=40;ABP=43	PTPRK	missense	PTPRK:ENST00000368207:missense_variant:MODERATE:exon7/34:c.935T>G:p.Leu312Arg:PF00041 [Fibronectin type III domain],PTPRK:ENST00000368210:missense_variant:MODERATE:exon7/32:c.935T>G:p.Leu312Arg:PF00041 [Fibronectin type III domain],PTPRK:ENST00000368213:missense_variant:MODERATE:exon7/31:c.935T>G:p.Leu312Arg:PF00041 [Fibronectin type III domain],PTPRK:ENST00000368215:missense_variant:MODERATE:exon7/30:c.935T>G:p.Leu312Arg:PF00041 [Fibronectin type III domain],PTPRK:ENST00000368226:missense_variant:MODERATE:exon7/30:c.935T>G:p.Leu312Arg:PF00041 [Fibronectin type III domain],PTPRK:ENST00000368227:missense_variant:MODERATE:exon7/31:c.935T>G:p.Leu312Arg:PF00041 [Fibronectin type III domain],PTPRK:ENST00000532331:missense_variant:MODERATE:exon7/33:c.935T>G:p.Leu312Arg:PF00041 [Fibronectin type III domain]	PTPRK:NM_001135648.3:missense_variant:MODERATE:exon7/31:c.935T>G:p.Leu312Arg:,PTPRK:NM_001291981.2:missense_variant:MODERATE:exon7/33:c.935T>G:p.Leu312Arg:,PTPRK:NM_001291982.2:missense_variant:MODERATE:exon7/19:c.935T>G:p.Leu312Arg:,PTPRK:NM_001291983.2:missense_variant:MODERATE:exon6/19:c.548T>G:p.Leu183Arg:,PTPRK:NM_001291984.2:missense_variant:MODERATE:exon7/30:c.935T>G:p.Leu312Arg:,PTPRK:NM_002844.4:missense_variant:MODERATE:exon7/30:c.935T>G:p.Leu312Arg:						rs76677621	0.0002				7.4800	D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00)	D(0.99),D(0.98),D(0.99),D(0.98),D(0.97),D(0.99),D(0.99)	0.94,0.96	24.10	0.63					0	4	0 / 0					PTPRK (inh=n/a oe_syn=1.02 oe_mis=0.69 oe_lof=0.21)
chr6	131277420	131277420	G	C	het		QUAL=2084;DP=175;AF=0.47;MQM=60;SAP=22;ABP=4	EPB41L2	missense	EPB41L2:ENST00000337057:missense_variant:MODERATE:exon2/20:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000368128:missense_variant:MODERATE:exon2/20:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000392427:missense_variant:MODERATE:exon2/15:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000445890:missense_variant:MODERATE:exon2/17:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000525193:missense_variant:MODERATE:exon1/14:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000525271:missense_variant:MODERATE:exon2/15:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000527411:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000527659:missense_variant:MODERATE:exon1/15:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000528282:missense_variant:MODERATE:exon2/17:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000529208:missense_variant:MODERATE:exon2/17:c.206C>G:p.Ser69Trp:,EPB41L2:ENST00000530481:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:	EPB41L2:NM_001135554.1:missense_variant:MODERATE:exon2/15:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001135555.3:missense_variant:MODERATE:exon2/15:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001199388.2:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001252660.1:missense_variant:MODERATE:exon2/17:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350299.1:missense_variant:MODERATE:exon2/22:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350301.1:missense_variant:MODERATE:exon2/21:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350302.1:missense_variant:MODERATE:exon2/20:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350303.1:missense_variant:MODERATE:exon2/19:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350304.1:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350305.1:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350306.1:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350307.1:missense_variant:MODERATE:exon2/19:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350308.1:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350309.1:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350310.1:missense_variant:MODERATE:exon2/18:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350311.1:missense_variant:MODERATE:exon2/17:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350312.1:missense_variant:MODERATE:exon2/17:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350313.1:missense_variant:MODERATE:exon2/17:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350314.1:missense_variant:MODERATE:exon2/16:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350315.1:missense_variant:MODERATE:exon2/16:c.206C>G:p.Ser69Trp:,EPB41L2:NM_001350320.1:intron_variant:MODIFIER:intron1/15:c.-501-29571C>G::,EPB41L2:NM_001431.4:missense_variant:MODERATE:exon2/20:c.206C>G:p.Ser69Trp:,EPB41L2:NR_146620.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/12:n.169-29571C>G::						rs72983784	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	4.5250	D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00)	D(0.99),D(0.99),D(0.99),D(0.99),D(0.98),D(0.99),D(0.99),D(0.99),D(0.99),D(0.99),D(0.99)	0.74,0.91	26.20	0.45					0	5	0 / 0					EPB41L2 (inh=n/a oe_syn=1.01 oe_mis=0.92 oe_lof=0.16)
chr6	161127501	161127501	A	G	het		QUAL=1621;DP=125;AF=0.51;MQM=60;SAP=4;ABP=3	PLG	missense	PLG:ENST00000308192:missense_variant:MODERATE:exon2/19:c.112A>G:p.Lys38Glu:PF00024 [PAN domain],PLG:ENST00000366924:missense_variant:MODERATE:exon2/4:c.112A>G:p.Lys38Glu:PF00024 [PAN domain]	PLG:NM_000301.3:missense_variant:MODERATE:exon2/19:c.112A>G:p.Lys38Glu:,PLG:NM_001168338.1:missense_variant:MODERATE:exon2/4:c.112A>G:p.Lys38Glu:		173350 [GENE=PLG PHENOS=Dysplasminogenemia,217090,Autosomal recessive/Plasminogen deficiency,type I,217090,Autosomal recessive];	13583 [pathogenic/likely pathogenic DISEASE=Otitis media, susceptibility to,Plasminogen deficiency, type I,not provided];	CM991050 [CLASS=DM MUT=ALT PHEN="Plasminogen deficiency" GENE=PLG];		rs73015965	0.0022	0.0030	0,.	0.0015,0.0028,0.0000,0.0051,0.0001	1.4510	D(0.00),D(0.00)	P(0.66),P(0.66)	0.10,0.27	19.20	0.64					1	56	0 / 12					PLG (inh=AR oe_syn=1.09 oe_mis=0.97 oe_lof=0.28)
chr7	88965159	88965159	T	G	het		QUAL=1322;DP=100;AF=0.51;MQM=60;SAP=3;ABP=3	ZNF804B	missense	ZNF804B:ENST00000333190:missense_variant:MODERATE:exon4/4:c.2863T>G:p.Leu955Val:	ZNF804B:NM_181646.5:missense_variant:MODERATE:exon4/4:c.2863T>G:p.Leu955Val:						rs73210814	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	0.4700	T(1.00)	B(0.00)	0.08,0.23	6.75	0.05					0	5	0 / 0					ZNF804B (inh=n/a oe_syn=1.14 oe_mis=1.08 oe_lof=0.75)
chr7	100634882	100634882	T	G	het	gene_blacklist	QUAL=2887;DP=228;AF=0.49;MQM=60;SAP=5;ABP=3	MUC12	synonymous	MUC12:ENST00000379442:synonymous_variant:LOW:exon5/15:c.1467T>G:p.Pro489=:,MUC12:ENST00000536621:synonymous_variant:LOW:exon2/12:c.1038T>G:p.Pro346=:	MUC12:NM_001164462.1:synonymous_variant:LOW:exon2/12:c.1038T>G:p.Pro346=:						rs73168377		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.3520			0.01,0.07	0.06						0	7	0 / 0					MUC12 (inh=n/a oe_syn=1.31 oe_mis=1.45 oe_lof=1.34)
chr7	100806448	100806448	C	G	het		QUAL=1959;DP=165;AF=0.47;MQM=60;SAP=3;ABP=5	VGF	synonymous	VGF:ENST00000249330:synonymous_variant:LOW:exon2/2:c.1677G>C:p.Ser559=:,VGF:ENST00000445482:synonymous_variant:LOW:exon2/2:c.1677G>C:p.Ser559=:	VGF:NM_003378.4:synonymous_variant:LOW:exon2/2:c.1677G>C:p.Ser559=:	regulatory_region_variant:promoter					rs79302583		0.0004	0,.	0.0000,0.0000,0.0001,0.0007,0.0000	-0.3210			0.10,0.74	10.75						0	10	0 / 2					AP1S1 (inh=AR oe_syn=0.92 oe_mis=0.47 oe_lof=0.33), MIR4653 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), VGF (inh=n/a oe_syn=1.13 oe_mis=0.96 oe_lof=0.19)
chr7	127222318	127222318	T	C	het		QUAL=2942;DP=227;AF=0.49;MQM=60;SAP=14;ABP=3	GCC1	missense	GCC1:ENST00000321407:missense_variant:MODERATE:exon2/2:c.2078A>G:p.Glu693Gly:	GCC1:NM_024523.6:missense_variant:MODERATE:exon2/2:c.2078A>G:p.Glu693Gly:						rs73234845	0.0002	0.0002	0,.	0.0000,0.0000,0.0000,0.0004,0.0000	6.8230	D(0.00)	P(0.86)	0.96,0.97	26.00	0.22					0	9	0 / 1					GCC1 (inh=n/a oe_syn=1.01 oe_mis=0.91 oe_lof=0.51)
chr7	140267004	140267004	C	T	het		QUAL=3798;DP=277;AF=0.52;MQM=60;SAP=37;ABP=4	DENND2A	missense	DENND2A:ENST00000275884:missense_variant:MODERATE:exon8/19:c.1661G>A:p.Arg554Gln:,DENND2A:ENST00000492720:missense_variant:MODERATE:exon8/13:c.1661G>A:p.Arg554Gln:,DENND2A:ENST00000496613:missense_variant:MODERATE:exon9/20:c.1661G>A:p.Arg554Gln:,DENND2A:ENST00000537639:missense_variant:MODERATE:exon7/18:c.1661G>A:p.Arg554Gln:	DENND2A:NM_001318052.1:missense_variant:MODERATE:exon8/19:c.1661G>A:p.Arg554Gln:,DENND2A:NM_001318053.2:missense_variant:MODERATE:exon9/14:c.1661G>A:p.Arg554Gln:,DENND2A:NM_001362678.1:missense_variant:MODERATE:exon9/20:c.1661G>A:p.Arg554Gln:,DENND2A:NM_015689.5:missense_variant:MODERATE:exon9/20:c.1661G>A:p.Arg554Gln:,DENND2A:NR_134477.1:non_coding_transcript_exon_variant:MODIFIER:exon7/18:n.1806G>A::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant					rs73165431	0.0002	0.0007	0,.	0.0001,0.0001,0.0000,0.0005,0.0001	3.6840	T(0.10),T(0.17),T(0.10),T(0.10)	B(0.35),B(0.27),B(0.35),B(0.35)	0.95,0.99	23.70	0.13		gain/acceptor/140267004-140267005/Medium/1.156934			0	10	0 / 1					DENND2A (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.25)
chr7	142242367	142242367	C	T	het		QUAL=1996;DP=158;AF=0.50;MQM=60;SAP=49;ABP=3	TRBV5-3	missense	TRBV5-3:ENST00000390362:missense_variant:MODERATE:exon2/2:c.257G>A:p.Arg86His:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs73162312	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.7430	T(0.23)	B(0.01)	0.00,0.15	2.01						0	10	0 / 2					TRBV9 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), TRBV5-3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), TRBV8-2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), TRBV7-3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr7	149571219	149571219	T	C	het		QUAL=4638;DP=342;AF=0.51;MQM=60;SAP=20;ABP=3	ATP6V0E2,ATP6V0E2-AS1	missense,intron&non_coding_transcript	ATP6V0E2:ENST00000421974:missense_variant:MODERATE:exon1/3:c.212T>C:p.Ile71Thr:PF05493 [ATP synthase subunit H],ATP6V0E2:ENST00000425642:missense_variant:MODERATE:exon1/4:c.65T>C:p.Ile22Thr:PF05493 [ATP synthase subunit H],ATP6V0E2:ENST00000456496:missense_variant:MODERATE:exon1/4:c.212T>C:p.Ile71Thr:PF05493 [ATP synthase subunit H],ATP6V0E2:ENST00000464662:missense_variant:MODERATE:exon1/3:c.65T>C:p.Ile22Thr:PF05493 [ATP synthase subunit H],ATP6V0E2-AS1:ENST00000464939:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.243-2334A>G::,ATP6V0E2:ENST00000479613:missense_variant:MODERATE:exon1/4:c.65T>C:p.Ile22Thr:PF05493 [ATP synthase subunit H],ATP6V0E2:ENST00000606024:missense_variant:MODERATE:exon1/3:c.65T>C:p.Ile22Thr:PF05493 [ATP synthase subunit H]	ATP6V0E2:NM_001100592.2:missense_variant:MODERATE:exon1/3:c.212T>C:p.Ile71Thr:,ATP6V0E2:NM_001289990.1:missense_variant:MODERATE:exon1/4:c.212T>C:p.Ile71Thr:,ATP6V0E2:NM_001367788.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-819T>C::,ATP6V0E2:NM_001367789.1:missense_variant:MODERATE:exon1/4:c.212T>C:p.Ile71Thr:,ATP6V0E2:NM_001367791.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-290T>C::,ATP6V0E2:NM_001367792.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-469T>C::,ATP6V0E2:NM_001367793.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-215T>C::,ATP6V0E2:NM_001367794.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-359T>C::,ATP6V0E2:NM_001367795.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-429T>C::,ATP6V0E2:NM_001367796.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-669T>C::,ATP6V0E2:NM_001367797.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-983T>C::,ATP6V0E2:NM_145230.3:missense_variant:MODERATE:exon1/4:c.212T>C:p.Ile71Thr:,ATP6V0E2:NR_110612.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1163T>C::	regulatory_region_variant:promoter					rs374353845		0.0004	0,.	0.0001,0.0002,0.0000,0.0008,0.0000	2.8510	D(0.01),T(0.19),D(0.03),T(0.19), ,D(0.01),D(0.01)	D(0.99),B(0.09),P(0.77),B(0.09), ,P(0.67),D(0.99)	0.75,0.99	29.70	0.23					0	8	0 / 0					ATP6V0E2-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), ATP6V0E2 (inh=n/a oe_syn=1.16 oe_mis=0.85 oe_lof=0.25)
chr7	150932567	150932567	C	T	het		QUAL=3255;DP=259;AF=0.49;MQM=60;SAP=36;ABP=3	CHPF2	missense	CHPF2:ENST00000035307:missense_variant:MODERATE:exon2/4:c.697C>T:p.Arg233Trp:,CHPF2:ENST00000495645:missense_variant:MODERATE:exon3/5:c.673C>T:p.Arg225Trp:	CHPF2:NM_001284295.2:missense_variant:MODERATE:exon3/5:c.673C>T:p.Arg225Trp:,CHPF2:NM_019015.2:missense_variant:MODERATE:exon2/4:c.697C>T:p.Arg233Trp:						rs56366346	0.0004	0.0001		0.0001,0.0000,0.0002,0.0001,0.0000	6.0680	D(0.00),D(0.00)	D(1.00),D(1.00)	0.97,0.96	31.00	0.45					0	5	0 / 0					CHPF2 (inh=n/a oe_syn=0.99 oe_mis=1.07 oe_lof=0.87), MIR671 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), SMARCD3 (inh=n/a oe_syn=1.05 oe_mis=0.55 oe_lof=0.22)
chr8	10470573	10470573	C	T	het		QUAL=4637;DP=366;AF=0.49;MQM=60;SAP=33;ABP=3	RP1L1	synonymous	RP1L1:ENST00000382483:synonymous_variant:LOW:exon4/4:c.1035G>A:p.Arg345=:	RP1L1:NM_178857.6:synonymous_variant:LOW:exon4/4:c.1035G>A:p.Arg345=:		608581 [GENE=RP1L1 PHENOS=Retinitis pigmentosa 88,618826,Autosomal recessive/Occult macular dystrophy,613587,Autosomal dominant];				rs73201157	0.0008	0.0002	0,.	0.0001,0.0001,0.0000,0.0003,0.0000	0.5260			0.26,0.97	6.15						0	5	0 / 0					RP1L1 (inh=AR+AD oe_syn=1.51 oe_mis=1.77 oe_lof=1.72)
chr8	11703241	11703241	C	G	het		QUAL=2748;DP=251;AF=0.45;MQM=60;SAP=55;ABP=9	CTSB	missense,3'UTR	CTSB:ENST00000345125:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease],CTSB:ENST00000353047:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease],CTSB:ENST00000415599:3_prime_UTR_variant:MODIFIER:exon7/8:c.*399G>C::,CTSB:ENST00000434271:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease],CTSB:ENST00000453527:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease],CTSB:ENST00000530640:missense_variant:MODERATE:exon9/11:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease],CTSB:ENST00000531089:missense_variant:MODERATE:exon10/12:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease],CTSB:ENST00000533455:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease],CTSB:ENST00000534510:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112 [Papain family cysteine protease]	CTSB:NM_001317237.2:missense_variant:MODERATE:exon9/10:c.479G>C:p.Gly160Ala:,CTSB:NM_001908.5:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:,CTSB:NM_147780.4:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:,CTSB:NM_147781.4:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:,CTSB:NM_147782.4:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:,CTSB:NM_147783.4:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region	116810 [GENE=CTSB PHENOS=Keratolytic winter erythema,148370,Autosomal dominant];				rs73209021	0.0004	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	7.2840	D(0.00),D(0.00), ,D(0.00),D(0.00),D(0.00),D(0.00),D(0.00),D(0.00)	D(0.98),D(0.98), ,D(0.98),D(0.98),D(0.98),D(0.98),D(0.98),D(0.98)	0.99,0.98	28.90	0.87					0	5	0 / 0					CTSB (inh=AD oe_syn=2.03 oe_mis=1.65 oe_lof=0.89)
chr8	22145071	22145071	C	T	het		QUAL=1843;DP=152;AF=0.48;MQM=60;SAP=22;ABP=4	PIWIL2	synonymous	PIWIL2:ENST00000356766:synonymous_variant:LOW:exon7/23:c.774C>T:p.Phe258=:,PIWIL2:ENST00000454009:synonymous_variant:LOW:exon7/23:c.774C>T:p.Phe258=:,PIWIL2:ENST00000521356:synonymous_variant:LOW:exon7/22:c.774C>T:p.Phe258=:	PIWIL2:NM_001135721.2:synonymous_variant:LOW:exon7/23:c.774C>T:p.Phe258=:,PIWIL2:NM_001330480.2:synonymous_variant:LOW:exon7/22:c.774C>T:p.Phe258=:,PIWIL2:NM_018068.5:synonymous_variant:LOW:exon7/23:c.774C>T:p.Phe258=:	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant					rs73225895	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	2.0020			0.37,0.92	12.90						0	5	0 / 0					PIWIL2 (inh=n/a oe_syn=1.01 oe_mis=1.01 oe_lof=0.42)
chr8	68334782	68334782	G	A	het		QUAL=1019;DP=69;AF=0.58;MQM=60;SAP=34;ABP=7	CPA6	missense	CPA6:ENST00000297769:missense_variant:MODERATE:exon9/9:c.539C>T:p.Ala180Val:,CPA6:ENST00000297770:missense_variant:MODERATE:exon11/11:c.1271C>T:p.Ala424Val:	CPA6:NM_020361.5:missense_variant:MODERATE:exon11/11:c.1271C>T:p.Ala424Val:,LOC102724708:NR_136224.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.470-19663G>A::		609562 [GENE=CPA6 PHENOS=Febrile seizures,familial,11,614418,Autosomal recessive/Epilepsy,familial temporal lobe,5,614417,Autosomal recessive,Autosomal dominant];	472761 [uncertain significance DISEASE=Febrile seizures, familial, 11];	CM1212272 [CLASS=FP MUT=ALT PHEN="Reduced protein expression" GENE=CPA6];		rs72654981	0.0002	0.0005	0,.	0.0002,0.0001,0.0000,0.0004,0.0001	9.4460	D(0.01),D(0.01)	D(0.99),D(0.99)	0.99,1.00	28.80	0.71					0	10	0 / 0					CPA6 (inh=AR+AD oe_syn=1.00 oe_mis=1.09 oe_lof=0.90)
chr8	75761461	75761461	G	A	het		QUAL=62;DP=92;AF=0.16;MQM=60;SAP=4;ABP=94	PI15,RP11-758M4.4	synonymous,intron&non_coding_transcript	PI15:ENST00000260113:synonymous_variant:LOW:exon6/6:c.750G>A:p.Thr250=:,RP11-758M4.4:ENST00000518128:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.192+17292C>T::,RP11-758M4.4:ENST00000522914:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.190-3273C>T::,PI15:ENST00000523773:synonymous_variant:LOW:exon5/5:c.750G>A:p.Thr250=:,RP11-758M4.4:ENST00000523860:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.178+17292C>T::	PI15:NM_001324403.2:synonymous_variant:LOW:exon6/6:c.750G>A:p.Thr250=:,PI15:NM_015886.5:synonymous_variant:LOW:exon6/6:c.750G>A:p.Thr250=:						rs373126603		0.0001	0,.	0.0000,0.0000,0.0001,0.0001,0.0001	-0.5210			0.05,0.78	8.69						0	3	0 / 0					PI15 (inh=n/a oe_syn=1.03 oe_mis=0.77 oe_lof=0.38)
chr8	102701594	102701594	G	A	het		QUAL=2624;DP=190;AF=0.54;MQM=60;SAP=48;ABP=5	NCALD	synonymous,intron	NCALD:ENST00000220931:synonymous_variant:LOW:exon4/4:c.525C>T:p.Ser175=:,NCALD:ENST00000311028:synonymous_variant:LOW:exon7/7:c.525C>T:p.Ser175=:,NCALD:ENST00000395923:synonymous_variant:LOW:exon6/6:c.525C>T:p.Ser175=:,NCALD:ENST00000519508:synonymous_variant:LOW:exon3/3:c.525C>T:p.Ser175=:,NCALD:ENST00000521599:synonymous_variant:LOW:exon7/7:c.525C>T:p.Ser175=:,NCALD:ENST00000522951:intron_variant:MODIFIER:intron3/3:c.485-207C>T::	NCALD:NM_001040624.1:synonymous_variant:LOW:exon8/8:c.525C>T:p.Ser175=:,NCALD:NM_001040625.1:synonymous_variant:LOW:exon7/7:c.525C>T:p.Ser175=:,NCALD:NM_001040626.1:synonymous_variant:LOW:exon7/7:c.525C>T:p.Ser175=:,NCALD:NM_001040627.1:synonymous_variant:LOW:exon6/6:c.525C>T:p.Ser175=:,NCALD:NM_001040628.1:synonymous_variant:LOW:exon8/8:c.525C>T:p.Ser175=:,NCALD:NM_001040629.1:synonymous_variant:LOW:exon7/7:c.525C>T:p.Ser175=:,NCALD:NM_001040630.1:synonymous_variant:LOW:exon6/6:c.525C>T:p.Ser175=:,NCALD:NM_032041.3:synonymous_variant:LOW:exon4/4:c.525C>T:p.Ser175=:	regulatory_region_variant:promoter_flanking_region					rs72674286	0.0002	0.0001	0,.	0.0001,0.0001,0.0000,0.0001,0.0000	-0.1240			0.47,0.98	10.18						0	7	0 / 0					NCALD (inh=n/a oe_syn=1.03 oe_mis=0.60 oe_lof=0.00)
chr8	139838971	139838971	C	T	het		QUAL=735;DP=75;AF=0.41;MQM=60;SAP=5;ABP=8	COL22A1	missense	COL22A1:ENST00000303045:missense_variant:MODERATE:exon6/65:c.899G>A:p.Arg300Gln:,COL22A1:ENST00000435777:missense_variant:MODERATE:exon6/64:c.899G>A:p.Arg300Gln:	COL22A1:NM_152888.3:missense_variant:MODERATE:exon6/65:c.899G>A:p.Arg300Gln:						rs72731614	0.0002	0.0001	0,.	0.0000,0.0001,0.0001,0.0001,0.0000	4.5150	D(0.03),D(0.04)	P(0.72),B(0.16)	0.77,0.98	26.70	0.16		gain/acceptor/139838971-139838972/Medium/4.061404			0	6	0 / 0					COL22A1 (inh=n/a oe_syn=1.07 oe_mis=1.03 oe_lof=0.77)
chr8	141889589	141889589	G	A	het		QUAL=2239;DP=165;AF=0.53;MQM=60;SAP=41;ABP=4	PTK2	missense	PTK2:ENST00000340930:missense_variant:MODERATE:exon4/33:c.343C>T:p.His115Tyr:,PTK2:ENST00000395218:missense_variant:MODERATE:exon4/33:c.343C>T:p.His115Tyr:,PTK2:ENST00000517887:missense_variant:MODERATE:exon3/31:c.475C>T:p.His159Tyr:,PTK2:ENST00000519419:missense_variant:MODERATE:exon4/32:c.475C>T:p.His159Tyr:,PTK2:ENST00000519881:missense_variant:MODERATE:exon3/3:c.343C>T:p.His115Tyr:,PTK2:ENST00000520892:missense_variant:MODERATE:exon4/4:c.343C>T:p.His115Tyr:,PTK2:ENST00000521059:missense_variant:MODERATE:exon4/32:c.343C>T:p.His115Tyr:,PTK2:ENST00000522684:missense_variant:MODERATE:exon4/32:c.343C>T:p.His115Tyr:,PTK2:ENST00000535192:missense_variant:MODERATE:exon2/29:c.343C>T:p.His115Tyr:	PTK2:NM_001199649.2:missense_variant:MODERATE:exon4/33:c.343C>T:p.His115Tyr:,PTK2:NM_001316342.2:intron_variant:MODIFIER:intron2/32:c.23+11053C>T::,PTK2:NM_001352694.2:missense_variant:MODERATE:exon3/31:c.343C>T:p.His115Tyr:,PTK2:NM_001352695.2:missense_variant:MODERATE:exon4/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352696.2:intron_variant:MODIFIER:intron3/33:c.23+11053C>T::,PTK2:NM_001352697.2:missense_variant:MODERATE:exon6/36:c.475C>T:p.His159Tyr:,PTK2:NM_001352698.2:missense_variant:MODERATE:exon4/36:c.382C>T:p.His128Tyr:,PTK2:NM_001352699.2:missense_variant:MODERATE:exon4/36:c.343C>T:p.His115Tyr:,PTK2:NM_001352700.2:missense_variant:MODERATE:exon3/35:c.343C>T:p.His115Tyr:,PTK2:NM_001352701.2:missense_variant:MODERATE:exon4/36:c.343C>T:p.His115Tyr:,PTK2:NM_001352702.2:missense_variant:MODERATE:exon4/36:c.343C>T:p.His115Tyr:,PTK2:NM_001352703.2:missense_variant:MODERATE:exon4/36:c.343C>T:p.His115Tyr:,PTK2:NM_001352704.2:missense_variant:MODERATE:exon4/35:c.343C>T:p.His115Tyr:,PTK2:NM_001352705.2:missense_variant:MODERATE:exon4/35:c.382C>T:p.His128Tyr:,PTK2:NM_001352706.2:missense_variant:MODERATE:exon3/34:c.343C>T:p.His115Tyr:,PTK2:NM_001352707.2:missense_variant:MODERATE:exon4/35:c.343C>T:p.His115Tyr:,PTK2:NM_001352708.2:missense_variant:MODERATE:exon4/35:c.343C>T:p.His115Tyr:,PTK2:NM_001352709.2:missense_variant:MODERATE:exon4/35:c.343C>T:p.His115Tyr:,PTK2:NM_001352710.2:missense_variant:MODERATE:exon4/35:c.343C>T:p.His115Tyr:,PTK2:NM_001352711.2:missense_variant:MODERATE:exon3/34:c.343C>T:p.His115Tyr:,PTK2:NM_001352712.2:missense_variant:MODERATE:exon5/36:c.343C>T:p.His115Tyr:,PTK2:NM_001352713.2:missense_variant:MODERATE:exon3/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352714.2:missense_variant:MODERATE:exon4/34:c.343C>T:p.His115Tyr:,PTK2:NM_001352715.2:missense_variant:MODERATE:exon3/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352716.2:missense_variant:MODERATE:exon4/35:c.343C>T:p.His115Tyr:,PTK2:NM_001352717.2:missense_variant:MODERATE:exon4/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352718.2:missense_variant:MODERATE:exon4/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352719.2:missense_variant:MODERATE:exon4/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352720.2:missense_variant:MODERATE:exon3/32:c.343C>T:p.His115Tyr:,PTK2:NM_001352721.2:missense_variant:MODERATE:exon3/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352722.2:missense_variant:MODERATE:exon4/34:c.343C>T:p.His115Tyr:,PTK2:NM_001352723.2:missense_variant:MODERATE:exon4/34:c.343C>T:p.His115Tyr:,PTK2:NM_001352724.2:missense_variant:MODERATE:exon4/34:c.343C>T:p.His115Tyr:,PTK2:NM_001352725.2:missense_variant:MODERATE:exon5/33:c.343C>T:p.His115Tyr:,PTK2:NM_001352726.2:missense_variant:MODERATE:exon4/34:c.343C>T:p.His115Tyr:,PTK2:NM_001352727.2:missense_variant:MODERATE:exon3/32:c.343C>T:p.His115Tyr:,PTK2:NM_001352728.2:missense_variant:MODERATE:exon3/30:c.343C>T:p.His115Tyr:,PTK2:NM_001352729.2:missense_variant:MODERATE:exon3/32:c.343C>T:p.His115Tyr:,PTK2:NM_001352730.2:intron_variant:MODIFIER:intron2/33:c.23+11053C>T::,PTK2:NM_001352731.2:intron_variant:MODIFIER:intron3/34:c.23+11053C>T::,PTK2:NM_001352732.2:intron_variant:MODIFIER:intron2/32:c.23+11053C>T::,PTK2:NM_001352733.2:intron_variant:MODIFIER:intron2/32:c.23+11053C>T::,PTK2:NM_001352734.2:intron_variant:MODIFIER:intron2/32:c.23+11053C>T::,PTK2:NM_001352735.2:intron_variant:MODIFIER:intron3/33:c.23+11053C>T::,PTK2:NM_001352736.2:missense_variant:MODERATE:exon4/34:c.40C>T:p.His14Tyr:,PTK2:NM_001352737.2:intron_variant:MODIFIER:intron3/32:c.23+11053C>T::,PTK2:NM_001352738.2:intron_variant:MODIFIER:intron2/32:c.23+11053C>T::,PTK2:NM_001352739.2:intron_variant:MODIFIER:intron3/32:c.23+11053C>T::,PTK2:NM_001352740.2:intron_variant:MODIFIER:intron3/32:c.23+11053C>T::,PTK2:NM_001352741.2:intron_variant:MODIFIER:intron2/30:c.23+11053C>T::,PTK2:NM_001352742.2:intron_variant:MODIFIER:intron2/31:c.23+11053C>T::,PTK2:NM_001352743.2:intron_variant:MODIFIER:intron3/32:c.23+11053C>T::,PTK2:NM_001352744.2:intron_variant:MODIFIER:intron2/31:c.23+11053C>T::,PTK2:NM_001352745.2:intron_variant:MODIFIER:intron2/30:c.23+11053C>T::,PTK2:NM_001352746.2:intron_variant:MODIFIER:intron2/30:c.23+11053C>T::,PTK2:NM_001352747.2:5_prime_UTR_variant:MODIFIER:exon3/34:c.-1297C>T::,PTK2:NM_001352748.2:missense_variant:MODERATE:exon3/19:c.343C>T:p.His115Tyr:,PTK2:NM_005607.5:missense_variant:MODERATE:exon4/32:c.409C>T:p.His137Tyr:,PTK2:NM_153831.4:missense_variant:MODERATE:exon4/32:c.343C>T:p.His115Tyr:,PTK2:NR_148036.2:non_coding_transcript_exon_variant:MODIFIER:exon4/35:n.622C>T::,PTK2:NR_148037.2:non_coding_transcript_exon_variant:MODIFIER:exon5/35:n.737C>T::,PTK2:NR_148038.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/32:n.474+11053C>T::,PTK2:NR_148039.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/31:n.474+11053C>T::						rs72683792	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	9.0060	T(0.19),T(0.19),T(0.15),T(0.15),D(0.00),D(0.00),T(0.18),T(0.18),T(0.17)	D(0.99),P(0.51),B(0.01),B(0.01),B(0.32),B(0.32),B(0.32),B(0.32),B(0.13)	0.99,0.99	25.00	0.49					0	5	0 / 0					PTK2 (inh=n/a oe_syn=1.03 oe_mis=0.60 oe_lof=0.14)
chr9	2096706	2096706	A	T	het		QUAL=573;DP=107;AF=0.29;MQM=60;SAP=6;ABP=44	SMARCA2	missense	SMARCA2:ENST00000349721:missense_variant:MODERATE:exon20/34:c.2933A>T:p.Tyr978Phe:PF00176 [SNF2 family N-terminal domain],SMARCA2:ENST00000357248:missense_variant:MODERATE:exon20/33:c.2933A>T:p.Tyr978Phe:PF00176 [SNF2 family N-terminal domain],SMARCA2:ENST00000382194:missense_variant:MODERATE:exon19/32:c.2933A>T:p.Tyr978Phe:PF00176 [SNF2 family N-terminal domain],SMARCA2:ENST00000382203:missense_variant:MODERATE:exon20/34:c.2933A>T:p.Tyr978Phe:PF00176 [SNF2 family N-terminal domain]	SMARCA2:NM_001289396.1:missense_variant:MODERATE:exon20/34:c.2933A>T:p.Tyr978Phe:,SMARCA2:NM_001289397.2:missense_variant:MODERATE:exon20/33:c.2759A>T:p.Tyr920Phe:,SMARCA2:NM_003070.5:missense_variant:MODERATE:exon20/34:c.2933A>T:p.Tyr978Phe:,SMARCA2:NM_139045.4:missense_variant:MODERATE:exon20/33:c.2933A>T:p.Tyr978Phe:		600014 [GENE=SMARCA2 PHENOS=Nicolaides-Baraitser syndrome,601358,Autosomal dominant];	366215 [likely benign DISEASE=Nicolaides-Baraitser syndrome];			rs78915420	0.0002				9.2830	D(0.01),D(0.02),D(0.02),D(0.01)	D(0.99),D(0.98),D(0.98),D(0.99)	0.97,0.98	28.30	0.93					0	5	0 / 0					SMARCA2 (inh=AD oe_syn=1.29 oe_mis=0.53 oe_lof=0.12)
chr9	116958287	116958287	C	T	het		QUAL=102;DP=222;AF=0.15;MQM=60;SAP=16;ABP=235	COL27A1	stop_gained	COL27A1:ENST00000356083:stop_gained:HIGH:exon7/61:c.2119C>T:p.Arg707Ter:PF01391 [Collagen triple helix repeat (20 copies)]	COL27A1:NM_032888.4:stop_gained:HIGH:exon7/61:c.2119C>T:p.Arg707Ter:		608461 [GENE=COL27A1 PHENOS=Steel syndrome,615155,Autosomal recessive];	559387 [pathogenic DISEASE=Steel syndrome];	CM1711556 [CLASS=DM MUT=ALT PHEN="Steel syndrome" GENE=COL27A1];		rs1401322428					0.5300			0.92,0.97	41.00						0	2	0 / 0					COL27A1 (inh=AR oe_syn=1.07 oe_mis=0.95 oe_lof=0.22)
chr9	124990964	124990964	G	C	het		QUAL=1230;DP=94;AF=0.54;MQM=60;SAP=22;ABP=4	LHX6	missense	LHX6:ENST00000340587:missense_variant:MODERATE:exon1/9:c.56C>G:p.Pro19Arg:,LHX6:ENST00000394319:missense_variant:MODERATE:exon1/10:c.56C>G:p.Pro19Arg:	LHX6:NM_014368.5:missense_variant:MODERATE:exon1/10:c.56C>G:p.Pro19Arg:,LHX6:NM_199160.4:missense_variant:MODERATE:exon1/9:c.56C>G:p.Pro19Arg:	regulatory_region_variant:promoter					rs757424954		0.0001	0,.	0.0000,0.0000,0.0000,0.0000,0.0000	2.8210	T(0.23),T(0.20)	B(0.14),B(0.26)	0.84,0.92	22.60	0.38					0	6	0 / 0					LHX6 (inh=n/a oe_syn=0.87 oe_mis=0.46 oe_lof=0.10)
chr9	131295875	131295875	G	A	het		QUAL=968;DP=76;AF=0.50;MQM=60;SAP=7;ABP=3	GLE1,RP11-216B9.6	missense,intron&non_coding_transcript	GLE1:ENST00000309971:missense_variant:MODERATE:exon10/16:c.1396G>A:p.Val466Ile:PF07817 [GLE1-like protein],GLE1:ENST00000372770:missense_variant:MODERATE:exon10/14:c.1396G>A:p.Val466Ile:PF07817 [GLE1-like protein],RP11-216B9.6:ENST00000434999:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.478+3231C>T::,GLE1:ENST00000539582:missense_variant:MODERATE:exon9/15:c.634G>A:p.Val212Ile:PF07817 [GLE1-like protein]	GLE1:NM_001003722.1:missense_variant:MODERATE:exon10/16:c.1396G>A:p.Val466Ile:,GLE1:NM_001499.2:missense_variant:MODERATE:exon10/14:c.1396G>A:p.Val466Ile:		603371 [GENE=GLE1 PHENOS=Congenital arthrogryposis with anterior horn cell disease,611890,Autosomal recessive/Lethal congenital contracture syndrome 1,253310,Autosomal recessive];				rs72756895	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	2.6790	T(0.14),T(0.14), ,T(0.13)	B(0.09),B(0.06), ,B(0.09)	0.84,0.76	13.37	0.06					0	8	0 / 1					GLE1 (inh=AR oe_syn=0.91 oe_mis=0.88 oe_lof=0.53)
chr9	131475583	131475583	G	C	het		QUAL=3605;DP=277;AF=0.49;MQM=60;SAP=3;ABP=3	PKN3	missense	PKN3:ENST00000291906:missense_variant:MODERATE:exon8/22:c.1009G>C:p.Asp337His:	PKN3:NM_001317926.2:missense_variant:MODERATE:exon8/22:c.1009G>C:p.Asp337His:,PKN3:NM_013355.5:missense_variant:MODERATE:exon8/22:c.1009G>C:p.Asp337His:						rs72758841	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	9.0780	D(0.00)	D(1.00)	0.99,0.99	31.00	0.65					0	7	0 / 0					PKN3 (inh=n/a oe_syn=0.94 oe_mis=0.85 oe_lof=0.72), RN7SL560P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr9	131821485	131821485	G	A	het		QUAL=1694;DP=162;AF=0.43;MQM=60;SAP=8;ABP=11	MIGA2	synonymous,missense	MIGA2:ENST00000277475:synonymous_variant:LOW:exon8/17:c.849G>A:p.Pro283=:,MIGA2:ENST00000358369:missense_variant:MODERATE:exon7/16:c.728G>A:p.Arg243His:PF10265 [Mitoguardin],MIGA2:ENST00000406926:missense_variant:MODERATE:exon7/14:c.728G>A:p.Arg243His:PF10265 [Mitoguardin]	MIGA2:NM_001329990.2:missense_variant:MODERATE:exon7/16:c.728G>A:p.Arg243His:,MIGA2:NM_032809.3:missense_variant:MODERATE:exon7/16:c.920G>A:p.Arg307His:,MIGA2:NR_138421.2:non_coding_transcript_exon_variant:MODIFIER:exon8/17:n.1048G>A::,MIGA2:NR_138422.2:non_coding_transcript_exon_variant:MODIFIER:exon7/14:n.927G>A::,MIGA2:NR_138423.2:non_coding_transcript_exon_variant:MODIFIER:exon7/17:n.927G>A::,MIGA2:NR_138424.2:non_coding_transcript_exon_variant:MODIFIER:exon7/16:n.927G>A::,MIGA2:NR_138425.2:non_coding_transcript_exon_variant:MODIFIER:exon7/16:n.927G>A::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site					rs72760509	0.0002	0.0001	0,.	0.0001,0.0000,0.0001,0.0001,0.0001	6.1760	 ,D(0.00),D(0.00)	 ,D(1.00),D(0.98)	0.92,0.95	28.20	0.29					0	5	0 / 0					MIGA2 (inh=n/a oe_syn=0.99 oe_mis=0.84 oe_lof=0.42)
chr9	139658350	139658350	C	T	het		QUAL=3489;DP=279;AF=0.49;MQM=60;SAP=11;ABP=3	LCN15	missense	LCN15:ENST00000316144:missense_variant:MODERATE:exon2/7:c.208G>A:p.Gly70Ser:PF00061 [Lipocalin / cytosolic fatty-acid binding protein family]	LCN15:NM_203347.2:missense_variant:MODERATE:exon2/7:c.208G>A:p.Gly70Ser:	regulatory_region_variant:promoter_flanking_region					rs72772789	0.0002	0.0001	0,.	0.0000,0.0001,0.0001,0.0001,0.0000	-0.5090	T(0.10)	B(0.04)	0.00,0.15	9.92	0.06					0	7	0 / 0					LCN15 (inh=n/a oe_syn=1.18 oe_mis=0.89 oe_lof=0.54)
chr9	139840596	139840596	G	A	het		QUAL=3253;DP=284;AF=0.45;MQM=60;SAP=28;ABP=9	C8G	missense	C8G:ENST00000224181:missense_variant:MODERATE:exon4/7:c.406G>A:p.Ala136Thr:PF00061 [Lipocalin / cytosolic fatty-acid binding protein family]	C8G:NM_000606.3:missense_variant:MODERATE:exon4/7:c.406G>A:p.Ala136Thr:						rs56188501	0.0008	0.0002	0,.	0.0001,0.0008,0.0000,0.0002,0.0000	2.4990	D(0.04)	D(1.00)	0.63,0.96	24.30	0.24					0	8	0 / 0					FBXW5 (inh=n/a oe_syn=1.44 oe_mis=1.27 oe_lof=1.08), C8G (inh=n/a oe_syn=1.43 oe_mis=1.09 oe_lof=1.54)
chr9	140082546	140082546	G	T	het		QUAL=2551;DP=172;AF=0.57;MQM=60;SAP=94;ABP=10	ANAPC2	synonymous	ANAPC2:ENST00000323927:synonymous_variant:LOW:exon2/13:c.127C>A:p.Arg43=:	ANAPC2:NM_013366.4:synonymous_variant:LOW:exon2/13:c.127C>A:p.Arg43=:	regulatory_region_variant:promoter					rs55750716	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	3.5780			0.60,0.93	13.59						0	5	0 / 0					ANAPC2 (inh=n/a oe_syn=1.20 oe_mis=0.70 oe_lof=0.06), SSNA1 (inh=n/a oe_syn=1.22 oe_mis=1.21 oe_lof=1.05), TPRN (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.40)
chr10	114925491	114925491	C	T	het		QUAL=2012;DP=179;AF=0.45;MQM=60;SAP=5;ABP=7	TCF7L2	3'UTR,synonymous	TCF7L2:ENST00000355717:3_prime_UTR_variant:MODIFIER:exon13/13:c.*98C>T::,TCF7L2:ENST00000355995:synonymous_variant:LOW:exon15/15:c.1620C>T:p.Pro540=:,TCF7L2:ENST00000369386:3_prime_UTR_variant:MODIFIER:exon7/7:c.*208C>T::,TCF7L2:ENST00000369397:synonymous_variant:LOW:exon14/14:c.1551C>T:p.Pro517=:,TCF7L2:ENST00000536810:synonymous_variant:LOW:exon14/14:c.1569C>T:p.Pro523=:,TCF7L2:ENST00000538897:3_prime_UTR_variant:MODIFIER:exon14/14:c.*98C>T::,TCF7L2:ENST00000542695:synonymous_variant:LOW:exon15/15:c.768C>T:p.Pro256=:,TCF7L2:ENST00000543371:synonymous_variant:LOW:exon14/14:c.1569C>T:p.Pro523=:,TCF7L2:ENST00000545257:synonymous_variant:LOW:exon15/15:c.1620C>T:p.Pro540=:	TCF7L2:NM_001146274.2:synonymous_variant:LOW:exon14/14:c.1569C>T:p.Pro523=:,TCF7L2:NM_001146283.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*98C>T::,TCF7L2:NM_001146284.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*98C>T::,TCF7L2:NM_001146285.1:synonymous_variant:LOW:exon13/13:c.1500C>T:p.Pro500=:,TCF7L2:NM_001146286.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*98C>T::,TCF7L2:NM_001198525.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*208C>T::,TCF7L2:NM_001198526.2:synonymous_variant:LOW:exon13/13:c.1500C>T:p.Pro500=:,TCF7L2:NM_001198527.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*196C>T::,TCF7L2:NM_001198528.2:3_prime_UTR_variant:MODIFIER:exon15/15:c.*196C>T::,TCF7L2:NM_001198529.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*98C>T::,TCF7L2:NM_001198530.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*98C>T::,TCF7L2:NM_001198531.2:3_prime_UTR_variant:MODIFIER:exon13/13:c.*98C>T::,TCF7L2:NM_001349870.2:3_prime_UTR_variant:MODIFIER:exon12/12:c.*196C>T::,TCF7L2:NM_001349871.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*196C>T::,TCF7L2:NM_001363501.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*98C>T::,TCF7L2:NM_001367943.1:synonymous_variant:LOW:exon15/15:c.1620C>T:p.Pro540=:,TCF7L2:NM_030756.5:synonymous_variant:LOW:exon14/14:c.1551C>T:p.Pro517=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	602228 [GENE=TCF7L2 PHENOS=Diabetes mellitus,type 2,susceptibility to,125853,Autosomal dominant];				rs76249005	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.7530			0.80,0.97	9.69						0	6	0 / 0					TCF7L2 (inh=AD oe_syn=1.21 oe_mis=0.64 oe_lof=0.12)
chr10	128923871	128923871	-	G	het		QUAL=1093;DP=141;AF=0.35;MQM=60;SAP=53;ABP=29	DOCK1	splice_region&intron	DOCK1:ENST00000280333:splice_region_variant&intron_variant:LOW:intron26/51:c.2688+7dup::	DOCK1:NM_001290223.1:splice_region_variant&intron_variant:LOW:intron26/51:c.2751+7dup::,DOCK1:NM_001380.4:splice_region_variant&intron_variant:LOW:intron26/51:c.2688+7dup::						rs58146499									10.33						0	4	0 / 0					DOCK1 (inh=n/a oe_syn=1.00 oe_mis=0.79 oe_lof=0.25)
chr11	299471	299471	C	T	het		QUAL=2033;DP=205;AF=0.41;MQM=60;SAP=4;ABP=16	IFITM5	missense	IFITM5:ENST00000382614:missense_variant:MODERATE:exon1/2:c.20G>A:p.Arg7His:	IFITM5:NM_001025295.3:missense_variant:MODERATE:exon1/2:c.20G>A:p.Arg7His:		614757 [GENE=IFITM5 PHENOS=Osteogenesis imperfecta,type V,610967,Autosomal dominant];				rs74557511	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0001	0.9620	D(0.03)	P(0.45)	0.71,0.97	23.60	0.36					0	7	0 / 0					PGGHG (inh=n/a oe_syn=1.13 oe_mis=0.98 oe_lof=0.75), IFITM5 (inh=AD oe_syn=1.02 oe_mis=1.21 oe_lof=1.70)
chr11	6638385	6638385	C	T	het		QUAL=1574;DP=158;AF=0.42;MQM=60;SAP=7;ABP=11	TPP1	splice_acceptor	TPP1:ENST00000299427:splice_acceptor_variant:HIGH:intron5/12:c.509-1G>A::,TPP1:ENST00000533371:splice_acceptor_variant:HIGH:intron4/11:c.-221-1G>A::	TPP1:NM_000391.4:splice_acceptor_variant:HIGH:intron5/12:c.509-1G>A::		607998 [GENE=TPP1 PHENOS=Spinocerebellar ataxia,autosomal recessive 7,609270,Autosomal recessive/Ceroid lipofuscinosis,neuronal,2,204500,Autosomal recessive];	207574 [pathogenic DISEASE=Neuronal ceroid lipofuscinosis,Ceroid lipofuscinosis neuronal 2,not provided];	CS991344 [CLASS=DM MUT=ALT PHEN="Neuronal ceroid lipofuscinosis late infantile" GENE=TPP1];		rs56144125	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	6.1790			0.98,0.96	34.00		7.27>-1.48	loss/acceptor/6638384-6638385/Medium/7.530206	1.000/0.938		0	7	0 / 0					TAF10 (inh=n/a oe_syn=1.21 oe_mis=0.77 oe_lof=0.00), TPP1 (inh=AR oe_syn=1.02 oe_mis=1.04 oe_lof=0.51), DCHS1 (inh=AR+AD oe_syn=0.93 oe_mis=0.85 oe_lof=0.16)
chr11	6644801	6644801	A	C	het		QUAL=1324;DP=110;AF=0.47;MQM=60;SAP=3;ABP=4	DCHS1	missense	DCHS1:ENST00000299441:missense_variant:MODERATE:exon21/21:c.8106T>G:p.His2702Gln:	DCHS1:NM_003737.4:missense_variant:MODERATE:exon21/21:c.8106T>G:p.His2702Gln:		603057 [GENE=DCHS1 PHENOS=Mitral valve prolapse 2,607829,Autosomal dominant/Van Maldergem syndrome 1,601390,Autosomal recessive];				rs72911012	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.1780	D(0.02)	B(0.06)	0.10,0.30	16.24	0.18					0	7	0 / 0					TPP1 (inh=AR oe_syn=1.02 oe_mis=1.04 oe_lof=0.51), DCHS1 (inh=AR+AD oe_syn=0.93 oe_mis=0.85 oe_lof=0.16)
chr11	10582240	10582240	A	G	het		QUAL=1468;DP=131;AF=0.47;MQM=60;SAP=3;ABP=4	LYVE1,IRAG1-AS1	missense,intron&non_coding_transcript	LYVE1:ENST00000256178:missense_variant:MODERATE:exon4/6:c.505T>C:p.Tyr169His:,LYVE1:ENST00000529598:missense_variant:MODERATE:exon2/4:c.193T>C:p.Tyr65His:,IRAG1-AS1:ENST00000529829:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.271+19151A>G::,IRAG1-AS1:ENST00000529979:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.246+19151A>G::	LYVE1:NM_006691.4:missense_variant:MODERATE:exon4/6:c.505T>C:p.Tyr169His:,MRVI1-AS1:NR_034093.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.307+19151A>G::,MRVI1-AS1:NR_034094.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.307+19151A>G::,MRVI1-AS1:NR_046374.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.307+19151A>G::,MRVI1-AS1:NR_046375.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.307+19151A>G::						rs72861055	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.2760	T(0.44),T(0.40), , 	B(0.00),B(0.00), , 	0.02,0.16	0.41	0.01					0	10	0 / 0					IRAG1-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), LYVE1 (inh=n/a oe_syn=1.03 oe_mis=0.96 oe_lof=0.81)
chr11	26586990	26586990	T	C	het		QUAL=3052;DP=256;AF=0.47;MQM=60;SAP=3;ABP=5	ANO3,MUC15	intron,missense	ANO3:ENST00000256737:intron_variant:MODIFIER:intron14/26:c.1447+5664T>C::,MUC15:ENST00000281268:missense_variant:MODERATE:exon2/3:c.497A>G:p.Asn166Ser:,MUC15:ENST00000436318:missense_variant:MODERATE:exon2/4:c.497A>G:p.Asn166Ser:,MUC15:ENST00000455601:missense_variant:MODERATE:exon2/4:c.416A>G:p.Asn139Ser:,ANO3:ENST00000525139:intron_variant:MODIFIER:intron14/26:c.1399+5664T>C::,MUC15:ENST00000527569:missense_variant:MODERATE:exon3/4:c.497A>G:p.Asn166Ser:,MUC15:ENST00000529533:missense_variant:MODERATE:exon3/5:c.497A>G:p.Asn166Ser:,ANO3:ENST00000531568:intron_variant:MODIFIER:intron11/23:c.1009+5664T>C::,ANO3:ENST00000537978:intron_variant:MODIFIER:intron15/27:c.1399+5664T>C::	MUC15:NM_001135091.2:missense_variant:MODERATE:exon3/5:c.497A>G:p.Asn166Ser:,MUC15:NM_001135092.2:missense_variant:MODERATE:exon3/4:c.497A>G:p.Asn166Ser:,ANO3:NM_001313726.1:intron_variant:MODIFIER:intron15/27:c.1630+5664T>C::,ANO3:NM_001313727.1:intron_variant:MODIFIER:intron11/23:c.1009+5664T>C::,ANO3:NM_031418.4:intron_variant:MODIFIER:intron14/26:c.1447+5664T>C::,MUC15:NM_145650.4:missense_variant:MODERATE:exon2/4:c.416A>G:p.Asn139Ser:		610110 [GENE=ANO3 PHENOS=Dystonia 24,615034,Autosomal dominant];				rs72877805	0.0004	0.0002	0,.	0.0001,0.0001,0.0000,0.0005,0.0000	0.0220	 ,T(0.17),T(0.17),T(0.19), ,T(0.17),T(0.17), , 	 ,B(0.14),B(0.06),B(0.06), ,B(0.14),B(0.06), , 	0.03,0.14	1.96	0.02					0	10	0 / 2					ANO3 (inh=AD oe_syn=1.01 oe_mis=0.70 oe_lof=0.58), MUC15 (inh=n/a oe_syn=0.87 oe_mis=1.11 oe_lof=0.70)
chr11	45924953	45924953	C	T	het		QUAL=1785;DP=161;AF=0.46;MQM=60;SAP=17;ABP=5	MAPK8IP1	synonymous	MAPK8IP1:ENST00000241014:synonymous_variant:LOW:exon6/12:c.1455C>T:p.Asn485=:,MAPK8IP1:ENST00000395629:synonymous_variant:LOW:exon6/12:c.1425C>T:p.Asn475=:	MAPK8IP1:NM_005456.4:synonymous_variant:LOW:exon6/12:c.1455C>T:p.Asn485=:		604641 [GENE=MAPK8IP1 PHENOS=Diabetes mellitus,noninsulin-dependent,125853,Autosomal dominant];				rs72902473	0.0006	0.0003	0,.	0.0003,0.0000,0.0000,0.0004,0.0000	-0.8700			0.10,0.77	4.65						0	8	0 / 1					MAPK8IP1 (inh=AD oe_syn=0.99 oe_mis=0.79 oe_lof=0.03), C11ORF94 (inh=n/a oe_syn=1.11 oe_mis=1.19 oe_lof=0.67)
chr11	111796904	111796904	A	G	het		QUAL=1833;DP=164;AF=0.45;MQM=60;SAP=19;ABP=7	C11orf52,HSPB2-C11orf52	missense,3'UTR&NMD_transcript	C11orf52:ENST00000278601:missense_variant:MODERATE:exon4/4:c.353A>G:p.Lys118Arg:PF15147 [Domain of unknown function (DUF4578)],HSPB2-C11orf52:ENST00000534100:3_prime_UTR_variant&NMD_transcript_variant:MODIFIER:exon5/5:c.*583A>G::	C11orf52:NM_080659.3:missense_variant:MODERATE:exon4/4:c.353A>G:p.Lys118Arg:,HSPB2-C11orf52:NR_037651.1:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.836A>G::						rs72991415	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0002,0.0000	3.2630	T(0.07), 	B(0.25), 	0.67,0.92	22.30	0.08					0	8	0 / 0					CRYAB (inh=AR+AD oe_syn=0.85 oe_mis=0.87 oe_lof=0.57), HSPB2-C11ORF52 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), C11ORF52 (inh=n/a oe_syn=0.73 oe_mis=0.75 oe_lof=0.94), DIXDC1 (inh=n/a oe_syn=0.92 oe_mis=0.79 oe_lof=0.53), RNA5SP351 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr11	121028581	121028581	C	G	het		QUAL=1749;DP=158;AF=0.46;MQM=60;SAP=100;ABP=5	TECTA	missense	TECTA:ENST00000264037:missense_variant:MODERATE:exon13/23:c.4337C>G:p.Thr1446Arg:PF12714 [TILa domain],TECTA:ENST00000392793:missense_variant:MODERATE:exon14/24:c.4337C>G:p.Thr1446Arg:PF12714 [TILa domain]	TECTA:NM_005422.2:missense_variant:MODERATE:exon13/23:c.4337C>G:p.Thr1446Arg:		602574 [GENE=TECTA PHENOS=Deafness,autosomal dominant 8/12,601543,Autosomal dominant/Deafness,autosomal recessive 21,603629,Autosomal recessive];	303025 [uncertain significance DISEASE=Nonsyndromic Hearing Loss, Dominant,Nonsyndromic Hearing Loss, Recessive];			rs72998913	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	4.6700	D(0.00),D(0.00)	D(0.94),D(0.94)	0.96,0.99	26.80	0.29					0	9	0 / 0					TECTA (inh=AR+AD oe_syn=0.99 oe_mis=0.87 oe_lof=0.45)
chr12	14610199	14610199	C	T	het		QUAL=844;DP=57;AF=0.60;MQM=60;SAP=7;ABP=8	ATF7IP	missense	ATF7IP:ENST00000261168:missense_variant:MODERATE:exon8/15:c.2128C>T:p.Pro710Ser:,ATF7IP:ENST00000536444:missense_variant:MODERATE:exon8/15:c.2125C>T:p.Pro709Ser:,ATF7IP:ENST00000540793:missense_variant:MODERATE:exon7/14:c.2128C>T:p.Pro710Ser:,ATF7IP:ENST00000543189:missense_variant:MODERATE:exon8/13:c.2125C>T:p.Pro709Ser:,ATF7IP:ENST00000544627:missense_variant:MODERATE:exon8/15:c.2152C>T:p.Pro718Ser:	ATF7IP:NM_001286514.2:missense_variant:MODERATE:exon8/15:c.2125C>T:p.Pro709Ser:,ATF7IP:NM_001286515.2:missense_variant:MODERATE:exon8/13:c.2125C>T:p.Pro709Ser:,ATF7IP:NM_018179.4:missense_variant:MODERATE:exon8/15:c.2128C>T:p.Pro710Ser:,ATF7IP:NM_181352.2:missense_variant:MODERATE:exon8/15:c.2152C>T:p.Pro718Ser:						rs73058771	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0002,0.0000	1.2310	T(0.10), ,T(0.10),T(0.10),T(0.10)	P(0.56),P(0.56),P(0.56),P(0.56),P(0.56)	0.41,0.40	21.50	0.07					0	5	0 / 0					ATF7IP (inh=n/a oe_syn=0.99 oe_mis=0.81 oe_lof=0.10)
chr12	21639421	21639421	T	A	het		QUAL=346;DP=39;AF=0.44;MQM=60;SAP=6;ABP=4	RECQL	missense	RECQL:ENST00000421138:missense_variant:MODERATE:exon6/16:c.493A>T:p.Ser165Cys:PF00270 [DEAD/DEAH box helicase],RECQL:ENST00000444129:missense_variant:MODERATE:exon5/15:c.493A>T:p.Ser165Cys:PF00270 [DEAD/DEAH box helicase]	RECQL:NM_002907.4:missense_variant:MODERATE:exon5/15:c.493A>T:p.Ser165Cys:,RECQL:NM_032941.2:missense_variant:MODERATE:exon6/16:c.493A>T:p.Ser165Cys:						rs73082680	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	7.2790	D(0.03),D(0.03)	B(0.26),B(0.26)	0.98,0.99	24.40	0.22					0	10	0 / 0					RECQL (inh=n/a oe_syn=1.04 oe_mis=0.96 oe_lof=0.97)
chr12	27623658	27623658	T	A	het		QUAL=1257;DP=81;AF=0.60;MQM=60;SAP=3;ABP=11	SMCO2	missense	SMCO2:ENST00000298876:missense_variant:MODERATE:exon2/8:c.94T>A:p.Phe32Ile:PF14992 [TMCO5 family],SMCO2:ENST00000416383:missense_variant:MODERATE:exon2/9:c.94T>A:p.Phe32Ile:PF14992 [TMCO5 family],SMCO2:ENST00000535986:missense_variant:MODERATE:exon1/8:c.94T>A:p.Phe32Ile:PF14992 [TMCO5 family]	SMCO2:NM_001145010.1:missense_variant:MODERATE:exon2/9:c.94T>A:p.Phe32Ile:						rs73086401		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.6560	D(0.01),D(0.01),D(0.01)	B(0.08),B(0.08),B(0.08)	0.25,0.56	12.44	0.04					0	5	0 / 0					SMCO2 (inh=n/a oe_syn=0.73 oe_mis=0.82 oe_lof=0.94)
chr12	27845809	27845809	C	T	het		QUAL=860;DP=75;AF=0.51;MQM=60;SAP=54;ABP=3	PPFIBP1	synonymous	PPFIBP1:ENST00000228425:synonymous_variant:LOW:exon30/30:c.3012C>T:p.Asn1004=:,PPFIBP1:ENST00000318304:synonymous_variant:LOW:exon29/29:c.3030C>T:p.Asn1010=:,PPFIBP1:ENST00000537927:synonymous_variant:LOW:exon27/27:c.2571C>T:p.Asn857=:,PPFIBP1:ENST00000542629:synonymous_variant:LOW:exon28/28:c.2937C>T:p.Asn979=:	PPFIBP1:NM_001198915.2:synonymous_variant:LOW:exon27/27:c.2571C>T:p.Asn857=:,PPFIBP1:NM_001198916.2:synonymous_variant:LOW:exon28/28:c.2937C>T:p.Asn979=:,PPFIBP1:NM_003622.4:synonymous_variant:LOW:exon30/30:c.3012C>T:p.Asn1004=:,PPFIBP1:NM_177444.3:synonymous_variant:LOW:exon29/29:c.3030C>T:p.Asn1010=:						rs55923847	0.0002	0.0001	0,.	0.0001,0.0001,0.0000,0.0001,0.0000	-0.6910			0.11,0.83	3.65						0	8	0 / 0					PPFIBP1 (inh=n/a oe_syn=0.92 oe_mis=0.91 oe_lof=0.57), REP15 (inh=n/a oe_syn=1.05 oe_mis=0.89 oe_lof=1.04)
chr12	40821881	40821881	T	A	het		QUAL=1997;DP=142;AF=0.54;MQM=60;SAP=18;ABP=5	MUC19,RP11-115F18.1	synonymous,intron&non_coding_transcript	MUC19:ENST00000454784:synonymous_variant:LOW:exon13/84:c.630T>A:p.Pro210=:,RP11-115F18.1:ENST00000552757:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/3:n.26-7768A>T::	MUC19:NM_173600.2:synonymous_variant:LOW:exon20/172:c.2382T>A:p.Pro794=:						rs73101540		0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-1.6800			0.04,0.72	2.00						0	7	0 / 0					MUC19 (inh=n/a oe_syn=1.00 oe_mis=0.95 oe_lof=0.79)
chr12	56352309	56352309	T	A	het		QUAL=1221;DP=107;AF=0.47;MQM=60;SAP=47;ABP=4	PMEL	synonymous	PMEL:ENST00000360714:synonymous_variant:LOW:exon5/12:c.417A>T:p.Pro139=:,PMEL:ENST00000449260:synonymous_variant:LOW:exon4/11:c.417A>T:p.Pro139=:,PMEL:ENST00000536427:synonymous_variant:LOW:exon5/13:c.417A>T:p.Pro139=:,PMEL:ENST00000539511:synonymous_variant:LOW:exon3/10:c.159A>T:p.Pro53=:,PMEL:ENST00000548493:synonymous_variant:LOW:exon5/12:c.417A>T:p.Pro139=:,PMEL:ENST00000548747:synonymous_variant:LOW:exon4/11:c.417A>T:p.Pro139=:,PMEL:ENST00000550447:synonymous_variant:LOW:exon3/7:c.306A>T:p.Pro102=:,PMEL:ENST00000550464:synonymous_variant:LOW:exon2/9:c.159A>T:p.Pro53=:,PMEL:ENST00000552882:synonymous_variant:LOW:exon5/12:c.417A>T:p.Pro139=:	PMEL:NM_001200053.1:synonymous_variant:LOW:exon2/9:c.159A>T:p.Pro53=:,PMEL:NM_001200054.1:synonymous_variant:LOW:exon4/11:c.417A>T:p.Pro139=:,PMEL:NM_001320121.1:synonymous_variant:LOW:exon4/12:c.417A>T:p.Pro139=:,PMEL:NM_001320122.1:synonymous_variant:LOW:exon4/12:c.417A>T:p.Pro139=:,PMEL:NM_006928.4:synonymous_variant:LOW:exon5/12:c.417A>T:p.Pro139=:	regulatory_region_variant:promoter_flanking_region					rs73123213	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-0.1970			0.07,0.53	11.17						0	5	0 / 0					DGKA (inh=n/a oe_syn=0.81 oe_mis=0.65 oe_lof=0.22), PMEL (inh=n/a oe_syn=1.01 oe_mis=0.87 oe_lof=0.94)
chr12	88474130	88474130	C	T	het		QUAL=716;DP=72;AF=0.44;MQM=60;SAP=42;ABP=5	CEP290	synonymous	CEP290:ENST00000309041:synonymous_variant:LOW:exon38/54:c.5061G>A:p.Ala1687=:,CEP290:ENST00000397838:synonymous_variant:LOW:exon30/46:c.2235G>A:p.Ala745=:,CEP290:ENST00000547691:synonymous_variant:LOW:exon13/29:c.2235G>A:p.Ala745=:,CEP290:ENST00000552810:synonymous_variant:LOW:exon38/54:c.5055G>A:p.Ala1685=:	CEP290:NM_025114.4:synonymous_variant:LOW:exon38/54:c.5055G>A:p.Ala1685=:		610142 [GENE=CEP290 PHENOS=Bardet-Biedl syndrome 14,615991,Autosomal recessive/Leber congenital amaurosis 10,611755/Senior-Loken syndrome 6,610189,Autosomal recessive/Meckel syndrome 4,611134,Autosomal recessive/Joubert syndrome 5,610188,Autosomal recessive];	166834 [uncertain significance(replaced by megSAP based on classifications:1x2,6x3) DISEASE=Nephronophthisis,Joubert syndrome,Leber congenital amaurosis,Meckel-Gruber syndrome,Renal dysplasia and retinal aplasia,Bardet-Biedl syndrome,not provided];			rs73192874	0.0002	0.0001	0,.	0.0002,0.0000,0.0001,0.0002,0.0001	0.2140			0.32,0.93	7.34						0	10	0 / 1					CEP290 (inh=AR oe_syn=0.90 oe_mis=0.94 oe_lof=0.89)
chr12	96260886	96260886	T	C	het		QUAL=397;DP=35;AF=0.49;MQM=60;SAP=3;ABP=3	CCDC38,SNRPF	missense,intron	CCDC38:ENST00000344280:missense_variant:MODERATE:exon16/16:c.1660A>G:p.Lys554Glu:,SNRPF:ENST00000552085:intron_variant:MODIFIER:intron2/4:c.129+5815T>C::,SNRPF:ENST00000553192:intron_variant:MODIFIER:intron2/2:c.129+5815T>C::	CCDC38:NM_182496.3:missense_variant:MODERATE:exon16/16:c.1660A>G:p.Lys554Glu:						rs73227775	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	2.5690	T(0.09), , 	B(0.23), , 	0.91,0.95	16.98	0.08					0	7	0 / 0					SNRPF (inh=n/a oe_syn=0.90 oe_mis=0.20 oe_lof=0.00), CCDC38 (inh=n/a oe_syn=1.10 oe_mis=0.97 oe_lof=0.76)
chr12	103234252	103234252	T	C	het		QUAL=1367;DP=102;AF=0.52;MQM=60;SAP=3;ABP=3	PAH	missense	PAH:ENST00000307000:missense_variant:MODERATE:exon13/14:c.1226A>G:p.Tyr409Cys:PF00351 [Biopterin-dependent aromatic amino acid hydroxylase],PAH:ENST00000553106:missense_variant:MODERATE:exon12/13:c.1241A>G:p.Tyr414Cys:PF00351 [Biopterin-dependent aromatic amino acid hydroxylase]	PAH:NM_000277.3:missense_variant:MODERATE:exon12/13:c.1241A>G:p.Tyr414Cys:,PAH:NM_001354304.2:missense_variant:MODERATE:exon13/14:c.1241A>G:p.Tyr414Cys:		612349 [GENE=PAH PHENOS=Hyperphenylalaninemia,non-PKU mild,261600,Autosomal recessive/Phenylketonuria,261600,Autosomal recessive];	593 [pathogenic DISEASE=Hyperphenylalaninemia, non-pku,Phenylketonuria,not provided];	CM910294 [CLASS=DM MUT=ALT PHEN="Phenylketonuria" GENE=PAH];		rs5030860	0.0002	0.0004	0,.	0.0000,0.0001,0.0000,0.0007,0.0000	7.2910	D(0.00),D(0.00)	D(1.00),D(1.00)	0.96,0.97	26.90	0.98					0	18	0 / 3					PAH (inh=AR oe_syn=1.11 oe_mis=1.12 oe_lof=1.12)
chr12	109941000	109941000	G	A	het		QUAL=382;DP=60;AF=0.33;MQM=60;SAP=24;ABP=17	UBE3B	splice_region&intron	UBE3B:ENST00000280774:splice_region_variant&intron_variant:LOW:intron14/19:c.1450+5G>A::,UBE3B:ENST00000342494:splice_region_variant&intron_variant:LOW:intron14/27:c.1450+5G>A::,UBE3B:ENST00000434735:splice_region_variant&intron_variant:LOW:intron14/27:c.1450+5G>A::	UBE3B:NM_130466.4:splice_region_variant&intron_variant:LOW:intron14/27:c.1450+5G>A::,UBE3B:NM_183415.3:splice_region_variant&intron_variant:LOW:intron14/27:c.1450+5G>A::		608047 [GENE=UBE3B PHENOS=Kaufman oculocerebrofacial syndrome,244450,Autosomal recessive];				rs201130963	0.0002	0.0001		0.0001,0.0000,0.0001,0.0001,0.0000	6.6880			0.99,0.95	18.96		5.28>1.23		1.000/1.000		0	4	0 / 0					UBE3B (inh=AR oe_syn=0.93 oe_mis=0.85 oe_lof=0.39)
chr12	117465867	117465867	G	A	het		QUAL=3124;DP=234;AF=0.51;MQM=60;SAP=26;ABP=3	FBXW8	missense	FBXW8:ENST00000309909:missense_variant:MODERATE:exon11/11:c.1687G>A:p.Val563Met:,FBXW8:ENST00000455858:missense_variant:MODERATE:exon11/11:c.1489G>A:p.Val497Met:	FBXW8:NM_012174.1:missense_variant:MODERATE:exon11/11:c.1489G>A:p.Val497Met:,FBXW8:NM_153348.3:missense_variant:MODERATE:exon11/11:c.1687G>A:p.Val563Met:						rs56350562	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	4.7460	T(0.17),T(0.15)	B(0.21),B(0.16)	0.91,0.96	21.70	0.07					0	5	0 / 0					FBXW8 (inh=n/a oe_syn=0.98 oe_mis=0.98 oe_lof=0.91)
chr12	132522533	132522533	C	T	het	gene_blacklist	QUAL=860;DP=76;AF=0.46;MQM=60;SAP=4;ABP=4	EP400	synonymous	EP400:ENST00000330386:synonymous_variant:LOW:exon31/52:c.5856C>T:p.Pro1952=:,EP400:ENST00000332482:synonymous_variant:LOW:exon31/52:c.5988C>T:p.Pro1996=:,EP400:ENST00000333577:synonymous_variant:LOW:exon33/54:c.6207C>T:p.Pro2069=:,EP400:ENST00000389561:synonymous_variant:LOW:exon32/53:c.6099C>T:p.Pro2033=:,EP400:ENST00000389562:synonymous_variant:LOW:exon32/53:c.6096C>T:p.Pro2032=:	EP400:NM_015409.5:synonymous_variant:LOW:exon32/53:c.6099C>T:p.Pro2033=:						rs55849852	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0001,0.0000	0.0300			0.10,0.55	2.81						0	9	0 / 0					EP400 (inh=n/a oe_syn=1.10 oe_mis=0.83 oe_lof=0.15)
chr12	132624695	132624695	C	G	het		QUAL=3664;DP=307;AF=0.47;MQM=60;SAP=13;ABP=6	DDX51	missense	DDX51:ENST00000397333:missense_variant:MODERATE:exon12/15:c.1723G>C:p.Glu575Gln:PF00271 [Helicase conserved C-terminal domain]	DDX51:NM_175066.4:missense_variant:MODERATE:exon12/15:c.1723G>C:p.Glu575Gln:						rs73164956	0.0002	0.0001		0.0001,0.0001,0.0000,0.0001,0.0000	4.6470	T(0.45)	B(0.06)	0.79,0.92	15.90	0.12					0	5	0 / 0					DDX51 (inh=n/a oe_syn=1.53 oe_mis=1.21 oe_lof=0.70), NOC4L (inh=n/a oe_syn=1.56 oe_mis=1.39 oe_lof=0.37)
chr13	27827961	27827961	T	C	het		QUAL=896;DP=76;AF=0.47;MQM=60;SAP=12;ABP=3	RPL21	synonymous	RPL21:ENST00000272274:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16=:PF01157 [Ribosomal protein L21e],RPL21:ENST00000311549:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16=:PF01157 [Ribosomal protein L21e],RPL21:ENST00000319826:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16=:PF01157 [Ribosomal protein L21e],RPL21:ENST00000326092:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16=:PF01157 [Ribosomal protein L21e]	RPL21:NM_000982.3:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16=:	regulatory_region_variant:promoter	603636 [GENE=RPL21 PHENOS=Hypotrichosis 12,615885,Autosomal dominant];				rs73161790	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	0.0210			0.67,0.90	11.89						0	7	0 / 0					RPL21 (inh=AD oe_syn=1.15 oe_mis=0.54 oe_lof=0.10), SNORD102 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), SNORA27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr13	45149445	45149445	T	C	het		QUAL=1593;DP=120;AF=0.51;MQM=60;SAP=4;ABP=3	TSC22D1	missense	TSC22D1:ENST00000458659:missense_variant:MODERATE:exon1/3:c.766A>G:p.Ser256Gly:,TSC22D1:ENST00000501704:missense_variant:MODERATE:exon1/2:c.766A>G:p.Ser256Gly:	TSC22D1:NM_001243799.1:missense_variant:MODERATE:exon1/2:c.766A>G:p.Ser256Gly:,TSC22D1:NM_183422.4:missense_variant:MODERATE:exon1/3:c.766A>G:p.Ser256Gly:	regulatory_region_variant:promoter					rs73190853	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	5.7880	D(0.00),D(0.01)	B(0.03),B(0.09)	0.87,0.94	22.70	0.07					0	7	0 / 0					TSC22D1 (inh=n/a oe_syn=1.28 oe_mis=1.10 oe_lof=0.16)
chr13	50080827	50080827	G	T	het		QUAL=1169;DP=70;AF=0.64;MQM=60;SAP=7;ABP=15	PHF11	missense	PHF11:ENST00000357596:missense_variant:MODERATE:exon3/11:c.34G>T:p.Asp12Tyr:,PHF11:ENST00000378319:missense_variant:MODERATE:exon2/10:c.151G>T:p.Asp51Tyr:,PHF11:ENST00000488958:missense_variant:MODERATE:exon2/10:c.34G>T:p.Asp12Tyr:	PHF11:NM_001040443.3:missense_variant:MODERATE:exon2/10:c.151G>T:p.Asp51Tyr:,PHF11:NM_001040444.2:missense_variant:MODERATE:exon2/10:c.34G>T:p.Asp12Tyr:,SETDB2-PHF11:NM_001320727.2:missense_variant:MODERATE:exon12/20:c.1633G>T:p.Asp545Tyr:,PHF11:NR_135322.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/8:n.144-6368G>T::,PHF11:NR_135323.2:non_coding_transcript_exon_variant:MODIFIER:exon3/12:n.305G>T::,SETDB2-PHF11:NR_135324.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron12/20:n.2663-6368G>T::						rs73188692	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	2.6480	D(0.01),D(0.01),D(0.01)	P(0.89),P(0.89),P(0.89)	0.82,0.39	22.00	0.35					0	5	0 / 0					PHF11 (inh=n/a oe_syn=0.89 oe_mis=0.77 oe_lof=0.80)
chr13	80911511	80911511	G	A	het		QUAL=3108;DP=227;AF=0.52;MQM=60;SAP=4;ABP=4	SPRY2	synonymous	SPRY2:ENST00000377102:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110=:,SPRY2:ENST00000377104:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110=:,SPRY2:ENST00000540649:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110=:	SPRY2:NM_001318536.1:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110=:,SPRY2:NM_001318537.1:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110=:,SPRY2:NM_001318538.1:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110=:,SPRY2:NM_005842.4:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110=:	regulatory_region_variant:promoter	602466 [GENE=SPRY2 PHENOS=IgA nephropathy,susceptibility to,3,616818,Autosomal dominant];				rs73245373	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.3200			0.78,0.92	11.37						0	5	0 / 0					SPRY2 (inh=AD oe_syn=1.21 oe_mis=0.79 oe_lof=0.00)
chr13	99554562	99554562	C	T	het		QUAL=1094;DP=79;AF=0.56;MQM=60;SAP=67;ABP=5	DOCK9	missense	DOCK9:ENST00000339416:missense_variant:MODERATE:exon12/54:c.1363G>A:p.Ala455Thr:,DOCK9:ENST00000376460:missense_variant:MODERATE:exon12/57:c.1360G>A:p.Ala454Thr:,DOCK9:ENST00000442173:missense_variant:MODERATE:exon12/33:c.1360G>A:p.Ala454Thr:,DOCK9:ENST00000448493:missense_variant:MODERATE:exon12/49:c.1396G>A:p.Ala466Thr:	DOCK9:NM_001130048.2:missense_variant:MODERATE:exon12/57:c.1360G>A:p.Ala454Thr:,DOCK9:NM_001130049.2:missense_variant:MODERATE:exon12/33:c.1363G>A:p.Ala455Thr:,DOCK9:NM_001130050.2:missense_variant:MODERATE:exon12/33:c.1360G>A:p.Ala454Thr:,DOCK9:NM_001318849.2:missense_variant:MODERATE:exon12/56:c.1363G>A:p.Ala455Thr:,DOCK9:NM_001366676.2:missense_variant:MODERATE:exon12/56:c.1396G>A:p.Ala466Thr:,DOCK9:NM_001366677.2:missense_variant:MODERATE:exon12/54:c.1396G>A:p.Ala466Thr:,DOCK9:NM_001366678.2:missense_variant:MODERATE:exon12/57:c.1396G>A:p.Ala466Thr:,DOCK9:NM_001366679.2:missense_variant:MODERATE:exon12/54:c.1360G>A:p.Ala454Thr:,DOCK9:NM_001366680.2:missense_variant:MODERATE:exon12/53:c.1360G>A:p.Ala454Thr:,DOCK9:NM_001366681.2:missense_variant:MODERATE:exon12/55:c.1360G>A:p.Ala454Thr:,DOCK9:NM_001366682.2:missense_variant:MODERATE:exon12/54:c.1360G>A:p.Ala454Thr:,DOCK9:NM_001366683.2:missense_variant:MODERATE:exon12/53:c.1360G>A:p.Ala454Thr:,DOCK9:NM_001366684.2:missense_variant:MODERATE:exon12/54:c.1360G>A:p.Ala454Thr:,DOCK9:NM_015296.3:missense_variant:MODERATE:exon12/57:c.1363G>A:p.Ala455Thr:						rs56010605	0.0004	0.0009	0,.	0.0000,0.0000,0.0001,0.0002,0.0008	0.6090	T(0.30),T(0.33),T(0.17),T(0.18)	B(0.04),B(0.02),B(0.03),B(0.03)	0.18,0.31	15.23	0.03					0	10	0 / 0					DOCK9 (inh=n/a oe_syn=0.99 oe_mis=0.74 oe_lof=0.12)
chr13	111102718	111102718	C	T	het		QUAL=1246;DP=115;AF=0.44;MQM=60;SAP=8;ABP=6	COL4A2	missense	COL4A2:ENST00000360467:missense_variant:MODERATE:exon20/48:c.1256C>T:p.Ala419Val:	COL4A2:NM_001846.4:missense_variant:MODERATE:exon20/48:c.1256C>T:p.Ala419Val:		120090 [GENE=COL4A2 PHENOS=Brain small vessel disease 2,614483,Autosomal dominant/Hemorrhage,intracerebral,susceptibility to,614519];	311122 [likely benign DISEASE=Acquired porencephaly];			rs72657933	0.0004	0.0001	0,.	0.0001,0.0001,0.0000,0.0001,0.0001	3.6370	D(0.00)	D(0.99)	0.70,0.53	23.10	0.33					0	7	0 / 0					COL4A2 (inh=AD oe_syn=0.95 oe_mis=0.81 oe_lof=0.45)
chr13	111160418	111160418	C	T	het		QUAL=3879;DP=273;AF=0.54;MQM=60;SAP=5;ABP=7	COL4A2,COL4A2-AS1	synonymous,intron&non_coding_transcript	COL4A2:ENST00000360467:synonymous_variant:LOW:exon47/48:c.4731C>T:p.Pro1577=:PF01413 [C-terminal tandem repeated domain in type 4 procollagen],COL4A2-AS1:ENST00000417970:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.81+28G>A::	COL4A2:NM_001846.4:synonymous_variant:LOW:exon47/48:c.4731C>T:p.Pro1577=:,COL4A2-AS1:NR_046583.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.81+28G>A::	regulatory_region_variant:promoter_flanking_region	120090 [GENE=COL4A2 PHENOS=Brain small vessel disease 2,614483,Autosomal dominant/Hemorrhage,intracerebral,susceptibility to,614519];	311185 [likely benign DISEASE=Acquired porencephaly];			rs72659607	0.0002	0.0002	0,.	0.0001,0.0000,0.0000,0.0001,0.0001	-4.5550			0.02,0.19	0.29			gain/acceptor/111160418-111160419/Medium/3.262939			0	7	0 / 0					COL4A2 (inh=AD oe_syn=0.95 oe_mis=0.81 oe_lof=0.45), COL4A2-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	22133849	22133849	A	G	het	gene_blacklist	QUAL=2745;DP=184;AF=0.55;MQM=60;SAP=3;ABP=8	OR4E2	missense	OR4E2:ENST00000408935:missense_variant:MODERATE:exon1/1:c.553A>G:p.Ile185Val:PF13853 [Olfactory receptor]	OR4E2:NM_001001912.2:missense_variant:MODERATE:exon1/1:c.553A>G:p.Ile185Val:						rs72686096	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.2580	T(0.07)	B(0.24)	0.24,0.97	18.83	0.12					1	7	0 / 0					OR4E2 (inh=n/a oe_syn=1.02 oe_mis=1.16 oe_lof=0.66), OR4E1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	31598427	31598427	T	C	het		QUAL=1488;DP=131;AF=0.46;MQM=60;SAP=27;ABP=5	HECTD1	missense	HECTD1:ENST00000399332:missense_variant:MODERATE:exon25/43:c.4150A>G:p.Ser1384Gly:,HECTD1:ENST00000553700:missense_variant:MODERATE:exon25/43:c.4150A>G:p.Ser1384Gly:	HECTD1:NM_015382.4:missense_variant:MODERATE:exon25/43:c.4150A>G:p.Ser1384Gly:						rs72670356	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	7.4550	T(0.08),T(0.08)	P(0.83),P(0.83)	0.97,0.97	24.40	0.19					1	5	0 / 0					HECTD1 (inh=n/a oe_syn=0.94 oe_mis=0.62 oe_lof=0.10)
chr14	50088957	50088957	C	G	het		QUAL=2916;DP=432;AF=0.31;MQM=60;SAP=5;ABP=135	MGAT2,RP11-649E7.5	missense,non_coding_transcript_exon	MGAT2:ENST00000305386:missense_variant:MODERATE:exon1/1:c.971C>G:p.Thr324Ser:PF05060 [N-acetylglucosaminyltransferase II (MGAT2)],RP11-649E7.5:ENST00000555043:non_coding_transcript_exon_variant:MODIFIER:exon1/2:n.1242G>C::	MGAT2:NM_002408.4:missense_variant:MODERATE:exon1/1:c.971C>G:p.Thr324Ser:	regulatory_region_variant:promoter	602616 [GENE=MGAT2 PHENOS=Congenital disorder of glycosylation,type IIa,212066,Autosomal recessive];	313257 [uncertain significance DISEASE=Congenital disorder of glycosylation];			rs78391102	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	2.0410	T(0.95), 	B(0.03), 	0.65,0.91	17.86	0.24					0	4	0 / 0					RPL36AL (inh=n/a oe_syn=0.93 oe_mis=0.58 oe_lof=0.62), MGAT2 (inh=AR oe_syn=1.05 oe_mis=0.91 oe_lof=0.34), DNAAF2 (inh=AR oe_syn=1.12 oe_mis=1.03 oe_lof=0.70)
chr14	56763353	56763353	C	T	het		QUAL=2121;DP=174;AF=0.47;MQM=60;SAP=4;ABP=4	PELI2	synonymous	PELI2:ENST00000267460:synonymous_variant:LOW:exon6/6:c.732C>T:p.Ser244=:PF04710 [Pellino]	PELI2:NM_021255.3:synonymous_variant:LOW:exon6/6:c.732C>T:p.Ser244=:						rs72720080	0.0002	0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	-0.0690			0.58,0.97	9.83						0	4	0 / 0					PELI2 (inh=n/a oe_syn=1.15 oe_mis=0.72 oe_lof=0.16)
chr14	59942585	59942585	A	T	het		QUAL=1445;DP=127;AF=0.46;MQM=60;SAP=3;ABP=4	L3HYPDH	splice_donor	L3HYPDH:ENST00000247194:splice_donor_variant:HIGH:intron4/4:c.939+2T>A::,L3HYPDH:ENST00000487285:splice_donor_variant:HIGH:intron4/4:c.426+2T>A::	L3HYPDH:NM_001331158.1:splice_donor_variant:HIGH:intron4/4:c.426+2T>A::,L3HYPDH:NM_001331159.1:splice_donor_variant:HIGH:intron4/4:c.426+2T>A::,L3HYPDH:NM_001331164.2:missense_variant:MODERATE:exon4/4:c.941T>A:p.Val314Glu:,L3HYPDH:NM_144581.2:splice_donor_variant:HIGH:intron4/4:c.939+2T>A::,L3HYPDH:NR_138571.1:non_coding_transcript_exon_variant:MODIFIER:exon4/5:n.1109T>A::,L3HYPDH:NR_138572.1:non_coding_transcript_exon_variant:MODIFIER:exon4/5:n.980T>A::,L3HYPDH:NR_138574.1:non_coding_transcript_exon_variant:MODIFIER:exon4/5:n.980T>A::,L3HYPDH:NR_138575.2:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.1162T>A::						rs72710953	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	6.7240			0.99,0.99	33.00		10.45>2.27	loss/donor/59942584-59942585/Medium/6.538007	1.000/0.926		0	5	0 / 0					L3HYPDH (inh=n/a oe_syn=0.85 oe_mis=1.07 oe_lof=0.87)
chr14	69994567	69994567	C	T	het		QUAL=1741;DP=145;AF=0.48;MQM=60;SAP=3;ABP=4	PLEKHD1	synonymous	PLEKHD1:ENST00000322564:synonymous_variant:LOW:exon12/13:c.1269C>T:p.Ser423=:	PLEKHD1:NM_001161498.2:synonymous_variant:LOW:exon12/13:c.1269C>T:p.Ser423=:						rs72723867		0.0001	0,.	0.0003,0.0001,0.0000,0.0001,0.0000	-2.9420			0.02,0.17	1.47						0	9	0 / 0					PLEKHD1 (inh=n/a oe_syn=0.71 oe_mis=0.72 oe_lof=0.47)
chr14	75248502	75248502	G	A	het		QUAL=3497;DP=265;AF=0.53;MQM=60;SAP=33;ABP=5	YLPM1	intron,missense	YLPM1:ENST00000238571:intron_variant:MODIFIER:intron3/15:c.1295-124G>A::,YLPM1:ENST00000325680:missense_variant:MODERATE:exon4/21:c.1756G>A:p.Gly586Arg:,YLPM1:ENST00000552421:missense_variant:MODERATE:exon4/20:c.1756G>A:p.Gly586Arg:	YLPM1:NM_019589.3:missense_variant:MODERATE:exon4/21:c.1756G>A:p.Gly586Arg:						rs72732190	0.0002	0.0001		0.0001,0.0001,0.0000,0.0001,0.0000	3.5000	 ,D(0.01),D(0.01)	 ,B(0.37),B(0.37)	0.97,0.98	23.10	0.13		loss/acceptor/75248501-75248502/Medium/11.129381&gain/acceptor/75248502-75248503/Medium/4.166458			0	5	0 / 0					YLPM1 (inh=n/a oe_syn=1.04 oe_mis=0.94 oe_lof=0.18)
chr14	88852188	88852188	G	A	het		QUAL=1298;DP=136;AF=0.40;MQM=59;SAP=4;ABP=16	SPATA7	splice_region&intron	SPATA7:ENST00000045347:splice_region_variant&intron_variant:LOW:intron1/12:c.19+7G>A::,SPATA7:ENST00000356583:splice_region_variant&intron_variant:LOW:intron1/10:c.19+7G>A::,SPATA7:ENST00000393545:splice_region_variant&intron_variant:LOW:intron1/11:c.19+7G>A::,SPATA7:ENST00000556553:splice_region_variant&intron_variant:LOW:intron2/11:c.19+7G>A::	SPATA7:NM_001040428.3:splice_region_variant&intron_variant:LOW:intron1/10:c.19+7G>A::,SPATA7:NM_018418.5:splice_region_variant&intron_variant:LOW:intron1/11:c.19+7G>A::	regulatory_region_variant:promoter	609868 [GENE=SPATA7 PHENOS=Retinitis pigmentosa,juvenile,autosomal recessive,604232/Leber congenital amaurosis 3,604232];	766822 [likely benign DISEASE=Leber congenital amaurosis 3];			rs199560035	0.0002	0.0001		0.0000,0.0001,0.0000,0.0001,0.0000	1.5140			0.32,0.31	9.72				0.000/0.004		0	7	0 / 0					SPATA7 (inh=AR oe_syn=0.82 oe_mis=0.99 oe_lof=0.80)
chr14	100801331	100801331	C	T	het		QUAL=1330;DP=123;AF=0.46;MQM=60;SAP=33;ABP=5	WARS1,RP11-638I2.8	missense,intron&non_coding_transcript	WARS1:ENST00000344102:missense_variant:MODERATE:exon10/10:c.1174G>A:p.Ala392Thr:PF00579 [tRNA synthetases class I (W and Y)],WARS1:ENST00000355338:missense_variant:MODERATE:exon11/11:c.1297G>A:p.Ala433Thr:PF00579 [tRNA synthetases class I (W and Y)],WARS1:ENST00000358655:missense_variant:MODERATE:exon10/10:c.1174G>A:p.Ala392Thr:PF00579 [tRNA synthetases class I (W and Y)],WARS1:ENST00000392882:missense_variant:MODERATE:exon11/11:c.1297G>A:p.Ala433Thr:PF00579 [tRNA synthetases class I (W and Y)],WARS1:ENST00000556645:missense_variant:MODERATE:exon11/11:c.1174G>A:p.Ala392Thr:PF00579 [tRNA synthetases class I (W and Y)],WARS1:ENST00000557135:missense_variant:MODERATE:exon12/12:c.1297G>A:p.Ala433Thr:PF00579 [tRNA synthetases class I (W and Y)],RP11-638I2.8:ENST00000557226:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.114+1091C>T::	WARS:NM_004184.4:missense_variant:MODERATE:exon11/11:c.1297G>A:p.Ala433Thr:,WARS:NM_173701.2:missense_variant:MODERATE:exon11/11:c.1297G>A:p.Ala433Thr:,WARS:NM_213645.2:missense_variant:MODERATE:exon10/10:c.1174G>A:p.Ala392Thr:,WARS:NM_213646.2:missense_variant:MODERATE:exon10/10:c.1174G>A:p.Ala392Thr:		191050 [GENE=WARS1 PHENOS=Neuronopathy,distal hereditary motor,type IX,617721,Autosomal dominant];				rs72713916	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0002,0.0000	-0.7680	T(0.49),T(0.51),T(0.49),T(0.51),T(0.49),T(0.51), 	B(0.00),B(0.00),B(0.00),B(0.00),B(0.00),B(0.00), 	0.08,0.16	0.09	0.07					0	7	0 / 0					SLC25A47 (inh=n/a oe_syn=1.11 oe_mis=0.93 oe_lof=1.16), WARS1 (inh=AD oe_syn=0.88 oe_mis=0.67 oe_lof=0.23)
chr14	104053708	104053708	G	A	het		QUAL=446;DP=94;AF=0.27;MQM=60;SAP=5;ABP=48	COA8,RP11-73M18.2	splice_region&intron	COA8:ENST00000247618:splice_region_variant&intron_variant:LOW:intron4/4:c.476+7G>A::,COA8:ENST00000409074:splice_region_variant&intron_variant:LOW:intron4/4:c.515+7G>A::,RP11-73M18.2:ENST00000472726:splice_region_variant&intron_variant:LOW:intron4/17:c.515+7G>A::,COA8:ENST00000556253:splice_region_variant&intron_variant:LOW:intron5/5:c.*30+7G>A::	APOPT1:NM_001302652.2:splice_region_variant&intron_variant:LOW:intron4/4:c.476+7G>A::,APOPT1:NM_001302653.2:splice_region_variant&intron_variant:LOW:intron5/5:c.*30+7G>A::,APOPT1:NM_001370595.1:splice_region_variant&intron_variant:LOW:intron4/4:c.476+7G>A::,APOPT1:NR_126431.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron5/5:n.683+7G>A::,APOPT1:NR_126432.2:splice_region_variant&intron_variant&non_coding_transcript_variant:LOW:intron3/3:n.454+7G>A::		616003 [GENE=COA8 PHENOS=Mitochondrial complex IV deficiency,220110,Mitochondrial,Autosomal recessive];	559338 [likely benign DISEASE=not provided];			rs114895750	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.1400			0.03,0.17	1.04				0.000/0.000		0	5	0 / 0					COA8 (inh=AR oe_syn=1.25 oe_mis=1.14 oe_lof=0.67)
chr14	104209000	104209000	C	T	het		QUAL=441;DP=84;AF=0.32;MQM=60;SAP=62;ABP=26	PPP1R13B	synonymous,5'UTR	PPP1R13B:ENST00000202556:synonymous_variant:LOW:exon10/17:c.1311G>A:p.Thr437=:,PPP1R13B:ENST00000423488:5_prime_UTR_variant:MODIFIER:exon2/8:c.-433G>A::	PPP1R13B:NM_015316.3:synonymous_variant:LOW:exon10/17:c.1311G>A:p.Thr437=:						rs2295142	0.0002	0.0001	0,.	0.0000,0.0001,0.0007,0.0000,0.0000	-1.2170			0.03,0.18	7.97						0	4	0 / 0					PPP1R13B (inh=n/a oe_syn=0.98 oe_mis=0.83 oe_lof=0.15)
chr14	106329457	106329457	G	C	het		QUAL=1206;DP=216;AF=0.25;MQM=60;SAP=12;ABP=116	IGHJ6	stop_gained	IGHJ6:ENST00000390560:stop_gained:HIGH:exon1/1:c.12C>G:p.Tyr4Ter:						(GTA)n (Simple_repeat)	rs374757249		0.0001	0,.		0.0890			0.14,0.19	37.00						2	3	0 / 0					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106329468	106329468	A	C	het		QUAL=944;DP=220;AF=0.25;MQM=59;SAP=8;ABP=122	IGHJ6	missense	IGHJ6:ENST00000390560:missense_variant:MODERATE:exon1/1:c.1T>G:p.Tyr1Asp:						(GTA)n (Simple_repeat)	rs112183172		0.0001	0,.		2.1730		 (0.00)	0.77,0.87	16.42						0	4	0 / 0					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106330046	106330046	T	G	het		QUAL=1632;DP=111;AF=0.57;MQM=60;SAP=18;ABP=7	IGHJ5	synonymous	IGHJ5:ENST00000488476:synonymous_variant:LOW:exon1/1:c.27A>C:p.Gly9=:							rs373584630		0.0001	0,.	0.0001,0.0001,0.0000,0.0001,0.0000	-3.4750			0.02,0.15	0.14						0	3	0 / 0					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106330067	106330067	C	G	het		QUAL=2066;DP=100;AF=0.29;MQM=60;SAP=12;ABP=41	IGHJ5	missense	IGHJ5:ENST00000488476:missense_variant:MODERATE:exon1/1:c.6G>C:p.Trp2Cys:							rs78872461		0.0003	0,.		-0.3240		B(0.01)	0.09,0.28	10.16						1	8	0 / 1					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106330067	106330067	C	T	het		QUAL=2066;DP=100;AF=0.57;MQM=60;SAP=27;ABP=7	IGHJ5	stop_gained	IGHJ5:ENST00000488476:stop_gained:HIGH:exon1/1:c.6G>A:p.Trp2Ter:							rs78872461		0.0003	0,.		-0.3240			0.06,0.24	37.00						0	5	0 / 0					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106330068	106330068	C	T	het		QUAL=2066;DP=100;AF=0.29;MQM=60;SAP=27;ABP=7	IGHJ5	stop_gained	IGHJ5:ENST00000488476:stop_gained:HIGH:exon1/1:c.5G>A:p.Trp2Ter:							rs370945053		0.0001	0,.		-1.5630			0.05,0.21	38.00						1	3	0 / 0					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106330070	106330070	G	A	het		QUAL=2066;DP=100;AF=0.29;MQM=60;SAP=12;ABP=41	IGHJ5	synonymous	IGHJ5:ENST00000488476:synonymous_variant:LOW:exon1/1:c.3C>T:p.Asn1=:							rs368220735		0.0002	0,.		0.8430			0.34,0.27	0.50						1	5	0 / 0					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106330466	106330466	A	T	het		QUAL=428;DP=91;AF=0.31;MQM=50;SAP=14;ABP=32	IGHJ4	missense	IGHJ4:ENST00000461719:missense_variant:MODERATE:exon1/1:c.5T>A:p.Phe2Tyr:							rs1433521247					2.6390		B(0.00)	0.22,0.56	12.08						0	4	0 / 0					MIR4537 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ6 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD7-27 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHJ1P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106351902	106351902	C	G	het		QUAL=207;DP=15;AF=0.80;MQM=37;SAP=6;ABP=15	IGHD3-22	stop_lost	IGHD3-22:ENST00000390571:stop_lost:HIGH:exon1/1:c.18G>C:p.Ter6TyrextTer?:	::intergenic_variant:MODIFIER::::						rs1384482202					-3.2820			0.00,0.08	0.01						1	1	0 / 0					IGHD1-26 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD6-25 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD5-24 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD4-23 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD3-22 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD2-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106357559	106357559	A	C	het		QUAL=128;DP=15;AF=0.47;MQM=60;SAP=6;ABP=3	IGHD6-19	missense	IGHD6-19:ENST00000390574:missense_variant:MODERATE:exon1/1:c.19T>G:p.Tyr7Asp:	::intergenic_variant:MODIFIER::::						rs781970231		0.0002		0.0007,0.0000,0.0000,0.0003,0.0000	-0.1200		 (0.00)	0.00,0.07	5.49						1	1	0 / 0					IGHD2-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD1-20 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD6-19 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD5-18 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD4-17 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHD3-16 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106471343	106471343	C	T	het		QUAL=87;DP=158;AF=0.15;MQM=60;SAP=4;ABP=169	IGHV1-3	missense	IGHV1-3:ENST00000390595:missense_variant:MODERATE:exon2/2:c.254G>A:p.Gly85Asp:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs782608349		0.0001		0.0000,0.0000,0.0000,0.0001,0.0004	1.0150	T(0.09)	B(0.25)	0.01,0.20	12.16						1	2	0 / 0					IGHVIII-2-1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHV1-3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691777	106691777	C	A	het		QUAL=2490;DP=356;AF=0.34;MQM=50;SAP=6;ABP=80	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.247G>T:p.Val83Leu:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs114994542		0.0000	0,.		2.0010	D(0.01)	B(0.14)	0.39,0.67	16.35						0	3	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691800	106691800	C	T	het		QUAL=1822;DP=263;AF=0.33;MQM=54;SAP=4;ABP=71	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.224G>A:p.Ser75Asn:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs553767931		0.0001	0,.	0.0001,0.0000,0.0001,0.0001,0.0005	-0.0880	T(0.12)	B(0.00)	0.08,0.08	9.04						1	5	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691802	106691802	A	T	het		QUAL=1822;DP=263;AF=0.33;MQM=54;SAP=4;ABP=71	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.222T>A:p.Ser74Arg:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs374986733					-0.6790	D(0.00)	B(0.01)	0.04,0.05	9.92						0	4	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691806	106691806	C	T	het		QUAL=1822;DP=263;AF=0.33;MQM=54;SAP=4;ABP=71	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.218G>A:p.Ser73Asn:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs367671361		0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	-4.0570	T(0.30)	B(0.00)	0.02,0.04	0.02						1	3	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691809	106691809	C	G	het		QUAL=1822;DP=263;AF=0.33;MQM=54;SAP=4;ABP=71	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.215G>C:p.Ser72Thr:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs199525856		0.0001		0.0000,0.0000,0.0001,0.0001,0.0000	-6.5120	T(0.49)	B(0.00)	0.02,0.04	0.01						0	6	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691812	106691812	C	T	het		QUAL=1822;DP=263;AF=0.33;MQM=54;SAP=4;ABP=71	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.212G>A:p.Ser71Asn:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs782791278		0.0001		0.0001,0.0000,0.0000,0.0000,0.0000	-0.6280	T(0.58)	B(0.01)	0.03,0.06	0.07						1	6	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691814	106691814	A	G	het		QUAL=1822;DP=263;AF=0.33;MQM=54;SAP=4;ABP=71	IGHV3-21	synonymous	IGHV3-21:ENST00000390607:synonymous_variant:LOW:exon2/2:c.210T>C:p.Ile70=:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs554396860	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.9100			0.03,0.05	0.48						0	4	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691865	106691865	C	T	het		QUAL=1854;DP=242;AF=0.32;MQM=50;SAP=32;ABP=69	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.159G>A:p.Met53Ile:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs192949902		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.2030	D(0.03)	B(0.06)	0.05,0.11	14.15						0	3	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691868	106691868	G	T	het		QUAL=1854;DP=242;AF=0.32;MQM=50;SAP=32;ABP=69	IGHV3-21	missense	IGHV3-21:ENST00000390607:missense_variant:MODERATE:exon2/2:c.156C>A:p.Ser52Arg:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs782384399		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-6.0290	T(0.30)	B(0.00)	0.01,0.04	0.01						0	6	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691872	106691872	-	A	het		QUAL=1854;DP=242;AF=0.32;MQM=50;SAP=32;ABP=69	IGHV3-21	frameshift	IGHV3-21:ENST00000390607:frameshift_variant:HIGH:exon2/2:c.151dup:p.Tyr51LeufsTer2:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region														22.50						0	3	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	106691876	106691876	T	-	het		QUAL=1854;DP=242;AF=0.32;MQM=50;SAP=32;ABP=69	IGHV3-21	frameshift	IGHV3-21:ENST00000390607:frameshift_variant:HIGH:exon2/2:c.148del:p.Ser50AlafsTer4:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region										-0.0070				14.71						0	3	0 / 0					IGHV3-21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr14	107178902	107178902	T	C	het		QUAL=51;DP=256;AF=0.16;MQM=46;SAP=21;ABP=266	IGHV2-70	missense	IGHV2-70:ENST00000390634:missense_variant:MODERATE:exon2/2:c.275A>G:p.Lys92Arg:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region					rs778628138		0.0001	0,.	0.0001,0.0001,0.0000,0.0001,0.0001	-0.1400	T(1.00)	B(0.06)	0.00,0.90	10.73						0	1	0 / 0					IGHV2-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGHV3-71 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr15	41229631	41229631	T	G	het		QUAL=1265;DP=168;AF=0.35;MQM=60;SAP=22;ABP=35	DLL4	missense	DLL4:ENST00000249749:missense_variant:MODERATE:exon10/11:c.1959T>G:p.Cys653Trp:	DLL4:NM_019074.4:missense_variant:MODERATE:exon10/11:c.1959T>G:p.Cys653Trp:		605185 [GENE=DLL4 PHENOS=Adams-Oliver syndrome 6,616589,Autosomal dominant];				rs533126562	0.0002				4.7120	T(0.18)	P(0.79)	0.91,0.95	25.80	0.79					0	4	0 / 0					DLL4 (inh=AD oe_syn=0.94 oe_mis=0.63 oe_lof=0.06)
chr15	49284748	49284750	TCC	-	het		QUAL=1028;DP=78;AF=0.54;MQM=60;SAP=4;ABP=4	SECISBP2L	inframe_deletion	SECISBP2L:ENST00000261847:inframe_deletion:MODERATE:exon17/17:c.2862_2864del:p.Glu955del:,SECISBP2L:ENST00000559471:inframe_deletion:MODERATE:exon18/18:c.2997_2999del:p.Glu1000del:	SECISBP2L:NM_001193489.2:inframe_deletion:MODERATE:exon18/18:c.2997_2999del:p.Glu1000del:,SECISBP2L:NM_014701.4:inframe_deletion:MODERATE:exon17/17:c.2862_2864del:p.Glu955del:					(TCT)n (Simple_repeat)	rs754730165		0.0002	0,.	0.0001,0.0001,0.0000,0.0002,0.0001	7.5050				22.00						0	10	0 / 2					SECISBP2L (inh=n/a oe_syn=1.02 oe_mis=0.82 oe_lof=0.23)
chr15	51757826	51757826	T	C	het		QUAL=288;DP=48;AF=0.31;MQM=60;SAP=4;ABP=18	DMXL2,RP11-707P17.1	missense,intron&non_coding_transcript	DMXL2:ENST00000251076:missense_variant:MODERATE:exon31/43:c.7540A>G:p.Met2514Val:,DMXL2:ENST00000449909:missense_variant:MODERATE:exon29/41:c.5632A>G:p.Met1878Val:,DMXL2:ENST00000543779:missense_variant:MODERATE:exon31/43:c.7543A>G:p.Met2515Val:,RP11-707P17.1:ENST00000561007:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/5:n.327-561T>C::	DMXL2:NM_001174116.2:missense_variant:MODERATE:exon31/43:c.7543A>G:p.Met2515Val:,DMXL2:NM_001174117.2:missense_variant:MODERATE:exon29/41:c.5632A>G:p.Met1878Val:,DMXL2:NM_015263.4:missense_variant:MODERATE:exon31/43:c.7540A>G:p.Met2514Val:		612186 [GENE=DMXL2 PHENOS=Deafness,autosomal dominant 71,617605,Autosomal dominant/Polyendocrine-polyneuropathy syndrome,616113,Autosomal recessive/Epileptic encephalopathy,early infantile,81,618663,Autosomal recessive];				rs72729259	0.0002	0.0004	0,.	0.0004,0.0009,0.0002,0.0002,0.0003	2.8260	T(0.20),T(0.29),T(0.20), 	B(0.01),P(0.45),B(0.02), 	0.92,0.98	17.24	0.07					0	10	0 / 0					DMXL2 (inh=AR oe_syn=1.03 oe_mis=0.83 oe_lof=0.10)
chr15	63948368	63948368	C	T	het		QUAL=2814;DP=222;AF=0.48;MQM=60;SAP=4;ABP=4	HERC1	synonymous	HERC1:ENST00000443617:synonymous_variant:LOW:exon49/78:c.9789G>A:p.Leu3263=:	HERC1:NM_003922.4:synonymous_variant:LOW:exon49/78:c.9789G>A:p.Leu3263=:		605109 [GENE=HERC1 PHENOS=Macrocephaly,dysmorphic facies,and psychomotor retardation,617011,Autosomal recessive];				rs56318707	0.0002	0.0001		0.0000,0.0001,0.0000,0.0001,0.0000	0.1530			0.81,0.96	10.99						0	5	0 / 0					HERC1 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.19)
chr15	65114756	65114756	C	T	het		QUAL=1623;DP=136;AF=0.51;MQM=60;SAP=51;ABP=3	PIF1	synonymous	PIF1:ENST00000268043:synonymous_variant:LOW:exon3/13:c.612G>A:p.Lys204=:,PIF1:ENST00000333425:synonymous_variant:LOW:exon3/13:c.612G>A:p.Lys204=:,PIF1:ENST00000559239:synonymous_variant:LOW:exon3/13:c.612G>A:p.Lys204=:	PIF1:NM_001286496.2:synonymous_variant:LOW:exon3/13:c.612G>A:p.Lys204=:,PIF1:NM_001286497.2:synonymous_variant:LOW:exon3/13:c.612G>A:p.Lys204=:,PIF1:NM_001286499.2:synonymous_variant:LOW:exon3/13:c.453G>A:p.Lys151=:,PIF1:NM_025049.4:synonymous_variant:LOW:exon3/13:c.612G>A:p.Lys204=:						rs72744798	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	0.4170			0.67,0.96	11.91						0	7	0 / 0					PIF1 (inh=n/a oe_syn=0.83 oe_mis=0.95 oe_lof=0.95)
chr15	71548995	71548995	C	T	het		QUAL=726;DP=94;AF=0.35;MQM=60;SAP=4;ABP=21	THSD4	missense	THSD4:ENST00000261862:missense_variant:MODERATE:exon5/17:c.956C>T:p.Ala319Val:,THSD4:ENST00000355327:missense_variant:MODERATE:exon6/18:c.956C>T:p.Ala319Val:	THSD4:NM_024817.2:missense_variant:MODERATE:exon5/17:c.956C>T:p.Ala319Val:						rs72759649	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	5.6300	D(0.00),D(0.00)	D(0.99),D(0.99)	0.92,0.99	28.10	0.39					0	5	0 / 0					THSD4 (inh=n/a oe_syn=0.98 oe_mis=0.95 oe_lof=0.39)
chr15	73428374	73428374	T	C	het		QUAL=432;DP=48;AF=0.42;MQM=60;SAP=19;ABP=6	NEO1	splice_region&intron	NEO1:ENST00000261908:splice_region_variant&intron_variant:LOW:intron5/28:c.1015+6T>C::,NEO1:ENST00000339362:splice_region_variant&intron_variant:LOW:intron6/29:c.1015+6T>C::,NEO1:ENST00000558964:splice_region_variant&intron_variant:LOW:intron5/27:c.1015+6T>C::,NEO1:ENST00000560262:splice_region_variant&intron_variant:LOW:intron5/27:c.1015+6T>C::	NEO1:NM_001172623.1:splice_region_variant&intron_variant:LOW:intron5/27:c.1015+6T>C::,NEO1:NM_001172624.1:splice_region_variant&intron_variant:LOW:intron5/27:c.1015+6T>C::,NEO1:NM_002499.4:splice_region_variant&intron_variant:LOW:intron5/28:c.1015+6T>C::						rs72741418	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0002,0.0000	0.0500			0.05,0.26	11.00		9.79>9.55		0.009/0.182		0	6	0 / 0					NEO1 (inh=n/a oe_syn=0.94 oe_mis=0.84 oe_lof=0.23)
chr15	78572759	78572759	A	G	het		QUAL=1263;DP=103;AF=0.50;MQM=60;SAP=22;ABP=3	DNAJA4	missense	DNAJA4:ENST00000343789:missense_variant:MODERATE:exon8/8:c.1151A>G:p.Asp384Gly:,DNAJA4:ENST00000394852:missense_variant:MODERATE:exon7/7:c.1151A>G:p.Asp384Gly:,DNAJA4:ENST00000394855:missense_variant:MODERATE:exon8/8:c.1238A>G:p.Asp413Gly:,DNAJA4:ENST00000446172:missense_variant:MODERATE:exon7/7:c.1070A>G:p.Asp357Gly:	DNAJA4:NM_001130182.1:missense_variant:MODERATE:exon7/7:c.1151A>G:p.Asp384Gly:,DNAJA4:NM_001130183.1:missense_variant:MODERATE:exon7/7:c.1070A>G:p.Asp357Gly:,DNAJA4:NM_018602.3:missense_variant:MODERATE:exon8/8:c.1238A>G:p.Asp413Gly:						rs77568880	0.0002	0.0004	0,.	0.0002,0.0001,0.0000,0.0009,0.0000	9.1450	D(0.00),D(0.00),D(0.01),D(0.00)	B(0.16),B(0.16),B(0.32),B(0.08)	0.98,0.97	24.60	0.43					0	9	0 / 3					DNAJA4 (inh=n/a oe_syn=1.04 oe_mis=0.83 oe_lof=0.40), WDR61 (inh=n/a oe_syn=0.88 oe_mis=0.57 oe_lof=0.39)
chr15	79186472	79186472	C	T	het		QUAL=2881;DP=200;AF=0.55;MQM=50;SAP=29;ABP=7	MORF4L1	synonymous	MORF4L1:ENST00000331268:synonymous_variant:LOW:exon11/13:c.819C>T:p.Leu273=:PF05712 [MRG],MORF4L1:ENST00000379535:synonymous_variant:LOW:exon11/13:c.777C>T:p.Leu259=:PF05712 [MRG],MORF4L1:ENST00000426013:synonymous_variant:LOW:exon10/12:c.702C>T:p.Leu234=:PF05712 [MRG],MORF4L1:ENST00000558502:synonymous_variant:LOW:exon8/10:c.438C>T:p.Leu146=:PF05712 [MRG],MORF4L1:ENST00000558746:synonymous_variant:LOW:exon9/10:c.621C>T:p.Leu207=:PF05712 [MRG],MORF4L1:ENST00000559345:synonymous_variant:LOW:exon10/12:c.438C>T:p.Leu146=:PF05712 [MRG]	MORF4L1:NM_001265603.1:synonymous_variant:LOW:exon8/10:c.438C>T:p.Leu146=:,MORF4L1:NM_001265604.1:synonymous_variant:LOW:exon10/12:c.438C>T:p.Leu146=:,MORF4L1:NM_001265605.1:synonymous_variant:LOW:exon10/12:c.438C>T:p.Leu146=:,MORF4L1:NM_006791.4:synonymous_variant:LOW:exon10/12:c.702C>T:p.Leu234=:,MORF4L1:NM_206839.2:synonymous_variant:LOW:exon11/13:c.819C>T:p.Leu273=:						rs56106800	0.0002	0.0001		0.0000,0.0001,0.0000,0.0001,0.0000	-0.3050			0.52,0.95	9.68						0	8	0 / 1					MORF4L1 (inh=n/a oe_syn=1.05 oe_mis=0.68 oe_lof=0.08), RNU6-415P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr15	82337623	82337623	C	T	het		QUAL=2300;DP=160;AF=0.58;MQM=60;SAP=106;ABP=11	MEX3B	intron,missense	MEX3B:ENST00000329713:intron_variant:MODIFIER:intron1/1:c.256+168G>A::,MEX3B:ENST00000558133:missense_variant:MODERATE:exon1/1:c.424G>A:p.Ala142Thr:	MEX3B:NM_032246.6:intron_variant:MODIFIER:intron1/1:c.256+168G>A::	regulatory_region_variant:promoter					rs114188987		0.0001	0,.	0.0000,0.0000,0.0000,0.0002,0.0000	3.1650	 ,T(0.20)	 , (0.00)	0.74,0.58	16.48						0	7	0 / 0					MEX3B (inh=n/a oe_syn=1.40 oe_mis=0.84 oe_lof=0.18)
chr15	89817440	89817440	G	A	het		QUAL=898;DP=105;AF=0.40;MQM=60;SAP=24;ABP=12	FANCI	synonymous	FANCI:ENST00000300027:synonymous_variant:LOW:exon12/37:c.1017G>A:p.Lys339=:PF14679 [FANCI helical domain 1],FANCI:ENST00000310775:synonymous_variant:LOW:exon12/38:c.1017G>A:p.Lys339=:PF14679 [FANCI helical domain 1]	FANCI:NM_001113378.1:synonymous_variant:LOW:exon12/38:c.1017G>A:p.Lys339=:,FANCI:NM_018193.3:synonymous_variant:LOW:exon12/37:c.1017G>A:p.Lys339=:		611360 [GENE=FANCI PHENOS=Fanconi anemia,complementation group I,609053,Autosomal recessive];				rs72762644	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	3.9550			0.94,0.98	11.19						0	10	0 / 0					FANCI (inh=AR oe_syn=1.15 oe_mis=1.15 oe_lof=0.83)
chr15	93595610	93595610	C	T	het		QUAL=2484;DP=205;AF=0.48;MQM=60;SAP=4;ABP=4	RGMA	synonymous,5'UTR,intron	RGMA:ENST00000329082:synonymous_variant:LOW:exon3/4:c.258G>A:p.Thr86=:PF06535 [Repulsive guidance molecule (RGM) N-terminus],RGMA:ENST00000425933:synonymous_variant:LOW:exon3/4:c.210G>A:p.Thr70=:PF06535 [Repulsive guidance molecule (RGM) N-terminus],RGMA:ENST00000538818:5_prime_UTR_variant:MODIFIER:exon4/5:c.-70G>A::,RGMA:ENST00000542321:synonymous_variant:LOW:exon2/3:c.210G>A:p.Thr70=:PF06535 [Repulsive guidance molecule (RGM) N-terminus],RGMA:ENST00000543599:synonymous_variant:LOW:exon3/4:c.210G>A:p.Thr70=:PF06535 [Repulsive guidance molecule (RGM) N-terminus],RGMA:ENST00000556087:synonymous_variant:LOW:exon3/3:c.210G>A:p.Thr70=:PF06535 [Repulsive guidance molecule (RGM) N-terminus],RGMA:ENST00000556658:5_prime_UTR_variant:MODIFIER:exon4/5:c.-70G>A::,RGMA:ENST00000557301:synonymous_variant:LOW:exon3/4:c.282G>A:p.Thr94=:PF06535 [Repulsive guidance molecule (RGM) N-terminus],RGMA:ENST00000557420:intron_variant:MODIFIER:intron1/1:c.83-6675G>A::	RGMA:NM_001166283.1:synonymous_variant:LOW:exon3/4:c.282G>A:p.Thr94=:,RGMA:NM_001166286.2:synonymous_variant:LOW:exon2/3:c.210G>A:p.Thr70=:,RGMA:NM_001166287.1:synonymous_variant:LOW:exon3/4:c.210G>A:p.Thr70=:,RGMA:NM_001166288.2:synonymous_variant:LOW:exon3/4:c.210G>A:p.Thr70=:,RGMA:NM_001166289.1:synonymous_variant:LOW:exon3/4:c.210G>A:p.Thr70=:,RGMA:NM_020211.3:synonymous_variant:LOW:exon3/4:c.258G>A:p.Thr86=:						rs56039462	0.0004	0.0001	0,.	0.0004,0.0000,0.0000,0.0001,0.0000	-1.6510			0.11,0.81	6.97						0	6	0 / 1					RGMA (inh=n/a oe_syn=1.09 oe_mis=0.84 oe_lof=0.27)
chr16	3639230	3639230	G	A	het		QUAL=2615;DP=235;AF=0.45;MQM=60;SAP=3;ABP=9	SLX4	missense	SLX4:ENST00000294008:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:	SLX4:NM_032444.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:		613278 [GENE=SLX4 PHENOS=Fanconi anemia,complementation group P,613951,Autosomal recessive];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4];		rs72778139	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0002,0.0000	0.3390	T(0.16)	B(0.06)	0.25,0.84	19.12	0.11					0	15	0 / 0					SLX4 (inh=AR oe_syn=1.24 oe_mis=1.16 oe_lof=0.68)
chr16	3712963	3712963	C	T	het		QUAL=2042;DP=200;AF=0.42;MQM=60;SAP=5;ABP=16	TRAP1,DNASE1	missense,intron	TRAP1:ENST00000246957:missense_variant:MODERATE:exon15/18:c.1714G>A:p.Glu572Lys:PF00183 [Hsp90 protein],DNASE1:ENST00000414110:intron_variant:MODIFIER:intron7/7:c.*45+158C>T::,TRAP1:ENST00000538171:missense_variant:MODERATE:exon14/17:c.1555G>A:p.Glu519Lys:PF00183 [Hsp90 protein],TRAP1:ENST00000575671:missense_variant:MODERATE:exon10/13:c.1087G>A:p.Glu363Lys:PF00183 [Hsp90 protein]	TRAP1:NM_001272049.2:missense_variant:MODERATE:exon14/17:c.1555G>A:p.Glu519Lys:,TRAP1:NM_016292.3:missense_variant:MODERATE:exon15/18:c.1714G>A:p.Glu572Lys:		125505 [GENE=DNASE1 PHENOS=Systemic lupus erythematosus,susceptibility to,152700,Autosomal dominant];	559146 [uncertain significance DISEASE=not provided];			rs55766649	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0004	7.1290	T(0.30), ,T(0.36),T(0.31)	B(0.03), ,B(0.02),B(0.03)	0.99,0.97	21.90	0.13					0	7	0 / 0					DNASE1 (inh=AD oe_syn=1.51 oe_mis=1.55 oe_lof=1.65), TRAP1 (inh=n/a oe_syn=1.41 oe_mis=1.37 oe_lof=1.09)
chr16	27788990	27788990	G	A	het		QUAL=2557;DP=207;AF=0.49;MQM=60;SAP=55;ABP=3	KATNIP	synonymous	KATNIP:ENST00000261588:synonymous_variant:LOW:exon26/28:c.4611G>A:p.Val1537=:	KIAA0556:NM_015202.4:synonymous_variant:LOW:exon26/28:c.4611G>A:p.Val1537=:		616650 [GENE=KATNIP PHENOS=Joubert syndrome 26,616784,Autosomal recessive];				rs72780133	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-4.5690			0.01,0.06	0.22						0	7	0 / 0					KATNIP (inh=AR oe_syn=1.01 oe_mis=1.01 oe_lof=0.73)
chr16	75669804	75669804	G	A	het		QUAL=1500;DP=155;AF=0.40;MQM=60;SAP=8;ABP=16	KARS1	splice_region&intron,intron	KARS1:ENST00000302445:splice_region_variant&intron_variant:LOW:intron5/13:c.669+6C>T::,KARS1:ENST00000319410:splice_region_variant&intron_variant:LOW:intron6/14:c.753+6C>T::,KARS1:ENST00000568378:intron_variant:MODIFIER:intron2/2:c.147-7917C>T::	KARS:NM_001130089.1:splice_region_variant&intron_variant:LOW:intron6/14:c.753+6C>T::,KARS:NM_005548.2:splice_region_variant&intron_variant:LOW:intron5/13:c.669+6C>T::		601421 [GENE=KARS1 PHENOS=Charcot-Marie-Tooth disease,recessive intermediate,B,613641,Autosomal recessive/Deafness,autosomal recessive 89,613916,Autosomal recessive];	320636 [uncertain significance DISEASE=Charcot-Marie-Tooth, Intermediate];			rs72789443	0.0008	0.0001	0,.	0.0000,0.0000,0.0008,0.0001,0.0000	0.0000			0.06,0.25	2.46		10.22>11.00		0.000/0.038		0	7	0 / 0					KARS1 (inh=AR oe_syn=1.24 oe_mis=1.11 oe_lof=0.61)
chr16	84495740	84495740	G	C	het		QUAL=596;DP=54;AF=0.48;MQM=60;SAP=36;ABP=3	ATP2C2,RP11-517C16.2	splice_region&intron,non_coding_transcript_exon	ATP2C2:ENST00000262429:splice_region_variant&intron_variant:LOW:intron26/26:c.2722+5G>C::,ATP2C2:ENST00000416219:splice_region_variant&intron_variant:LOW:intron27/27:c.2809+5G>C::,RP11-517C16.2:ENST00000565700:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.924C>G::	ATP2C2:NM_001286527.2:splice_region_variant&intron_variant:LOW:intron27/27:c.2809+5G>C::,ATP2C2:NM_001291454.1:splice_region_variant&intron_variant:LOW:intron23/23:c.2269+5G>C::,ATP2C2:NM_014861.3:splice_region_variant&intron_variant:LOW:intron26/26:c.2722+5G>C::,ATP2C2-AS1:NR_146503.1:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.924C>G::						rs72806654	0.0002	0.0001		0.0001,0.0003,0.0000,0.0001,0.0000	9.2470			0.99,0.97	24.90		9.27>1.23	gain/acceptor/84495739-84495740/Medium/6.735259	1.000/0.964		0	7	0 / 0					ATP2C2 (inh=n/a oe_syn=1.68 oe_mis=1.66 oe_lof=1.53), ATP2C2-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr17	16062134	16062134	G	C	het		QUAL=1682;DP=131;AF=0.50;MQM=60;SAP=15;ABP=3	NCOR1	synonymous	NCOR1:ENST00000268712:synonymous_variant:LOW:exon6/46:c.672C>G:p.Ser224=:,NCOR1:ENST00000395848:synonymous_variant:LOW:exon3/19:c.345C>G:p.Ser115=:,NCOR1:ENST00000395851:synonymous_variant:LOW:exon5/45:c.672C>G:p.Ser224=:	NCOR1:NM_001190438.1:synonymous_variant:LOW:exon3/19:c.345C>G:p.Ser115=:,NCOR1:NM_001190440.1:synonymous_variant:LOW:exon5/45:c.672C>G:p.Ser224=:,NCOR1:NM_006311.4:synonymous_variant:LOW:exon6/46:c.672C>G:p.Ser224=:						rs72835314	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0001	0.6300			0.82,0.93	10.01						0	6	0 / 0					NCOR1 (inh=n/a oe_syn=0.98 oe_mis=0.70 oe_lof=0.11)
chr17	28778817	28778817	T	C	het		QUAL=1186;DP=103;AF=0.47;MQM=60;SAP=3;ABP=4	CPD	missense	CPD:ENST00000225719:missense_variant:MODERATE:exon14/21:c.3158T>C:p.Ile1053Thr:PF00246 [Zinc carboxypeptidase],CPD:ENST00000543464:missense_variant:MODERATE:exon14/21:c.2417T>C:p.Ile806Thr:PF00246 [Zinc carboxypeptidase]	CPD:NM_001199775.1:missense_variant:MODERATE:exon14/21:c.2417T>C:p.Ile806Thr:,CPD:NM_001304.5:missense_variant:MODERATE:exon14/21:c.3158T>C:p.Ile1053Thr:						rs72809814	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	-0.4350	T(0.48),T(0.51)	B(0.00),B(0.00)	0.06,0.20	7.96	0.03					0	10	0 / 0					CPD (inh=n/a oe_syn=0.93 oe_mis=0.73 oe_lof=0.29)
chr17	55957068	55957068	G	A	het		QUAL=1114;DP=107;AF=0.44;MQM=60;SAP=3;ABP=6	CUEDC1	missense,5'UTR	CUEDC1:ENST00000360238:missense_variant:MODERATE:exon3/11:c.368C>T:p.Ser123Leu:,CUEDC1:ENST00000407144:missense_variant:MODERATE:exon3/11:c.368C>T:p.Ser123Leu:,CUEDC1:ENST00000577830:missense_variant:MODERATE:exon3/11:c.368C>T:p.Ser123Leu:,CUEDC1:ENST00000577840:5_prime_UTR_variant:MODIFIER:exon2/10:c.-44C>T::	CUEDC1:NM_001271875.2:missense_variant:MODERATE:exon3/11:c.368C>T:p.Ser123Leu:,CUEDC1:NM_001292025.1:missense_variant:MODERATE:exon3/11:c.368C>T:p.Ser123Leu:						rs72839904	0.0004	0.0001	0,.	0.0000,0.0000,0.0001,0.0001,0.0000	9.1270	D(0.00),D(0.00),D(0.00), 	D(0.98),D(0.98),D(0.98), 	0.97,0.99	29.20	0.24					0	5	0 / 0					CUEDC1 (inh=n/a oe_syn=0.84 oe_mis=0.80 oe_lof=0.70)
chr17	61561896	61561896	G	A	het		QUAL=1914;DP=158;AF=0.49;MQM=60;SAP=62;ABP=3	ACE	missense	ACE:ENST00000290866:missense_variant:MODERATE:exon12/25:c.1915G>A:p.Gly639Ser:PF01401 [Angiotensin-converting enzyme],ACE:ENST00000428043:missense_variant:MODERATE:exon12/24:c.1915G>A:p.Gly639Ser:PF01401 [Angiotensin-converting enzyme]	ACE:NM_000789.4:missense_variant:MODERATE:exon12/25:c.1915G>A:p.Gly639Ser:		106180 [GENE=ACE PHENOS=Renal tubular dysgenesis,267430,Autosomal recessive/Myocardial infarction,susceptibility to/Microvascular complications of diabetes 3,612624/Angiotensin I-converting enzyme,benign serum increase/SARS,progression of/Stroke,hemorrhagic,614519];	324389 [uncertain significance DISEASE=Renal dysplasia];			rs72845024	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0001	3.2170	T(0.28),T(0.26)	B(0.02),B(0.01)	0.87,0.94	16.39	0.04					0	9	0 / 1					ACE (inh=AR oe_syn=1.24 oe_mis=1.07 oe_lof=0.87)
chr17	61987944	61987944	C	A	het		QUAL=2223;DP=179;AF=0.49;MQM=60;SAP=25;ABP=3	CSHL1	intron,missense	CSHL1:ENST00000259003:intron_variant:MODIFIER:intron2/4:c.74-118G>T::,CSHL1:ENST00000309894:intron_variant:MODIFIER:intron2/4:c.191-49G>T::,CSHL1:ENST00000346606:intron_variant:MODIFIER:intron1/3:c.-96-45G>T::,CSHL1:ENST00000392824:missense_variant:MODERATE:exon2/3:c.351G>T:p.Gln117His:,CSHL1:ENST00000438387:intron_variant:MODIFIER:intron1/3:c.11-118G>T::,CSHL1:ENST00000450719:intron_variant:MODIFIER:intron1/2:c.-96-45G>T::,CSHL1:ENST00000561003:intron_variant:MODIFIER:intron1/2:c.11-118G>T::	CSHL1:NM_001318.4:intron_variant:MODIFIER:intron1/3:c.-96-45G>T::,CSHL1:NM_001321067.2:intron_variant:MODIFIER:intron1/3:c.11-49G>T::,CSHL1:NM_001321068.2:intron_variant:MODIFIER:intron2/4:c.74-118G>T::,CSHL1:NM_001321069.2:intron_variant:MODIFIER:intron2/4:c.70-45G>T::,CSHL1:NM_022579.3:intron_variant:MODIFIER:intron2/4:c.191-49G>T::,CSHL1:NM_022580.3:intron_variant:MODIFIER:intron1/3:c.11-118G>T::,CSHL1:NM_022581.3:intron_variant:MODIFIER:intron2/4:c.191-118G>T::						rs55681556	0.0004	0.0004	0,.	0.0001,0.0000,0.0000,0.0006,0.0000	-0.2300	 , , ,D(0.00), , , 	 , , ,P(0.81), , , 	0.02,0.17	3.09	0.25					0	10	0 / 0					CSHL1 (inh=n/a oe_syn=1.43 oe_mis=1.43 oe_lof=1.43)
chr17	76462874	76462874	C	G	het	gene_blacklist	QUAL=2353;DP=193;AF=0.49;MQM=60;SAP=16;ABP=3	DNAH17	missense	DNAH17:ENST00000389840:missense_variant:MODERATE:exon56/81:c.8761G>C:p.Gly2921Arg:PF12780 [P-loop containing dynein motor region D4],DNAH17:ENST00000585328:missense_variant:MODERATE:exon56/81:c.8788G>C:p.Gly2930Arg:PF12780 [P-loop containing dynein motor region D4]	DNAH17:NM_173628.4:missense_variant:MODERATE:exon56/81:c.8803G>C:p.Gly2935Arg:		610063 [GENE=DNAH17 PHENOS=Spermatogenic failure 39,618643,Autosomal recessive];				rs72925862	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	7.3240	D(0.00),D(0.00)	D(1.00),D(1.00)	0.98,0.99	29.90	0.53					0	7	0 / 0					DNAH17 (inh=n/a oe_syn=1.40 oe_mis=1.17 oe_lof=0.65)
chr17	76471352	76471352	G	A	het	gene_blacklist	QUAL=582;DP=102;AF=0.31;MQM=60;SAP=25;ABP=34	DNAH17	splice_region&intron	DNAH17:ENST00000389840:splice_region_variant&intron_variant:LOW:intron54/80:c.8469+8C>T::,DNAH17:ENST00000585328:splice_region_variant&intron_variant:LOW:intron54/80:c.8496+8C>T::	DNAH17:NM_173628.4:splice_region_variant&intron_variant:LOW:intron54/80:c.8511+8C>T::		610063 [GENE=DNAH17 PHENOS=Spermatogenic failure 39,618643,Autosomal recessive];				rs116826317					0.3530			0.02,0.16	0.42				0.000/0.000		0	3	0 / 0					DNAH17 (inh=n/a oe_syn=1.40 oe_mis=1.17 oe_lof=0.65)
chr17	77044002	77044002	C	T	het		QUAL=2846;DP=212;AF=0.51;MQM=60;SAP=30;ABP=3	C1QTNF1	synonymous	C1QTNF1:ENST00000311661:synonymous_variant:LOW:exon3/3:c.432C>T:p.Gly144=:PF00386 [C1q domain],C1QTNF1:ENST00000339142:synonymous_variant:LOW:exon5/5:c.678C>T:p.Gly226=:PF00386 [C1q domain],C1QTNF1:ENST00000354124:synonymous_variant:LOW:exon4/4:c.708C>T:p.Gly236=:PF00386 [C1q domain],C1QTNF1:ENST00000392445:synonymous_variant:LOW:exon4/4:c.678C>T:p.Gly226=:PF00386 [C1q domain],C1QTNF1:ENST00000578229:synonymous_variant:LOW:exon4/4:c.432C>T:p.Gly144=:PF00386 [C1q domain],C1QTNF1:ENST00000579760:synonymous_variant:LOW:exon4/4:c.678C>T:p.Gly226=:PF00386 [C1q domain],C1QTNF1:ENST00000580454:synonymous_variant:LOW:exon5/5:c.678C>T:p.Gly226=:PF00386 [C1q domain],C1QTNF1:ENST00000580474:synonymous_variant:LOW:exon3/3:c.678C>T:p.Gly226=:PF00386 [C1q domain],C1QTNF1:ENST00000581774:synonymous_variant:LOW:exon4/4:c.678C>T:p.Gly226=:PF00386 [C1q domain],C1QTNF1:ENST00000583904:synonymous_variant:LOW:exon4/4:c.678C>T:p.Gly226=:PF00386 [C1q domain]	C1QTNF1:NM_030968.5:synonymous_variant:LOW:exon4/4:c.678C>T:p.Gly226=:,C1QTNF1:NM_153372.2:synonymous_variant:LOW:exon4/4:c.678C>T:p.Gly226=:,C1QTNF1:NM_198593.4:synonymous_variant:LOW:exon4/4:c.678C>T:p.Gly226=:,C1QTNF1:NM_198594.4:synonymous_variant:LOW:exon3/3:c.432C>T:p.Gly144=:,C1QTNF1:NR_049769.3:non_coding_transcript_exon_variant:MODIFIER:exon4/4:n.1003C>T::						rs72853332	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	0.7450			0.87,0.98	10.81						0	5	0 / 0					C1QTNF1 (inh=n/a oe_syn=0.95 oe_mis=0.89 oe_lof=0.58)
chr17	79504083	79504083	G	A	het		QUAL=997;DP=83;AF=0.54;MQM=60;SAP=101;ABP=4	FSCN2	missense	FSCN2:ENST00000334850:missense_variant:MODERATE:exon5/5:c.1528G>A:p.Gly510Arg:PF06268 [Fascin domain],FSCN2:ENST00000417245:missense_variant:MODERATE:exon5/5:c.1456G>A:p.Gly486Arg:PF06268 [Fascin domain]	FSCN2:NM_001077182.3:missense_variant:MODERATE:exon5/5:c.1528G>A:p.Gly510Arg:,FSCN2:NM_012418.4:missense_variant:MODERATE:exon5/5:c.1456G>A:p.Gly486Arg:	regulatory_region_variant:promoter_flanking_region	607643 [GENE=FSCN2 PHENOS=Retinitis pigmentosa 30,607921];				rs1030790374		0.0000		0.0000,0.0000,0.0000,0.0000,0.0000	0.5340	T(0.44),T(0.45)	B(0.01),B(0.00)	0.16,0.23	13.68	0.07					0	8	0 / 0					FSCN2 (inh=AD oe_syn=1.19 oe_mis=1.02 oe_lof=1.01), FAAP100 (inh=n/a oe_syn=1.20 oe_mis=0.91 oe_lof=0.46)
chr18	2700877	2700877	A	G	het		QUAL=1263;DP=109;AF=0.47;MQM=60;SAP=18;ABP=4	SMCHD1,RP11-703M24.5	synonymous,intron&non_coding_transcript	SMCHD1:ENST00000261598:synonymous_variant:LOW:exon12/46:c.1608A>G:p.Lys536=:,SMCHD1:ENST00000320876:synonymous_variant:LOW:exon12/48:c.1608A>G:p.Lys536=:,RP11-703M24.5:ENST00000583546:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.371-8999T>C::	SMCHD1:NM_015295.2:synonymous_variant:LOW:exon12/48:c.1608A>G:p.Lys536=:		614982 [GENE=SMCHD1 PHENOS=Fascioscapulohumeral muscular dystrophy 2,digenic,158901/Bosma arhinia microphthalmia syndrome,603457,Autosomal dominant];	260630 [likely benign(replaced by megSAP based on classifications:2x2,1x3) DISEASE=Facioscapulohumeral muscular dystrophy 2,not specified,not provided];			rs72862973	0.0004	0.0002	0,.	0.0001,0.0000,0.0000,0.0003,0.0000	1.8500			0.73,0.97	11.89						0	9	0 / 2					SMCHD1 (inh=AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.09)
chr18	13826694	13826694	T	C	het		QUAL=1064;DP=89;AF=0.51;MQM=60;SAP=44;ABP=3	MC5R	synonymous	MC5R:ENST00000324750:synonymous_variant:LOW:exon1/1:c.930T>C:p.Ile310=:	MC5R:NM_005913.3:synonymous_variant:LOW:exon2/2:c.930T>C:p.Ile310=:						rs72872410	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.0350			0.64,0.96	2.31						0	7	0 / 0					MC5R (inh=n/a oe_syn=1.01 oe_mis=0.99 oe_lof=1.10)
chr18	29790526	29790526	G	A	het		QUAL=681;DP=80;AF=0.39;MQM=60;SAP=28;ABP=12	MEP1B	missense	MEP1B:ENST00000269202:missense_variant:MODERATE:exon10/15:c.982G>A:p.Glu328Lys:PF00629 [MAM domain meprin/A5/mu],MEP1B:ENST00000581447:missense_variant:MODERATE:exon10/15:c.982G>A:p.Glu328Lys:PF00629 [MAM domain meprin/A5/mu]	MEP1B:NM_001308171.2:missense_variant:MODERATE:exon10/15:c.982G>A:p.Glu328Lys:,MEP1B:NM_005925.3:missense_variant:MODERATE:exon10/15:c.982G>A:p.Glu328Lys:						rs115830020	0.0002				9.4140	D(0.01),D(0.01)	P(0.58),P(0.51)	0.99,1.00	27.70	0.49					0	4	0 / 0					MEP1B (inh=n/a oe_syn=0.76 oe_mis=0.90 oe_lof=0.97)
chr18	67755337	67755337	T	G	het		QUAL=2112;DP=157;AF=0.52;MQM=60;SAP=16;ABP=4	RTTN	missense,3'UTR	RTTN:ENST00000255674:missense_variant:MODERATE:exon31/49:c.4190A>C:p.Glu1397Ala:,RTTN:ENST00000437017:missense_variant:MODERATE:exon31/36:c.4190A>C:p.Glu1397Ala:,RTTN:ENST00000454359:3_prime_UTR_variant:MODIFIER:exon30/48:c.*1461A>C::	RTTN:NM_001318520.2:missense_variant:MODERATE:exon30/48:c.1454A>C:p.Glu485Ala:,RTTN:NM_173630.4:missense_variant:MODERATE:exon31/49:c.4190A>C:p.Glu1397Ala:	regulatory_region_variant:CTCF_binding_site	610436 [GENE=RTTN PHENOS=Microcephaly,short stature,and polymicrogyria with seizures,614833,Autosomal recessive];				rs72959893	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	4.8430	D(0.04),D(0.04), 	B(0.03),B(0.03), 	0.89,0.96	22.50	0.08					0	8	0 / 0					RTTN (inh=AR oe_syn=1.03 oe_mis=0.99 oe_lof=0.61)
chr19	4175104	4175104	C	T	het		QUAL=3814;DP=291;AF=0.50;MQM=60;SAP=4;ABP=3	SIRT6	missense	SIRT6:ENST00000305232:missense_variant:MODERATE:exon6/7:c.578G>A:p.Arg193Gln:,SIRT6:ENST00000337491:missense_variant:MODERATE:exon7/8:c.659G>A:p.Arg220Gln:PF02146 [Sir2 family],SIRT6:ENST00000381935:missense_variant:MODERATE:exon6/7:c.443G>A:p.Arg148Gln:PF02146 [Sir2 family],SIRT6:ENST00000594279:missense_variant:MODERATE:exon7/8:c.403G>A:p.Gly135Ser:,SIRT6:ENST00000601488:missense_variant:MODERATE:exon6/7:c.436G>A:p.Gly146Ser:	SIRT6:NM_001193285.3:missense_variant:MODERATE:exon6/7:c.578G>A:p.Arg193Gln:,SIRT6:NM_001321058.2:missense_variant:MODERATE:exon6/7:c.443G>A:p.Arg148Gln:,SIRT6:NM_001321059.2:missense_variant:MODERATE:exon6/7:c.476G>A:p.Arg159Gln:,SIRT6:NM_001321060.2:missense_variant:MODERATE:exon7/8:c.619G>A:p.Gly207Ser:,SIRT6:NM_001321061.2:missense_variant:MODERATE:exon5/6:c.362G>A:p.Arg121Gln:,SIRT6:NM_001321062.2:missense_variant:MODERATE:exon5/6:c.254G>A:p.Arg85Gln:,SIRT6:NM_001321063.2:missense_variant:MODERATE:exon6/7:c.436G>A:p.Gly146Ser:,SIRT6:NM_001321064.1:missense_variant:MODERATE:exon7/8:c.403G>A:p.Gly135Ser:,SIRT6:NM_016539.4:missense_variant:MODERATE:exon7/8:c.659G>A:p.Arg220Gln:						rs75244031	0.0004	0.0001		0.0000,0.0001,0.0001,0.0001,0.0001	2.1400	T(0.35),T(0.30),T(0.20),T(0.15),T(0.08)	B(0.00),B(0.01),B(0.01),B(0.00),B(0.10)	0.60,0.91	18.15	0.07					0	5	0 / 0					CREB3L3 (inh=n/a oe_syn=1.21 oe_mis=0.96 oe_lof=1.01), SIRT6 (inh=n/a oe_syn=0.95 oe_mis=0.88 oe_lof=0.33)
chr19	6040135	6040135	C	T	het		QUAL=2118;DP=187;AF=0.46;MQM=60;SAP=36;ABP=6	RFX2	synonymous	RFX2:ENST00000303657:synonymous_variant:LOW:exon5/18:c.378G>A:p.Ala126=:PF04589 [RFX1 transcription activation region],RFX2:ENST00000359161:synonymous_variant:LOW:exon5/18:c.378G>A:p.Ala126=:PF04589 [RFX1 transcription activation region],RFX2:ENST00000592546:synonymous_variant:LOW:exon5/17:c.378G>A:p.Ala126=:PF04589 [RFX1 transcription activation region]	RFX2:NM_000635.4:synonymous_variant:LOW:exon5/18:c.378G>A:p.Ala126=:,RFX2:NM_134433.3:synonymous_variant:LOW:exon5/17:c.378G>A:p.Ala126=:						rs76146093	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-1.9470			0.02,0.05	0.03						0	6	0 / 0					RFX2 (inh=n/a oe_syn=0.91 oe_mis=0.66 oe_lof=0.08)
chr19	6535014	6535014	C	A	het		QUAL=2448;DP=175;AF=0.54;MQM=60;SAP=45;ABP=6	TNFSF9	synonymous	TNFSF9:ENST00000245817:synonymous_variant:LOW:exon3/3:c.702C>A:p.Val234=:PF00229 [TNF(Tumour Necrosis Factor) family]	TNFSF9:NM_003811.4:synonymous_variant:LOW:exon3/3:c.702C>A:p.Val234=:						rs72987335	0.0002	0.0001		0.0001,0.0000,0.0000,0.0001,0.0000	1.1340			0.34,0.44	1.96						0	7	0 / 0					TNFSF9 (inh=n/a oe_syn=0.98 oe_mis=1.11 oe_lof=0.24)
chr19	8174220	8174220	G	T	het	gene_blacklist	QUAL=2765;DP=235;AF=0.46;MQM=60;SAP=4;ABP=6	FBN3	synonymous	FBN3:ENST00000270509:synonymous_variant:LOW:exon35/63:c.4509C>A:p.Gly1503=:,FBN3:ENST00000600128:synonymous_variant:LOW:exon36/64:c.4509C>A:p.Gly1503=:,FBN3:ENST00000601739:synonymous_variant:LOW:exon36/64:c.4509C>A:p.Gly1503=:	FBN3:NM_001321431.1:synonymous_variant:LOW:exon36/64:c.4509C>A:p.Gly1503=:,FBN3:NM_032447.5:synonymous_variant:LOW:exon36/64:c.4509C>A:p.Gly1503=:						rs73007464	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.3090			0.18,0.92	3.83						0	7	0 / 0					FBN3 (inh=n/a oe_syn=1.00 oe_mis=0.94 oe_lof=0.62)
chr19	13255588	13255588	C	T	het		QUAL=3155;DP=225;AF=0.53;MQM=60;SAP=7;ABP=5	STX10	missense	STX10:ENST00000242770:missense_variant:MODERATE:exon6/8:c.568G>A:p.Glu190Lys:,STX10:ENST00000343587:missense_variant:MODERATE:exon5/7:c.421G>A:p.Glu141Lys:PF05739 [SNARE domain],STX10:ENST00000587230:missense_variant:MODERATE:exon6/8:c.568G>A:p.Glu190Lys:PF05739 [SNARE domain],STX10:ENST00000589083:missense_variant:MODERATE:exon6/7:c.568G>A:p.Glu190Lys:PF05739 [SNARE domain]	STX10:NM_001271609.2:missense_variant:MODERATE:exon6/8:c.568G>A:p.Glu190Lys:,STX10:NM_001271610.2:missense_variant:MODERATE:exon6/7:c.568G>A:p.Glu190Lys:,STX10:NM_001271611.2:missense_variant:MODERATE:exon5/7:c.421G>A:p.Glu141Lys:,STX10:NM_003765.3:missense_variant:MODERATE:exon6/8:c.568G>A:p.Glu190Lys:						rs73006877	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0001	3.4040	D(0.00),D(0.00),D(0.00),D(0.00)	D(0.97),P(0.77),P(0.81),D(0.97)	0.96,0.99	29.80	0.28					1	6	0 / 0					NACC1 (inh=AD oe_syn=0.97 oe_mis=0.39 oe_lof=0.00), STX10 (inh=n/a oe_syn=0.98 oe_mis=1.00 oe_lof=0.96)
chr19	17476145	17476145	T	A	het		QUAL=1464;DP=162;AF=0.41;MQM=60;SAP=29;ABP=15	PLVAP	missense	PLVAP:ENST00000252590:missense_variant:MODERATE:exon3/6:c.1129A>T:p.Met377Leu:PF06637 [PV-1 protein (PLVAP)]	PLVAP:NM_031310.3:missense_variant:MODERATE:exon3/6:c.1129A>T:p.Met377Leu:		607647 [GENE=PLVAP PHENOS=Diarrhea 10,protein-losing enteropathy type,618183,Autosomal recessive];				rs73016435	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.3980	T(0.64)	B(0.00)	0.01,0.17	0.02	0.02		gain/donor/17476144-17476145/Medium/2.045499			0	5	0 / 0					PLVAP (inh=AR oe_syn=1.11 oe_mis=0.91 oe_lof=0.60)
chr19	18392236	18392236	C	A	het		QUAL=2838;DP=222;AF=0.50;MQM=60;SAP=4;ABP=3	JUND	missense	JUND:ENST00000252818:missense_variant:MODERATE:exon1/1:c.59G>T:p.Gly20Val:PF03957 [Jun-like transcription factor]	JUND:NM_001286968.2:5_prime_UTR_variant:MODIFIER:exon1/1:c.-71G>T::,JUND:NM_005354.6:missense_variant:MODERATE:exon1/1:c.59G>T:p.Gly20Val:	regulatory_region_variant:promoter					rs41478151		0.0002	0,.	0.0000,0.0003,0.0000,0.0004,0.0000	0.2690	T(0.11)	B(0.01)	0.81,0.20	9.43	0.02		gain/donor/18392235-18392236/Medium/2.552562			0	6	0 / 0					JUND (inh=n/a oe_syn=1.39 oe_mis=0.65 oe_lof=0.00), MIR3188 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), RPL39P38 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr19	33167775	33167775	-	G	het		QUAL=1688;DP=141;AF=0.50;MQM=60;SAP=25;ABP=3	RGS9BP	frameshift	RGS9BP:ENST00000334176:frameshift_variant:HIGH:exon1/1:c.614dup:p.Cys206LeufsTer94:	RGS9BP:NM_207391.3:frameshift_variant:HIGH:exon1/1:c.614dup:p.Cys206LeufsTer94:		607814 [GENE=RGS9BP PHENOS=Bradyopsia,608415];		CI100092 [CLASS=DM MUT=ALT PHEN="Retinal dysfunction" GENE=RGS9BP];		rs757764760		0.0004	0,.	0.0001,0.0002,0.0014,0.0004,0.0002					22.70						0	9	0 / 1					ANKRD27 (inh=n/a oe_syn=1.05 oe_mis=1.03 oe_lof=0.87), RGS9BP (inh=AR oe_syn=0.81 oe_mis=0.83 oe_lof=0.87)
chr19	37619845	37619845	C	T	het		QUAL=516;DP=89;AF=0.31;MQM=60;SAP=23;ABP=30	ZNF420,CTC-454I21.4	intron,missense,intron&non_coding_transcript	ZNF420:ENST00000304239:intron_variant:MODIFIER:intron5/5:c.1411+541C>T::,ZNF420:ENST00000337995:missense_variant:MODERATE:exon5/5:c.1952C>T:p.Ala651Val:PF13465 [Zinc-finger double domain],CTC-454I21.4:ENST00000587645:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.166-111G>A::	ZNF420:NM_001329515.2:intron_variant:MODIFIER:intron5/5:c.1915+37C>T::,ZNF420:NM_001329516.2:intron_variant:MODIFIER:intron4/4:c.1915+37C>T::,ZNF420:NM_001329517.1:missense_variant:MODERATE:exon6/6:c.1739C>T:p.Ala580Val:,ZNF420:NM_001329518.1:missense_variant:MODERATE:exon5/5:c.1739C>T:p.Ala580Val:,ZNF420:NM_001329519.1:missense_variant:MODERATE:exon5/5:c.1739C>T:p.Ala580Val:,ZNF420:NM_001329520.1:missense_variant:MODERATE:exon4/4:c.1739C>T:p.Ala580Val:,ZNF420:NM_001329521.2:intron_variant:MODIFIER:intron6/6:c.1702+37C>T::,ZNF420:NM_001329522.2:intron_variant:MODIFIER:intron5/5:c.1411+541C>T::,ZNF420:NM_001329524.2:intron_variant:MODIFIER:intron6/6:c.1198+541C>T::,ZNF420:NM_144689.5:missense_variant:MODERATE:exon5/5:c.1952C>T:p.Ala651Val:	regulatory_region_variant:promoter_flanking_region					rs73023546	0.0002	0.0001	0,.	0.0000,0.0001,0.0000,0.0001,0.0000	-0.1450	 ,T(0.08), 	 ,D(1.00), 	0.00,0.14	23.10	0.14					0	7	0 / 0					ZNF420 (inh=n/a oe_syn=0.97 oe_mis=0.74 oe_lof=0.71)
chr19	40433583	40433583	G	A	het	gene_blacklist	QUAL=4660;DP=354;AF=0.50;MQM=60;SAP=5;ABP=3	FCGBP	missense	FCGBP:ENST00000221347:missense_variant:MODERATE:exon2/36:c.686C>T:p.Ala229Val:	FCGBP:NM_003890.2:missense_variant:MODERATE:exon2/36:c.686C>T:p.Ala229Val:						rs73052606	0.0002	0.0001	0,.	0.0002,0.0000,0.0001,0.0001,0.0000	1.4820	T(0.21)	B(0.01)	0.26,0.90	12.28	0.02					0	10	0 / 0					FCGBP (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=0.65)
chr19	44223138	44223138	G	T	het		QUAL=1831;DP=181;AF=0.42;MQM=60;SAP=3;ABP=13	IRGC	missense	IRGC:ENST00000244314:missense_variant:MODERATE:exon2/2:c.428G>T:p.Arg143Leu:PF05049 [Interferon-inducible GTPase (IIGP)]	IRGC:NM_019612.4:missense_variant:MODERATE:exon2/2:c.428G>T:p.Arg143Leu:						rs56159111	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0002,0.0000	1.2840	T(0.09)	P(0.49)	0.09,0.24	16.12	0.13					0	9	0 / 1					IRGC (inh=n/a oe_syn=1.12 oe_mis=0.82 oe_lof=0.36)
chr19	52520240	52520240	G	A	het		QUAL=921;DP=84;AF=0.44;MQM=60;SAP=3;ABP=6	ZNF614	missense,intron	ZNF614:ENST00000270649:missense_variant:MODERATE:exon5/5:c.611C>T:p.Pro204Leu:,ZNF614:ENST00000356322:intron_variant:MODIFIER:intron5/5:c.481+130C>T::	ZNF614:NM_025040.4:missense_variant:MODERATE:exon5/5:c.611C>T:p.Pro204Leu:						rs73052084	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	0.6100	T(0.23), 	B(0.17), 	0.08,0.21	1.07	0.04					0	5	0 / 0					ZNF614 (inh=n/a oe_syn=0.99 oe_mis=0.96 oe_lof=0.64)
chr19	55349065	55349065	A	T	hom		QUAL=2222;DP=76;AF=0.97;MQM=60;SAP=20;ABP=0	KIR2DS4,KIR3DL1	synonymous,intron	KIR2DS4:ENST00000339924:synonymous_variant:LOW:exon3/8:c.105A>T:p.Pro35=:,KIR3DL1:ENST00000402254:intron_variant:MODIFIER:intron6/8:c.1000+12532A>T::	KIR2DS4:NM_001281971.2:synonymous_variant:LOW:exon3/8:c.105A>T:p.Pro35=:,KIR2DS4:NM_001281972.2:synonymous_variant:LOW:exon3/7:c.105A>T:p.Pro35=:	regulatory_region_variant:promoter_flanking_region	604946 [GENE=KIR3DL1 PHENOS=AIDS,delayed/rapid progression to,609423];				rs544475193	0.0004	0.0001		0.0000,0.0000,0.0001,0.0001,0.0000	-2.8040			0.00,0.08	0.38			loss/acceptor/55349065-55349066/Medium/7.935136			6	2	0 / 0					KIR3DL1 (inh=n/a oe_syn=1.20 oe_mis=1.30 oe_lof=1.24), KIR2DS4 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr20	35766208	35766208	G	C	het		QUAL=707;DP=93;AF=0.35;MQM=60;SAP=22;ABP=20	MROH8	splice_region&intron	MROH8:ENST00000217333:splice_region_variant&intron_variant:LOW:intron9/20:c.1136+5C>G::,MROH8:ENST00000400441:splice_region_variant&intron_variant:LOW:intron13/24:c.1649+5C>G::,MROH8:ENST00000441008:splice_region_variant&intron_variant:LOW:intron15/26:c.1607+5C>G::	MROH8:NM_152503.7:splice_region_variant&intron_variant:LOW:intron13/24:c.1649+5C>G::,MROH8:NM_213631.3:splice_region_variant&intron_variant:LOW:intron13/13:c.1649+5C>G::,MROH8:NM_213632.3:splice_region_variant&intron_variant:LOW:intron12/12:c.1544+5C>G::						rs114766119	0.0002	0.0001		0.0000,0.0001,0.0000,0.0000,0.0004	-0.2540			0.18,0.87	11.84		8.88>10.77				0	3	0 / 0					MROH8 (inh=n/a oe_syn=0.97 oe_mis=0.91 oe_lof=0.64)
chr20	52773814	52773814	G	A	het		QUAL=2592;DP=186;AF=0.53;MQM=60;SAP=3;ABP=5	CYP24A1	synonymous	CYP24A1:ENST00000216862:synonymous_variant:LOW:exon11/12:c.1449C>T:p.Tyr483=:PF00067 [Cytochrome P450],CYP24A1:ENST00000395954:synonymous_variant:LOW:exon9/10:c.1023C>T:p.Tyr341=:PF00067 [Cytochrome P450],CYP24A1:ENST00000395955:synonymous_variant:LOW:exon10/11:c.1251C>T:p.Tyr417=:	CYP24A1:NM_000782.5:synonymous_variant:LOW:exon11/12:c.1449C>T:p.Tyr483=:,CYP24A1:NM_001128915.2:synonymous_variant:LOW:exon10/11:c.1251C>T:p.Tyr417=:	regulatory_region_variant:open_chromatin_region	126065 [GENE=CYP24A1 PHENOS=Hypercalcemia,infantile,1,143880,Autosomal recessive];	338812 [uncertain significance DISEASE=Infantile hypercalcemia];			rs73135773	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-1.2420			0.04,0.19	0.18						0	5	0 / 0					CYP24A1 (inh=AR oe_syn=1.12 oe_mis=1.19 oe_lof=1.15)
chr20	55026995	55026995	G	A	het		QUAL=1203;DP=91;AF=0.53;MQM=60;SAP=6;ABP=4	CASS4	missense,intron	CASS4:ENST00000360314:missense_variant:MODERATE:exon6/7:c.763G>A:p.Val255Ile:,CASS4:ENST00000371336:missense_variant:MODERATE:exon5/6:c.763G>A:p.Val255Ile:,CASS4:ENST00000434344:intron_variant:MODIFIER:intron4/4:c.642+1260G>A::	CASS4:NM_001164114.2:missense_variant:MODERATE:exon5/6:c.601G>A:p.Val201Ile:,CASS4:NM_001164115.2:intron_variant:MODIFIER:intron4/4:c.642+1260G>A::,CASS4:NM_001164116.2:missense_variant:MODERATE:exon6/7:c.763G>A:p.Val255Ile:,CASS4:NM_020356.4:missense_variant:MODERATE:exon5/6:c.763G>A:p.Val255Ile:	regulatory_region_variant:TF_binding_site					rs73159591	0.0002	0.0001		0.0001,0.0002,0.0001,0.0001,0.0000	-1.4800	T(0.30),T(0.30), 	B(0.00),B(0.00), 	0.09,0.22	0.06	0.01					0	7	0 / 0					CASS4 (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.23)
chr20	62250651	62250651	C	T	het		QUAL=2835;DP=262;AF=0.44;MQM=60;SAP=11;ABP=11	GMEB2	missense	GMEB2:ENST00000266068:missense_variant:MODERATE:exon1/9:c.100G>A:p.Val34Met:,GMEB2:ENST00000370077:missense_variant:MODERATE:exon2/10:c.100G>A:p.Val34Met:	GMEB2:NM_012384.5:missense_variant:MODERATE:exon2/10:c.100G>A:p.Val34Met:						rs73134074	0.0002	0.0001		0.0001,0.0000,0.0000,0.0001,0.0000	3.7410	T(0.05),T(0.05)	B(0.03),B(0.03)	0.92,0.98	21.30	0.23					0	7	0 / 0					GMEB2 (inh=n/a oe_syn=1.02 oe_mis=0.66 oe_lof=0.05)
chr21	38459593	38459593	G	A	het		QUAL=1391;DP=124;AF=0.46;MQM=60;SAP=12;ABP=5	TTC3	synonymous,intron	TTC3:ENST00000354749:synonymous_variant:LOW:exon1/45:c.36G>A:p.Ala12=:,TTC3:ENST00000355666:synonymous_variant:LOW:exon2/46:c.36G>A:p.Ala12=:,TTC3:ENST00000399010:synonymous_variant:LOW:exon2/11:c.36G>A:p.Ala12=:,TTC3:ENST00000399017:synonymous_variant:LOW:exon2/46:c.36G>A:p.Ala12=:,TTC3:ENST00000540756:intron_variant:MODIFIER:intron1/17:c.-86+13929G>A::	TTC3:NM_001001894.2:synonymous_variant:LOW:exon2/46:c.36G>A:p.Ala12=:,TTC3:NM_001320703.2:synonymous_variant:LOW:exon2/47:c.102G>A:p.Ala34=:,TTC3:NM_001320704.2:synonymous_variant:LOW:exon2/47:c.36G>A:p.Ala12=:,TTC3:NM_001330681.2:intron_variant:MODIFIER:intron1/36:c.-86+13929G>A::,TTC3:NM_001330682.2:intron_variant:MODIFIER:intron1/36:c.-86+13820G>A::,TTC3:NM_001330683.2:synonymous_variant:LOW:exon2/46:c.36G>A:p.Ala12=:,TTC3:NM_001353936.2:intron_variant:MODIFIER:intron1/36:c.-86+13810G>A::,TTC3:NM_001353937.2:5_prime_UTR_variant:MODIFIER:exon2/45:c.-2066G>A::,TTC3:NM_001353938.2:intron_variant:MODIFIER:intron1/35:c.-1257+13820G>A::,TTC3:NM_003316.4:synonymous_variant:LOW:exon2/46:c.36G>A:p.Ala12=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter_flanking_region					rs73201925	0.0002	0.0001	0,.	0.0000,0.0000,0.0002,0.0001,0.0000	-1.7710			0.02,0.06	0.23						0	5	0 / 0					TTC3 (inh=n/a oe_syn=1.01 oe_mis=0.95 oe_lof=0.73)
chr21	41427767	41427767	A	G	het		QUAL=1524;DP=114;AF=0.53;MQM=60;SAP=10;ABP=4	DSCAM	splice_region&synonymous	DSCAM:ENST00000400454:splice_region_variant&synonymous_variant:LOW:exon29/33:c.4920T>C:p.Ser1640=:	DSCAM:NM_001271534.3:splice_region_variant&synonymous_variant:LOW:exon29/33:c.4920T>C:p.Ser1640=:,DSCAM:NM_001389.5:splice_region_variant&synonymous_variant:LOW:exon29/33:c.4920T>C:p.Ser1640=:,DSCAM:NR_073202.3:splice_region_variant&non_coding_transcript_exon_variant:LOW:exon29/33:n.5226T>C::						rs73221349	0.0002	0.0001	0,.	0.0001,0.0000,0.0000,0.0002,0.0000	1.5610			0.89,0.98	12.39		6.36>6.37		0.000/0.056		0	8	0 / 0					DSCAM (inh=n/a oe_syn=1.07 oe_mis=0.74 oe_lof=0.11)
chr22	22385627	22385627	A	G	het		QUAL=1242;DP=252;AF=0.27;MQM=60;SAP=6;ABP=123	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4902T>C::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.116A>G:p.Lys39Arg:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4902T>C::	regulatory_region_variant:promoter_flanking_region					rs546553527	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.6680	 ,T(0.81)	 ,B(0.01)	0.01,0.13	6.18						0	4	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385660	22385660	G	A	het		QUAL=557;DP=251;AF=0.20;MQM=59;SAP=7;ABP=206	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4935C>T::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.149G>A:p.Ser50Asn:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4935C>T::	regulatory_region_variant:promoter_flanking_region					rs760624399		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-1.2780	 ,T(0.63)	 ,B(0.01)	0.01,0.09	0.01						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385669	22385669	T	C	het		QUAL=729;DP=270;AF=0.20;MQM=59;SAP=10;ABP=209	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4944A>G::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.158T>C:p.Ile53Thr:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4944A>G::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant					rs542590499	0.0004	0.0001		0.0001,0.0000,0.0000,0.0000,0.0000	0.5450	 ,D(0.04)	 ,B(0.41)	0.02,0.25	16.73						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385687	22385687	A	G	het		QUAL=372;DP=266;AF=0.17;MQM=59;SAP=8;ABP=250	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4962T>C::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.176A>G:p.Gln59Arg:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4962T>C::	regulatory_region_variant:promoter_flanking_region					rs776546982		0.0001		0.0000,0.0000,0.0001,0.0000,0.0000	-0.0850	 ,T(0.34)	 ,B(0.02)	0.01,0.14	2.73						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385692	22385702	GAGAAGGGCCC	-	het		QUAL=409;DP=234;AF=0.18;MQM=59;SAP=5;ABP=206	PRAMENP,IGLV4-69	intron&non_coding_transcript,frameshift	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4977_254-4967del::,IGLV4-69:ENST00000390282:frameshift_variant:HIGH:exon2/2:c.181_191del:p.Glu61SerfsTer7:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4977_254-4967del::	regulatory_region_variant:promoter_flanking_region										1.6130							gain/donor/22385695-22385696/Medium/7.464467			0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385704	22385706	CGG	-	het		QUAL=409;DP=234;AF=0.18;MQM=59;SAP=5;ABP=206	PRAMENP,IGLV4-69	intron&non_coding_transcript,inframe_deletion	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4981_254-4979del::,IGLV4-69:ENST00000390282:inframe_deletion:MODERATE:exon2/2:c.193_195del:p.Arg65del:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4981_254-4979del::	regulatory_region_variant:promoter_flanking_region										0.3130				7.73			loss/donor/22385706-22385707/Medium/6.094373&gain/donor/22385706-22385705/Medium/5.272368			0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385714	22385714	T	C	het		QUAL=306;DP=267;AF=0.16;MQM=59;SAP=3;ABP=264	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4989A>G::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.203T>C:p.Met68Thr:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4989A>G::	regulatory_region_variant:promoter_flanking_region					rs1311499280					0.6000	 ,D(0.00)	 ,B(0.36)	0.06,0.21	15.99						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385719	22385719	C	G	het		QUAL=243;DP=267;AF=0.16;MQM=59;SAP=3;ABP=269	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4994G>C::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.208C>G:p.Leu70Val:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-4994G>C::	regulatory_region_variant:promoter_flanking_region					rs555475796		0.0001		0.0000,0.0001,0.0000,0.0001,0.0000	-0.3620	 ,T(0.98)	 ,B(0.01)	0.01,0.11	0.01						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385728	22385728	G	A	het		QUAL=184;DP=279;AF=0.15;MQM=59;SAP=3;ABP=293	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5003C>T::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.217G>A:p.Asp73Asn:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5003C>T::	regulatory_region_variant:promoter_flanking_region					rs561500013	0.0004	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.1210	 ,T(0.13)	 ,B(0.12)	0.05,0.14	12.01						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385741	22385741	G	C	het		QUAL=104;DP=270;AF=0.15;MQM=59;SAP=3;ABP=293	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5016C>G::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.230G>C:p.Ser77Thr:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5016C>G::	regulatory_region_variant:promoter_flanking_region,TF_binding_site_variant					rs113792022	0.0010	0.0001		0.0001,0.0000,0.0000,0.0001,0.0000	-0.7370	 ,T(0.36)	 ,B(0.00)	0.02,0.13	5.32						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385781	22385781	C	T	het		QUAL=409;DP=244;AF=0.18;MQM=58;SAP=3;ABP=220	PRAMENP,IGLV4-69	intron&non_coding_transcript,synonymous	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5056G>A::,IGLV4-69:ENST00000390282:synonymous_variant:LOW:exon2/2:c.270C>T:p.Ser90=:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5056G>A::	regulatory_region_variant:promoter_flanking_region					rs538650616	0.0002	0.0001		0.0000,0.0000,0.0001,0.0001,0.0000	-1.8220			0.02,0.14	3.93						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385831	22385831	A	C	het		QUAL=342;DP=178;AF=0.20;MQM=56;SAP=5;ABP=145	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5106T>G::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.320A>C:p.Glu107Ala:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5106T>G::						rs540871320					3.4590	 ,D(0.00)	 ,P(0.73)	0.75,0.89	23.00						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385838	22385838	C	A	het		QUAL=142;DP=168;AF=0.17;MQM=55;SAP=9;ABP=159	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5113G>T::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.327C>A:p.Asp109Glu:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5113G>T::						rs370357625	0.0002	0.0001		0.0001,0.0000,0.0000,0.0001,0.0000	-0.4860	 ,T(0.18)	 ,B(0.15)	0.12,0.22	0.18						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385843	22385843	A	G	het		QUAL=131;DP=149;AF=0.17;MQM=55;SAP=8;ABP=140	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5118T>C::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.332A>G:p.Tyr111Cys:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5118T>C::						rs756659797		0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.2350	 ,D(0.01)	 ,P(0.65)	0.35,0.31	17.27						0	3	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	22385849	22385849	A	C	het		QUAL=64;DP=144;AF=0.17;MQM=55;SAP=9;ABP=142	PRAMENP,IGLV4-69	intron&non_coding_transcript,missense	PRAMENP:ENST00000337471:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5124T>G::,IGLV4-69:ENST00000390282:missense_variant:MODERATE:exon2/2:c.338A>C:p.Gln113Pro:PF07686 [Immunoglobulin V-set domain]	PRAMENP:NR_135291.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/6:n.254-5124T>G::						rs746353786					-3.1510	 ,T(0.11)	 ,B(0.22)	0.01,0.11	6.34						0	2	0 / 0					PRAMENP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-70 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV4-69 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVI-68 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	23029588	23029588	C	A	het		QUAL=3321;DP=207;AF=0.61;MQM=60;SAP=32;ABP=26	IGLV3-25	missense	IGLV3-25:ENST00000390305:missense_variant:MODERATE:exon2/2:c.190C>A:p.Leu64Met:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::	regulatory_region_variant:promoter_flanking_region,regulatory_region_variant:CTCF_binding_site					rs5751507		0.0001	0,.	0.0003,0.0001,0.0000,0.0001,0.0000	0.0380	T(0.06)	B(0.34)	0.04,0.17	8.05						3	2	0 / 0					IGLV3-25 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	23040691	23040691	G	A	het		QUAL=2375;DP=187;AF=0.52;MQM=53;SAP=9;ABP=4	IGLV2-23	missense	IGLV2-23:ENST00000390306:missense_variant:MODERATE:exon2/2:c.139G>A:p.Asp47Asn:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::						rs577222941	0.0004	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	-0.4030	T(0.99)	B(0.31)	0.05,0.12	0.90						0	4	0 / 0					IGLV3-24 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV2-23 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVVI-22-1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	23040729	23040729	G	C	het		QUAL=1846;DP=154;AF=0.49;MQM=55;SAP=21;ABP=3	IGLV2-23	missense	IGLV2-23:ENST00000390306:missense_variant:MODERATE:exon2/2:c.177G>C:p.Gln59His:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::						rs11558640		0.0001		0.0001,0.0001,0.0000,0.0001,0.0000	1.9440	T(0.07)	B(0.06)	0.70,0.87	13.44						2	4	0 / 0					IGLV3-24 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV2-23 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVVI-22-1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	23040748	23040748	A	C	het		QUAL=1557;DP=143;AF=0.49;MQM=49;SAP=18;ABP=3	IGLV2-23	missense	IGLV2-23:ENST00000390306:missense_variant:MODERATE:exon2/2:c.196A>C:p.Lys66Gln:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::						rs563335533	0.0004	0.0001		0.0001,0.0000,0.0000,0.0001,0.0000	-1.3630	D(0.01)	P(0.85)	0.02,0.10	15.98						2	3	0 / 0					IGLV3-24 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV2-23 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVVI-22-1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	23040770	23040770	G	C	het		QUAL=1335;DP=134;AF=0.49;MQM=45;SAP=18;ABP=3	IGLV2-23	missense	IGLV2-23:ENST00000390306:missense_variant:MODERATE:exon2/2:c.218G>C:p.Ser73Thr:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::						rs371620489		0.0001	0,.	0.0004,0.0001,0.0001,0.0001,0.0000	-3.7890	T(0.13)	B(0.01)	0.05,0.05	0.29			loss/donor/23040770-23040771/Medium/3.778397			2	3	0 / 0					IGLV3-24 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV2-23 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVVI-22-1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	23040822	23040822	C	T	het		QUAL=989;DP=126;AF=0.47;MQM=36;SAP=3;ABP=4	IGLV2-23	synonymous	IGLV2-23:ENST00000390306:synonymous_variant:LOW:exon2/2:c.270C>T:p.Asn90=:PF07686 [Immunoglobulin V-set domain]	::intergenic_variant:MODIFIER::::						rs569703819	0.0004	0.0001		0.0000,0.0000,0.0000,0.0000,0.0001	-0.1030			0.07,0.07	0.34						1	4	0 / 0					IGLV3-24 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLV2-23 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), IGLVVI-22-1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr22	32804176	32804176	G	T	het		QUAL=872;DP=69;AF=0.51;MQM=60;SAP=3;ABP=3	RTCB	missense	RTCB:ENST00000216038:missense_variant:MODERATE:exon3/12:c.226C>A:p.Pro76Thr:PF01139 [tRNA-splicing ligase RtcB],RTCB:ENST00000451746:missense_variant:MODERATE:exon3/8:c.226C>A:p.Pro76Thr:PF01139 [tRNA-splicing ligase RtcB]	RTCB:NM_014306.5:missense_variant:MODERATE:exon3/12:c.226C>A:p.Pro76Thr:						rs73168800	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	9.7690	D(0.00),D(0.00)	D(1.00),D(1.00)	1.00,1.00	28.10	0.69					0	5	0 / 0					RTCB (inh=n/a oe_syn=1.13 oe_mis=0.74 oe_lof=0.33)
chr22	43267405	43267405	T	C	het		QUAL=4059;DP=320;AF=0.49;MQM=60;SAP=31;ABP=3	PACSIN2	synonymous	PACSIN2:ENST00000263246:synonymous_variant:LOW:exon11/11:c.1419A>G:p.Gln473=:PF14604 [Variant SH3 domain],PACSIN2:ENST00000337959:synonymous_variant:LOW:exon10/10:c.1296A>G:p.Gln432=:PF14604 [Variant SH3 domain],PACSIN2:ENST00000402229:synonymous_variant:LOW:exon11/11:c.1419A>G:p.Gln473=:PF14604 [Variant SH3 domain],PACSIN2:ENST00000403744:synonymous_variant:LOW:exon11/11:c.1419A>G:p.Gln473=:PF14604 [Variant SH3 domain],PACSIN2:ENST00000407585:synonymous_variant:LOW:exon10/10:c.1296A>G:p.Gln432=:PF14604 [Variant SH3 domain]	PACSIN2:NM_001184970.3:synonymous_variant:LOW:exon11/11:c.1419A>G:p.Gln473=:,PACSIN2:NM_001184971.1:synonymous_variant:LOW:exon10/10:c.1296A>G:p.Gln432=:,PACSIN2:NM_001349968.1:synonymous_variant:LOW:exon11/11:c.1302A>G:p.Gln434=:,PACSIN2:NM_001349969.1:synonymous_variant:LOW:exon12/12:c.1425A>G:p.Gln475=:,PACSIN2:NM_001349970.1:synonymous_variant:LOW:exon12/12:c.1425A>G:p.Gln475=:,PACSIN2:NM_001349971.1:synonymous_variant:LOW:exon11/11:c.1302A>G:p.Gln434=:,PACSIN2:NM_001349972.1:synonymous_variant:LOW:exon11/11:c.1302A>G:p.Gln434=:,PACSIN2:NM_001349973.1:synonymous_variant:LOW:exon11/11:c.1302A>G:p.Gln434=:,PACSIN2:NM_001349974.1:synonymous_variant:LOW:exon10/10:c.1179A>G:p.Gln393=:,PACSIN2:NM_007229.3:synonymous_variant:LOW:exon11/11:c.1419A>G:p.Gln473=:						rs73176839	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0001,0.0000	-0.2780			0.22,0.96	8.99						0	7	0 / 0					PACSIN2 (inh=n/a oe_syn=1.04 oe_mis=0.79 oe_lof=0.24)
chr22	45255644	45255644	G	T	het		QUAL=1358;DP=160;AF=0.37;MQM=57;SAP=6;ABP=27	ARHGAP8,PRR5-ARHGAP8	intron,missense	ARHGAP8:ENST00000336963:intron_variant:MODIFIER:intron10/10:c.878-2511G>T::,PRR5-ARHGAP8:ENST00000352766:missense_variant:MODERATE:exon16/17:c.1541G>T:p.Arg514Leu:PF00620 [RhoGAP domain],ARHGAP8:ENST00000356099:missense_variant:MODERATE:exon11/12:c.911G>T:p.Arg304Leu:PF00620 [RhoGAP domain],PRR5-ARHGAP8:ENST00000361473:missense_variant:MODERATE:exon14/15:c.1304G>T:p.Arg435Leu:PF00620 [RhoGAP domain],ARHGAP8:ENST00000389773:missense_variant:MODERATE:exon14/15:c.1277G>T:p.Arg426Leu:PF00620 [RhoGAP domain],ARHGAP8:ENST00000389774:missense_variant:MODERATE:exon12/13:c.1004G>T:p.Arg335Leu:PF00620 [RhoGAP domain],ARHGAP8:ENST00000517296:missense_variant:MODERATE:exon16/17:c.1541G>T:p.Arg514Leu:PF00620 [RhoGAP domain]	ARHGAP8:NM_001017526.1:missense_variant:MODERATE:exon12/13:c.1004G>T:p.Arg335Leu:,ARHGAP8:NM_001198726.1:intron_variant:MODIFIER:intron10/10:c.878-2511G>T::,PRR5-ARHGAP8:NM_181334.5:missense_variant:MODERATE:exon14/15:c.1304G>T:p.Arg435Leu:,ARHGAP8:NM_181335.2:missense_variant:MODERATE:exon11/12:c.911G>T:p.Arg304Leu:						rs78823624	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0002,0.0000	3.9620	 ,T(0.08),T(0.10),T(0.07),T(0.07),T(0.11),T(0.08)	 ,B(0.04),P(0.89),B(0.28),B(0.28),B(0.10),B(0.04)	0.68,0.89	16.33	0.25					1	5	0 / 0					PRR5-ARHGAP8 (inh=n/a oe_syn=1.46 oe_mis=1.55 oe_lof=1.24), ARHGAP8 (inh=n/a oe_syn=1.63 oe_mis=1.64 oe_lof=1.34)
chr22	46773124	46773124	T	C	het	gene_blacklist	QUAL=1380;DP=100;AF=0.56;MQM=60;SAP=92;ABP=6	CELSR1	missense	CELSR1:ENST00000262738:missense_variant:MODERATE:exon24/35:c.7418A>G:p.Tyr2473Cys:PF00002 [7 transmembrane receptor (Secretin family)]	CELSR1:NM_014246.3:missense_variant:MODERATE:exon24/35:c.7418A>G:p.Tyr2473Cys:	regulatory_region_variant:promoter_flanking_region					rs73177077	0.0002	0.0001	0,.	0.0000,0.0000,0.0000,0.0002,0.0000	3.5150	D(0.01)	D(1.00)	0.90,0.97	24.40	0.36					0	7	0 / 0					CELSR1 (inh=n/a oe_syn=1.15 oe_mis=0.92 oe_lof=0.17)
chr22	50682446	50682446	T	C	het		QUAL=3374;DP=262;AF=0.50;MQM=60;SAP=5;ABP=3	TUBGCP6	missense	TUBGCP6:ENST00000248846:missense_variant:MODERATE:exon1/25:c.443A>G:p.Tyr148Cys:,TUBGCP6:ENST00000439308:missense_variant:MODERATE:exon1/25:c.443A>G:p.Tyr148Cys:	TUBGCP6:NM_020461.4:missense_variant:MODERATE:exon1/25:c.443A>G:p.Tyr148Cys:	regulatory_region_variant:promoter	610053 [GENE=TUBGCP6 PHENOS=Microcephaly and chorioretinopathy,autosomal recessive,1,251270,Autosomal recessive];				rs73187278	0.0002	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	7.5290	D(0.00),D(0.00)	D(1.00),D(1.00)	0.96,0.95	24.80	0.43					0	5	0 / 0					TUBGCP6 (inh=AR oe_syn=1.24 oe_mis=1.08 oe_lof=0.74), HDAC10 (inh=n/a oe_syn=1.15 oe_mis=1.06 oe_lof=1.17)
chrX	2853146	2853146	C	T	het		QUAL=2112;DP=195;AF=0.44;MQM=59;SAP=7;ABP=10	ARSL	synonymous	ARSL:ENST00000381134:synonymous_variant:LOW:exon11/11:c.1497G>A:p.Pro499=:PF14707 [C-terminal region of aryl-sulfatase],ARSL:ENST00000540563:synonymous_variant:LOW:exon10/10:c.1362G>A:p.Pro454=:PF14707 [C-terminal region of aryl-sulfatase],ARSL:ENST00000545496:synonymous_variant:LOW:exon12/12:c.1572G>A:p.Pro524=:PF14707 [C-terminal region of aryl-sulfatase]	ARSE:NM_000047.3:synonymous_variant:LOW:exon11/11:c.1497G>A:p.Pro499=:,ARSE:NM_001282628.1:synonymous_variant:LOW:exon12/12:c.1572G>A:p.Pro524=:,ARSE:NM_001282631.2:synonymous_variant:LOW:exon10/10:c.1335G>A:p.Pro445=:,ARSE:NM_001369079.1:synonymous_variant:LOW:exon11/11:c.1524G>A:p.Pro508=:,ARSE:NM_001369080.1:synonymous_variant:LOW:exon12/12:c.1572G>A:p.Pro524=:	regulatory_region_variant:promoter_flanking_region	300180 [GENE=ARSL PHENOS=Chondrodysplasia punctata,X-linked recessive,302950,X-linked recessive];				rs75821383	0.0005	0.0002	0,1	0.0004,0.0001,0.0000,0.0001,0.0000	-3.1160			0.01,0.08	0.03						1	6	0 / 0					ARSL (inh=XLR oe_syn=0.93 oe_mis=0.66 oe_lof=0.19)
chrX	10098055	10098055	C	T	het		QUAL=1847;DP=148;AF=0.50;MQM=60;SAP=20;ABP=3	WWC3	missense	WWC3:ENST00000380861:missense_variant:MODERATE:exon18/23:c.2492C>T:p.Pro831Leu:,WWC3:ENST00000454666:missense_variant:MODERATE:exon17/22:c.2492C>T:p.Pro831Leu:	WWC3:NM_015691.3:missense_variant:MODERATE:exon18/23:c.2492C>T:p.Pro831Leu:						rs55787431	0.0003	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.2050	T(0.13),T(0.13)	B(0.00),B(0.00)	0.35,0.30	12.44	0.05					1	6	0 / 1					WWC3 (inh=n/a oe_syn=1.03 oe_mis=0.81 oe_lof=0.07)
chrX	21900695	21900695	G	T	het		QUAL=1034;DP=78;AF=0.55;MQM=60;SAP=25;ABP=5	MBTPS2	synonymous	MBTPS2:ENST00000379484:synonymous_variant:LOW:exon11/11:c.1482G>T:p.Gly494=:PF02163 [Peptidase family M50]	MBTPS2:NM_015884.4:synonymous_variant:LOW:exon11/11:c.1482G>T:p.Gly494=:	regulatory_region_variant:promoter_flanking_region	300294 [GENE=MBTPS2 PHENOS=IFAP syndrome with or without BRESHECK syndrome,308205,X-linked recessive/Keratosis follicularis spinulosa decalvans,X-linked,308800,X-linked recessive/Osteogenesis imperfecta,type XIX,301014,X-linked recessive/Olmsted syndrome,X-linked,300918,X-linked recessive];				rs73195148	0.0003	0.0001		0.0000,0.0000,0.0000,0.0001,0.0000	1.6450			0.75,0.98	10.08						0	5	0 / 0					MBTPS2 (inh=XLR oe_syn=0.98 oe_mis=0.58 oe_lof=0.00)
chrX	63444310	63444310	C	T	het		QUAL=831;DP=171;AF=0.27;MQM=60;SAP=35;ABP=82	ASB12,MTMR8	missense	ASB12:ENST00000362002:missense_variant:MODERATE:exon3/3:c.862G>A:p.Val288Ile:PF07525 [SOCS box],ASB12:ENST00000396130:missense_variant:MODERATE:exon2/2:c.835G>A:p.Val279Ile:PF07525 [SOCS box],MTMR8:ENST00000453546:missense_variant:MODERATE:exon11/11:c.1987G>A:p.Val663Ile:PF07525 [SOCS box]	ASB12:NM_130388.4:missense_variant:MODERATE:exon3/3:c.862G>A:p.Val288Ile:						rs748815216	0.0003	0.0001	0,0	0.0001,0.0001,0.0001,0.0001,0.0001	0.4740	T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00)	0.02,0.93	10.63	0.03					0	5	0 / 0					ASB12 (inh=n/a oe_syn=0.90 oe_mis=1.23 oe_lof=0.85), MTMR8 (inh=n/a oe_syn=1.22 oe_mis=1.41 oe_lof=1.37)
chrX	134986656	134986656	A	G	het		QUAL=1216;DP=105;AF=0.49;MQM=59;SAP=15;ABP=3	SAGE1	missense	SAGE1:ENST00000324447:missense_variant:MODERATE:exon4/20:c.241A>G:p.Ile81Val:,SAGE1:ENST00000370709:missense_variant:MODERATE:exon3/19:c.241A>G:p.Ile81Val:,SAGE1:ENST00000535938:missense_variant:MODERATE:exon4/20:c.241A>G:p.Ile81Val:,SAGE1:ENST00000537770:missense_variant:MODERATE:exon4/12:c.241A>G:p.Ile81Val:	SAGE1:NM_018666.3:missense_variant:MODERATE:exon4/20:c.241A>G:p.Ile81Val:						rs73226720	0.0003	0.0001	0,0	0.0000,0.0000,0.0000,0.0001,0.0000	-1.1000	T(1.00),T(1.00),T(1.00),T(1.00)	B(0.00),B(0.00),B(0.00),B(0.00)	0.00,0.06	0.01	0.16					3	4	0 / 0					SAGE1 (inh=n/a oe_syn=1.01 oe_mis=1.06 oe_lof=0.95)
chrX	135067675	135067675	G	C	het		QUAL=527;DP=70;AF=0.37;MQM=60;SAP=30;ABP=13	SLC9A6	missense,intron	SLC9A6:ENST00000370695:missense_variant:MODERATE:exon1/16:c.14G>C:p.Gly5Ala:,SLC9A6:ENST00000370698:missense_variant:MODERATE:exon1/16:c.14G>C:p.Gly5Ala:,SLC9A6:ENST00000370701:intron_variant:MODIFIER:intron1/16:c.-57+39G>C::	SLC9A6:NM_001042537.1:missense_variant:MODERATE:exon1/16:c.14G>C:p.Gly5Ala:,SLC9A6:NM_001177651.2:intron_variant:MODIFIER:intron1/16:c.-57+39G>C::,SLC9A6:NM_001330652.2:intron_variant:MODIFIER:intron1/16:c.-57+44G>C::,SLC9A6:NM_006359.3:missense_variant:MODERATE:exon1/16:c.14G>C:p.Gly5Ala:	regulatory_region_variant:promoter,TF_binding_site_variant	300231 [GENE=SLC9A6 PHENOS=Mental retardation,X-linked syndromic,Christianson type,300243,X-linked dominant];			G-rich (Low_complexity)						2.0660	T(1.00),T(1.00), 	B(0.00),B(0.00), 	0.55,0.64	14.49	0.13					0	4	0 / 0					SLC9A6 (inh=AD oe_syn=0.96 oe_mis=0.50 oe_lof=0.04)
